| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABCB1 Haplotypes Are Associated With Lower P-Gp Activity and Major Molecular Response But Do Not Affect Imatinib Plasma Levels In Chronic Myeloid Leukemia Patients
|
Vivona, Douglas
|
|
|
122 |
21 |
p. 3860
|
artikel
|
| 2 |
ABC Expression As Additionally Marker To Monitoring Response In CML - A Preliminary Study
|
Alves, Raquel
|
|
|
122 |
21 |
p. 5183
|
artikel
|
| 3 |
Aberrant DNA Methylation Is Associated With Poor Outcomes In Juvenile Myelomonocytic Leukemia
|
Sakaguchi, Hirotoshi
|
|
|
122 |
21 |
p. 517
|
artikel
|
| 4 |
Aberrant Expression Of miRNA and mRNA Of Cell Cycle and Adhesion-Related Genes In Bone Marrow Stroma Cells Derived From Patients With Multiple Myeloma
|
Berenstein, Rimma
|
|
|
122 |
21 |
p. 3149
|
artikel
|
| 5 |
Aberrant G-CSFR Signaling in Congenital Neutropenia
|
Skokowa, Julia
|
|
|
122 |
21 |
p. SCI-45
|
artikel
|
| 6 |
Aberrant 5-Hydroxymethylcytosine Levels Correlate With Poor Overall Survival In Acute Myeloid Leukemia
|
Kroeze, Leonie I
|
|
|
122 |
21 |
p. 1261
|
artikel
|
| 7 |
Aberrant Megakaryocytic/Erythroid Progenitors Contributes To Transformation Of Cbfb-SMMHC Induced Acute Myeloid Leukemia
|
Cai, Qi
|
|
|
122 |
21 |
p. 1652
|
artikel
|
| 8 |
Aberrant Overexpression Of CD14 In Granulocytes Sensitizes Innate Immune Response In mDia1 Heterozygous Myelodysplastic Syndromes
|
Keerthivasan, Ganesan
|
|
|
122 |
21 |
p. 1557
|
artikel
|
| 9 |
Aberrant Splicing In Patients With AML Is Associated With Over- Expression Of Specific Splicing Factors
|
Adamia, Sophia
|
|
|
122 |
21 |
p. 3749
|
artikel
|
| 10 |
Aberrant Type-2-Lactosaminoglycan Synthesis Severely Impairs Thrombopoiesis
|
Giannini, Silvia
|
|
|
122 |
21 |
p. 2320
|
artikel
|
| 11 |
Aberrant Upregulation Of Alternatively Spliced Isoforms Of Son In Myeloid Leukemia: Implications In Hematopoiesis and Leukemogenesis
|
Kim, Jung-Hyun
|
|
|
122 |
21 |
p. 3731
|
artikel
|
| 12 |
Aberration Of SF3B1 Results In Deregulated Splicing Of Key Genes and Pathways In Myelodysplastic Syndromes
|
Dolatshad, Hamid
|
|
|
122 |
21 |
p. 2747
|
artikel
|
| 13 |
A Biomarker Assay For The Detection Of Contact System Activation
|
Faucette, Ryan R
|
|
|
122 |
21 |
p. 2347
|
artikel
|
| 14 |
A Biomarker-Based Grading System At Onset Of GvHD Predicts NRM Better Than The Modified Glucksberg Grading System
|
Levine, John E.
|
|
|
122 |
21 |
p. 145
|
artikel
|
| 15 |
A “Biomedical Analytics” Approach Suggests a Role For TNF Superfamily Signaling In Acquired Hemophilia Patients Who Do Not Respond To Rituximab Treatment
|
Smith, Keri Csencsits
|
|
|
122 |
21 |
p. 3592
|
artikel
|
| 16 |
A Bi-Specific T Cell Engaging Monoclonal Antibody (mAb) Derived From a TCR-Like Mab Specific For WT1/HLA-A0201 (ESK-BiTE) Shows a Potent Activity Against Human AML and Ph+ ALL In Mouse Models
|
Pankov, Dmitry
|
|
|
122 |
21 |
p. 2521
|
artikel
|
| 17 |
Abnormal Expression Of Shelterin Is Associated With Short Telomere and Immune Disorder In Severe Aplastic Anemia
|
Shao, Zonghong
|
|
|
122 |
21 |
p. 5562
|
artikel
|
| 18 |
Abnormal Expression Of The Major Coxsackie-Adenovirus Receptor CAR On Immature Dysplastic CD105+ Erythroid Progenitor Cells In Patients With MDS and Related Bone Marrow Neoplasms
|
Machherndl-Spandl, Sigrid
|
|
|
122 |
21 |
p. 2818
|
artikel
|
| 19 |
Abnormal Expression Of WT1-As, MEG3 and ANRIL Long Non-Coding RNAs In Primary Myelofibrosis and Their Clinical Correlates
|
Pennucci, Valentina
|
|
|
122 |
21 |
p. 2845
|
artikel
|
| 20 |
Abnormalities Of FAM46C, AHCYL1, CDC14A and CDKN2C Genes Located At Chromosome 1p Detected By QM-FISH Identifies Deletion Of 1p32.3 Covered CDKN2C Is An Independent Adverse Prognostic Marker In Multiple Myeloma
|
Li, Fei
|
|
|
122 |
21 |
p. 3145
|
artikel
|
| 21 |
Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children's Oncology Group Report
|
Hirsch, Betsy
|
|
|
122 |
21 |
p. 612
|
artikel
|
| 22 |
Abnormal Numbers Of Regulatory T Cell (Tregs) Subsets Are Sigificantly Associated With Adverse Disease Outcome In Lower Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
|
Braun, Thorsten
|
|
|
122 |
21 |
p. 2785
|
artikel
|
| 23 |
Abnormal Reproductive Measures and Seminal Plasma Findings in Men With Thalassemia Major (TM) and Iron Overload
|
Titi Singer, Sylvia
|
|
|
122 |
21 |
p. 4707
|
artikel
|
| 24 |
ABO Blood Group Mismatch Does Not Affect Survival Or Transfusion Requirements In Patients Undergoing Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation
|
Brierley, Charlotte K
|
|
|
122 |
21 |
p. 3352
|
artikel
|
| 25 |
ABO Group As a Thrombotic Risk Factor In Children With Acute Lymphoblastic Leukemia: A Retrospective Study Of 523 Pediatric Patients
|
Mizrahi, Terry
|
|
|
122 |
21 |
p. 2370
|
artikel
|
| 26 |
A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results
|
Koreth, John
|
|
|
122 |
21 |
p. 3335
|
artikel
|
| 27 |
ABR, a Novel Inducer Of Transcription Factor C/EBPα, Is Necessary For Myeloid Differentiation and a Prognostic Factor In Acute Myeloid Leukemia
|
Namasu, Carolina Yaeko
|
|
|
122 |
21 |
p. 3814
|
artikel
|
| 28 |
Absence Of BRAF and KRAS Hotspot Mutations In Primary Mediastinal and Other Diffuse Large B-Cell Lymphoma
|
Nagel, Philipp D
|
|
|
122 |
21 |
p. 4325
|
artikel
|
| 29 |
Absence Of Mutation In Cereblon (CRBN) and DNA Damage Binding Protein 1 (DDB1) Genes In Myeloma Cells and Patients and Its Clinical Significance
|
Thakurta, Anjan
|
|
|
122 |
21 |
p. 3139
|
artikel
|
| 30 |
Absence Of The E3 Ubiquitin Ligase SKP2 Attenuates Notch-Induced T-Cell Leukemogenesis
|
Rodriguez-Rodriguez, Sonia
|
|
|
122 |
21 |
p. 1272
|
artikel
|
| 31 |
Absolute Monocyte Count and Serum CD14 As Prognostic Markers In Chronic Lymphocytic Leukemia
|
Friedman, Daphne R.
|
|
|
122 |
21 |
p. 5297
|
artikel
|
| 32 |
Absolute Monocyte Count Trichotomizes Chronic Lymphocytic Leukemia Into High Risk Patients With Immune Dysregulation, Disease Progression and Poor Survival
|
Herishanu, Yair
|
|
|
122 |
21 |
p. 4724
|
artikel
|
| 33 |
Absolute T Cell Counts At Diagnosis Predict Absolute Lymphocyte Counts Throughout Therapy For Pediatric Acute Lymphoblastic Leukemia: Evidence For Age-Related Loss Of T Cells and Poor Outcome
|
Boston, Catherine H.
|
|
|
122 |
21 |
p. 2599
|
artikel
|
| 34 |
Absolut Lymphocyte Count At Diagnosis Is Predictive Of Survival In Patients With Classical Hodgkin Lymphoma: A Retrospective Multicenter Brazilian Study
|
Perini, Guilherme Fleury
|
|
|
122 |
21 |
p. 4236
|
artikel
|
| 35 |
ABT-888 Plus Bendamustine Is Safe and Has Shown Preliminary Efficacy In Patients With Lymphoma
|
Gerecitano, John F.
|
|
|
122 |
21 |
p. 4366
|
artikel
|
| 36 |
ABT-737 Restores Prednisolone Sensitivity In Early T-Cell Precursor Acute Lymphoblastic Leukemia With High MEF2C Expression
|
Goto, Sachiko
|
|
|
122 |
21 |
p. 3830
|
artikel
|
| 37 |
A Canadian Blood and Marrow Transplant Group (CBMTG) Randomised Trial Comparing G-CSF Mobilized Peripheral Blood Versus G-CSF Stimulated Bone Marrow In Recipients Of Sibling Allografts For Hematologic Malignancies
|
Couban, Stephen
|
|
|
122 |
21 |
p. 709
|
artikel
|
| 38 |
A Carboxy-Terminally Truncated G-CSF Receptor Abolishes Apoptosis Induction By Neutrophil Elastase G185R Mutant In Myeloid Cells,
|
Dong, Fan
|
|
|
122 |
21 |
p. 443
|
artikel
|
| 39 |
A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia
|
Aljawai, Yosra
|
|
|
122 |
21 |
p. 1713
|
artikel
|
| 40 |
ACase Of Asymptomatic Pediatric Chronic MyelogenousLeukemia With Hyperleukocytosis
|
Berger, David A
|
|
|
122 |
21 |
p. 5198
|
artikel
|
| 41 |
A Case Of Refractory Autoimmune Hemolytic Anemia In a Patient With Digeorge Syndrome Treated Successfully With Plasma Exchange
|
Damlaj, Moussab
|
|
|
122 |
21 |
p. 4829
|
artikel
|
| 42 |
A Case Of Vitamin C Deficiency Manifesting With Easy Bruising: Suggestion For a Supplementation Protocol
|
Zaidi, Aisha
|
|
|
122 |
21 |
p. 4743
|
artikel
|
| 43 |
A Case Series Of Continuous Low Dose Lenalidomide In Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma
|
Sawas, Ahmed
|
|
|
122 |
21 |
p. 5134
|
artikel
|
| 44 |
Acceptable Results Of Allo-HSCT From Unrelated Donors In AML Patients Who Failed To Achieve The Complete Remission
|
Markiewicz, Miroslaw
|
|
|
122 |
21 |
p. 5520
|
artikel
|
| 45 |
Access To Therapeutic Surgical Procedures For Pathologic Fractures In Multiple Myeloma Patients: Analysis of Nationwide Inpatient Sample (NIS)
|
Shah, Nishi N
|
|
|
122 |
21 |
p. 1709
|
artikel
|
| 46 |
Accrual Of Patients With Relapsed and Refractory DLBCL Onto Clinical Trials
|
Marton, Ashley
|
|
|
122 |
21 |
p. 3041
|
artikel
|
| 47 |
Accumulation Of Gene Alterations Of TP53, Crebbp and IKZF1 Is a Prognostic Factor In Adult Acute Lymphoblastic Leukemia
|
Tokunaga, Kenji
|
|
|
122 |
21 |
p. 1386
|
artikel
|
| 48 |
Accuracy Of Adverse Event Reporting Compared To Patient Chart Abstraction On a Phase III NCI-Funded Clinical Trial For Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group
|
Miller, Tamara P.
|
|
|
122 |
21 |
p. 931
|
artikel
|
| 49 |
Accurate Classification Of GCB/ABC and MYC/BCL2 Diffuse Large B-Cell Lymphoma With a 14 Genes Expression Signature and a Simple and Robust RT-MLPA Assay
|
Ruminy, Philippe
|
|
|
122 |
21 |
p. 84
|
artikel
|
| 50 |
Accurate Detection Of Renal Involvement In Pediatric Patients With Acute Lymphoblastic Leukemia By Utilizing 3D-Reconstruction Models Of Enhanced CT and Its Clinical Implications
|
Fujiki, Toshihiro
|
|
|
122 |
21 |
p. 4991
|
artikel
|
| 51 |
Accurate Needle Placement - A Must For a Safe and Effective Bone Marrow Biopsy Procedure: An Anatomical and CT Based Cadaver Study
|
Pathak, Swati
|
|
|
122 |
21 |
p. 1752
|
artikel
|
| 52 |
A CD19/CD3 Bispecific Tandab, AFM11, Recruits T Cells To Potently and Safely Kill CD19+ Tumor Cells
|
Zhukovsky, Eugene
|
|
|
122 |
21 |
p. 4405
|
artikel
|
| 53 |
A Cell-Based High-Throughput Screen For Novel Inducers Of Fetal Hemoglobin For Treatment Of Sickle Cell Disease, Cooley's Anemia and β-Thalassemias
|
Peterson, Kenneth R
|
|
|
122 |
21 |
p. 925
|
artikel
|
| 54 |
Achievement and Maintenance Of Deeper Molecular Response By Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Residual Disease On Long-Term Imatinib: ENESTcmr 36-Month Follow-Up
|
Leber, Brian
|
|
|
122 |
21 |
p. 94-95
|
artikel
|
| 55 |
Achievement Of a MR5.0 Within the Randomized CML-Study IV: Feasibility, Differences Between Treatment Arms, and Prognostic Implications
|
Müller, Martin C.
|
|
|
122 |
21 |
p. 4008
|
artikel
|
| 56 |
Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience
|
Minauchi, Koichiro
|
|
|
122 |
21 |
p. 2697
|
artikel
|
| 57 |
A Cohort Study Of 15,912 Patients On The Long-Term Quality Of Vka Therapy After Extreme Overanticoagulation
|
Kooistra, Hilde A.M.
|
|
|
122 |
21 |
p. 2384
|
artikel
|
| 58 |
A Combined Molecular and Clinical Prognostic Index For Relapse and Survival In Cytogenetically Normal AML (PINA)
|
Pastore, Friederike
|
|
|
122 |
21 |
p. 1303
|
artikel
|
| 59 |
A Comparative Analysis Of Next-Generation Sequencing and Real-Time Quantitative PCR For Minimal Residual Disease Detection In Follicular Lymphomas
|
Pott, Christiane
|
|
|
122 |
21 |
p. 4293
|
artikel
|
| 60 |
A Comparative Study Of The Outcome Of Isolated Chromosome 13q and Clonal Progression Detected By I-FISH Do Additional Cytogenetic Abnormalities Impact Survival In Multiple Myeloma
|
Peres, Edward
|
|
|
122 |
21 |
p. 2160
|
artikel
|
| 61 |
A Comparison Between Next-Generation Sequencing and ASO-qPCR For Minimal Residual Disease Detection In Multiple Myeloma: The Clinical Value In ASCT Setting
|
Takamatsu, Hiroyuki
|
|
|
122 |
21 |
p. 1843
|
artikel
|
| 62 |
A Comparison Of Acute Myelogenous Leukemia Induction Therapies: High Dose Daunorubicin Vs Idarubicin
|
Ho, Viet Q.
|
|
|
122 |
21 |
p. 3951
|
artikel
|
| 63 |
A Comparison Of Hemostatic and Inflammatory Markers In Overt and Non-Overt DIC
|
Hoppensteadt, Debra
|
|
|
122 |
21 |
p. 3577
|
artikel
|
| 64 |
A Comparison Of Long-Term Outcomes Of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors In CML Patients Relapsed After Allogeneic Hemopoietic Stem Cell Transplantation
|
Shanavas, Mohamed
|
|
|
122 |
21 |
p. 5501
|
artikel
|
| 65 |
A Comparison Of Sickle Cell Anemia Between Patients From Nigeria and The United States
|
Saraf, Santosh L.
|
|
|
122 |
21 |
p. 997
|
artikel
|
| 66 |
A Complex Molecular Network Controls Palmitoylation-Dependant CD95 Sensitivity Of CLL Cells
|
Berg, Valeska
|
|
|
122 |
21 |
p. 4148
|
artikel
|
| 67 |
Acquired Factor VIII Inhibitor: A Single Institution Experience With 62 Patients
|
Wysokinska, Ewa M.
|
|
|
122 |
21 |
p. 3610
|
artikel
|
| 68 |
Acquired Hemophagocytic Lymphohistiocytosis Among Adults: A Single Center Experience
|
Khawaja, Muhammad Rizwan
|
|
|
122 |
21 |
p. 2277
|
artikel
|
| 69 |
Acquired Hemophilia A. Experience Of a Single Center
|
Alzate, Mauricio A
|
|
|
122 |
21 |
p. 4781
|
artikel
|
| 70 |
Acquired Stem Cell Properties In Therapy-Induced Senescence Of Lymphomas and Acute Leukemias In Vitro and In Vivo
|
Däbritz, J. Henry M.
|
|
|
122 |
21 |
p. 4193
|
artikel
|
| 71 |
Acquired Von Willebrand Disease – To Treat Or Not To Treat The Inhibitor?
|
Shah, Surbhi
|
|
|
122 |
21 |
p. 4744
|
artikel
|
| 72 |
Acquired Von Willebrand Factor Deficiency Caused By Left Ventricular Assist Devices Is Adamts-13 Dependent
|
Jilma-Stohlawetz, Petra
|
|
|
122 |
21 |
p. 3602
|
artikel
|
| 73 |
Acquired Whim Syndrome: A Possible New Side Effect Of Dasatinib!
|
Yadav, Satya Prakash
|
|
|
122 |
21 |
p. 4933
|
artikel
|
| 74 |
Acquisition Of Compound BCR-ABL1 Alleles As A Mechanism Of Resistance To Ponatinib In Chronic Myeloid Leukemia
|
Gibbons, Don L
|
|
|
122 |
21 |
p. 853
|
artikel
|
| 75 |
AC220 (Quizartinib) Can Be Safely Combined With Conventional Chemotherapy In Older Patients With Newly Diagnosed Acute Myeloid Leukaemia: Experience From The AML18 Pilot Trial
|
Burnett, Alan K.
|
|
|
122 |
21 |
p. 622
|
artikel
|
| 76 |
Actin and Myosin-II Inhibition Increase Megakaryocyte Proplatelet Formation Through a Caspase Dependent Mechanism
|
Avanzi, Mauro P.
|
|
|
122 |
21 |
p. 3652
|
artikel
|
| 77 |
Activated Factor VII–Antithrombin Complex Plasma Concentration Is An Independent Predictor Of Total and Cardiovascular Mortality In Patients With Coronary Artery Disease and Its Prognostic Significance Is Improved By Using Factor VII Genotype-Specific Threshold Levels
|
Martinelli, Nicola
|
|
|
122 |
21 |
p. 2339
|
artikel
|
| 78 |
Activated Protein C Levels Found In Trauma Patients Are Insufficient To Inactivate Platelet Factor Va and Produce Coagulopathy In An In Vitro Model
|
Meledeo, Michael A
|
|
|
122 |
21 |
p. 4767
|
artikel
|
| 79 |
Activated Sumoylation Is a Hallmark Of Burkitt's Lymphoma and MYC Driven Cancer Leading To Synthetic Lethal Interactions With Sumoylation Inhibitors
|
Hoellein, Alexander
|
|
|
122 |
21 |
p. 3783
|
artikel
|
| 80 |
Activating FLT3 Mutations Display a Wide Range Of Transforming Potential and a Characteristic Pathway Profile Associated With Prognosis In Acute Myeloid Leukemia
|
Janke, Hanna
|
|
|
122 |
21 |
p. 1312
|
artikel
|
| 81 |
Activating Individual αIIbβ3 Molecules Using An Anti-αIIb-Transmembrane Domain Peptide Causes αIIbβ3 Oligomerization and αIIbβ3-Mediated Outside-In Signaling
|
Zhu, Hua
|
|
|
122 |
21 |
p. 3506
|
artikel
|
| 82 |
Activating Mutations In Fyn Kinase In Peripheral T-Cell Lymphomas
|
Couronne, Lucile
|
|
|
122 |
21 |
p. 811
|
artikel
|
| 83 |
Activation Induced Cytidine Deaminase-Associated DNA Repair Pathways Influence Germinal Center B Cell Lymphomagenesis
|
Gu, Xiwen
|
|
|
122 |
21 |
p. 1247
|
artikel
|
| 84 |
Activation Of Akt Enhances Ribosomal RNA Synthesis In AML Cells Through a Novel Isoform Of TIF-1A and Inhibition Of Filamin A Cleavage
|
Truong Nguyen, Le Xuan
|
|
|
122 |
21 |
p. 1266
|
artikel
|
| 85 |
Activation Of Autophagy By Bone Marrow Adipocytes Protects Myeloma Cells From Chemotherapy-Induced Apoptosis
|
Yang, Jing
|
|
|
122 |
21 |
p. 1915
|
artikel
|
| 86 |
Activation Of Dendritic Cells In The Umbilical Cord Blood Can Improve The Autologous NK Cytotoxic Activity
|
Wang, Jian
|
|
|
122 |
21 |
p. 5436
|
artikel
|
| 87 |
Activation Of EphrinB2/EphB4 Influences Myeloid Leukemia Cell Migration and Invasion
|
Zhou, Xuan
|
|
|
122 |
21 |
p. 1360
|
artikel
|
| 88 |
Activation Of Natural Killer Cells By Soypeptide Lunasin and Cytokine: Implication In Cancer Immunotherapy For Lymphoma
|
Tung, Chun-Yu
|
|
|
122 |
21 |
p. 1042
|
artikel
|
| 89 |
Activation Of p53 By MDM2-Inhibition Sensitizes Quiescent Blast Crisis CML Stem/Progenitor Cells To Bcl-2 Inhibitor- and Tyrosine Kinase Inhibitor-Induced Cell Death
|
Carter, Bing Z
|
|
|
122 |
21 |
p. 1476
|
artikel
|
| 90 |
Activation Of TAK1 By MYD88 L265P Drives Malignant B Cell Growth In Non-Hodgkin Lymphomas
|
Ansell, Stephen M
|
|
|
122 |
21 |
p. 245
|
artikel
|
| 91 |
Activation Of TLR4-MyD88 Pathway Impairs HSC Function During Acute Inflammation
|
Zhang, Huajia
|
|
|
122 |
21 |
p. 2431
|
artikel
|
| 92 |
Activation-Resistant Homozygous Protein C R229W Mutation Causing Familial Perinatal Intracranial Hemorrhage
|
Alsultan, Abdulrahman
|
|
|
122 |
21 |
p. 3587
|
artikel
|
| 93 |
Activities and Mechanism Based Combinations Of Omacetaxine In Acute Myeloid Leukemia
|
Chen, Rong
|
|
|
122 |
21 |
p. 1288
|
artikel
|
| 94 |
Activities Of Commonly Used Tyrosine Kinase Inhibitors Against Wild-Type C-KIT and Potential Impact On Normal Hematopoiesis
|
Galanis, Allison
|
|
|
122 |
21 |
p. 3846
|
artikel
|
| 95 |
Activity Of a JAK1/JAK2 Inhibitor In a Patient With KIT-Mutated Systemic Mastocytosis (SM) Associated With Myelofibrosis
|
Santos, Fabio P S
|
|
|
122 |
21 |
p. 5246
|
artikel
|
| 96 |
Activity Of Omacetaxine Mepesuccinate Against Ponatinib Resistant Philadelphia Chromosome Positive Leukemia Cells
|
Okabe, Seiichi
|
|
|
122 |
21 |
p. 3840
|
artikel
|
| 97 |
Activity Of Single Agent Temsirolimus and Associated Impact On Bone Marrow Vascularization and T-Cell Composition In Patients With Myelodysplastic Syndromes – Result Of The Prospective Temds Trial Of The German MDS-SG
|
Wermke, Martin
|
|
|
122 |
21 |
p. 2808
|
artikel
|
| 98 |
Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation
|
Mensen, Angela
|
|
|
122 |
21 |
p. 4605
|
artikel
|
| 99 |
Acute Cholecystitis Occurs More Commonly Than Expected Following Allogeneic Hematopoietic Stem Cell Transplantation and Is Ineffectively Diagnosed Using Abdominal Ultrasound
|
Bagley, Stephen J.
|
|
|
122 |
21 |
p. 2046
|
artikel
|
| 100 |
Acute Differentiation Syndrome Is a Biological Consequence Of Treatment With Azanucleoside In Isocitrate Dehydrogenase-1 (IDH-1) and SFR2mutated Myelodysplasia Derived Acute Myelogenous Leukemia
|
Rivero, Gustavo A.
|
|
|
122 |
21 |
p. 4982
|
artikel
|
| 101 |
Acute Inflammatory Processes Are Induced By Hemolysis and Reversed By Hydroxyurea
|
Almeida, Camila Bononi
|
|
|
122 |
21 |
p. 951
|
artikel
|
| 102 |
Acute Lymphoblastic Leukemia (ALL) With Low-Hypodiploid/Near-Triploid Karyotype Is a Specific Clinical Entity Characterized By a High TP53 Mutation Frequency
|
Patterer, Verena
|
|
|
122 |
21 |
p. 615
|
artikel
|
| 103 |
Acute Lymphoblastic Leukemia Is a Bcl-2 Dependent Disease: Proteomic Profiling and Pre-Clinical Efficacy Of a Selective Bcl-2 Antagonist ABT-199
|
Konopleva, Marina
|
|
|
122 |
21 |
p. 3919
|
artikel
|
| 104 |
Acute Lymphoblastic Leukemia Treated With Modified Hyper C-VAD Protocol In Iran
|
Jalaeikho, Hassan
|
|
|
122 |
21 |
p. 5014
|
artikel
|
| 105 |
Acute Myeloid Leukemia Alters The Mesenchymal Stem Cell Potential Of The HSC Niche: Evidence For Modulation By β-Adrenergic Signals
|
Hanoun, Maher
|
|
|
122 |
21 |
p. 342
|
artikel
|
| 106 |
Acute Myeloid Leukemia Diagnosed During Pregnancy: Facing Challenges. Systematic Review and Analysis Of 174 Reported Cases
|
Henig, Israel
|
|
|
122 |
21 |
p. 1421
|
artikel
|
| 107 |
Acute Myeloid Leukemia In Patient Over 90 Years Old: Where Do We Go From Here? Case Report
|
Bellesso, Marcelo
|
|
|
122 |
21 |
p. 5034
|
artikel
|
| 108 |
Acute Myeloid Leukemia: Pretreatment Biochemical and Clinical Variables Predictive For Risk Status Based On Validated Cytogenetic and Molecular Abnormalities
|
Srour, Samer A
|
|
|
122 |
21 |
p. 4962
|
artikel
|
| 109 |
Acute Myeloid Leukemia Survival In Elderly Patients In The United States
|
Shah, Binay K.
|
|
|
122 |
21 |
p. 1690
|
artikel
|
| 110 |
Acute Myeloid Leukemia: The Outcome Is Determined By Age, Genetic Group, White Blood Cell Count, Lactate Dehydrogenase, Rather Than By Chemotherapy Intensity
|
Buchner, Thomas
|
|
|
122 |
21 |
p. 1447
|
artikel
|
| 111 |
Acute Myeloid Leukemia With Isolated Trisomy 13 Is a Genetically Homogenous Entity With a High Frequency Of Mutations In Genes Encoding Components Of The Splicing Machinery and Extremely Poor Prognosis
|
Herold, Tobias
|
|
|
122 |
21 |
p. 608
|
artikel
|
| 112 |
Acute Myeloid Leukemia With t(8;21)/RUNX1-RUNX1T1 demonstrate a High Number Of Secondary Genetic Lesions: Frequency and Impact On Clinical Outcome
|
Theresa Krauth, Maria
|
|
|
122 |
21 |
p. 2565
|
artikel
|
| 113 |
Acute Promyelocytic Leukemia In Canada: Poor Outcomes In Older Patients Remain
|
Seftel, Matthew D.
|
|
|
122 |
21 |
p. 1714
|
artikel
|
| 114 |
Acute Treatment Of Pulmonary Embolism With Rivaroxaban - Real Life Data From The Prospective Dresden Noac Registry (NCT01588119)
|
Köhler, Christina
|
|
|
122 |
21 |
p. 2380
|
artikel
|
| 115 |
ACY-1215, a First-In-Class Selective Inhibitor Of HDAC6, Demonstrates Significant Synergy With Immunomodulatory Drugs (IMiDs) In Preclinical Models Of Multiple Myeloma (MM)
|
Quayle, Steven N
|
|
|
122 |
21 |
p. 1952
|
artikel
|
| 116 |
ACY-1215, a Selective Histone Deacetylase (HDAC) 6 Inhibitor, In Combination With Lenalidomide and Dexamethasone (dex), Is Well Tolerated Without Dose Limiting Toxicity (DLT) In Patients (Pts) With Multiple Myeloma (MM) At Doses Demonstrating Biologic Activity: Interim Results Of a Phase 1b Trial
|
Yee, Andrew
|
|
|
122 |
21 |
p. 3190
|
artikel
|
| 117 |
ACY-1215, a Selective Histone Deacetylase (HDAC) 6 Inhibitor: Interim Results Of Combination Therapy With Bortezomib In Patients With Multiple Myeloma (MM)
|
Raje, Noopur
|
|
|
122 |
21 |
p. 759
|
artikel
|
| 118 |
A Cyclopropane-Derived Stable Analog Of Fd-895 Induces Apoptosis and Inhibition Of mRNA Splicing In Lymphoma and Chronic Lymphocytic Leukemia: A Novel Therapeutic Approach
|
Kumar, Deepak
|
|
|
122 |
21 |
p. 2884
|
artikel
|
| 119 |
ADAM28 Metalloprotease Domain Is Sufficient For Proteolytic Cleavage Of Von Willlebrand Factor
|
Hanby, Hayley A.
|
|
|
122 |
21 |
p. 1087
|
artikel
|
| 120 |
ADAMTS13 Expressed In Glioblastoma and Astrocytoma Cells Can Modulate Endothelial Cell Migration
|
Lee, Manfai
|
|
|
122 |
21 |
p. 2306
|
artikel
|
| 121 |
ADAMTS13 Expressed In Platelets Offers Systemic Protection Against Arterial Thrombosis and Therapeutic Benefits In Murine Models Of Thrombotic Thrombocytopenic Purpura
|
Pickens, Brandy
|
|
|
122 |
21 |
p. 446
|
artikel
|
| 122 |
Adamts-18 Is a Novel Candidate Gene Of Vascular Development That Is Related To Aggravated Thrombosis: Evidence From a Adamts-18 Knock Out Mice
|
Zhang, Wei
|
|
|
122 |
21 |
p. 31
|
artikel
|
| 123 |
ADARB1 Is Involved In a Reduced Maturation Of The miR15a/Mir-16-1 Family In Chronic Lymphocytic Leukemia
|
Mertens, Daniel
|
|
|
122 |
21 |
p. 1252
|
artikel
|
| 124 |
ADAR1 Is Essential For Erythroid Development
|
Liddicoat, Brian
|
|
|
122 |
21 |
p. 9
|
artikel
|
| 125 |
Adding The KIT Inhibitor Dasatinib (DAS) To Standard Induction and Consolidation Therapy For Newly Diagnosed Patients (pts) With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): Initial Results Of The CALGB 10801 (Alliance) Study
|
Marcucci, Guido
|
|
|
122 |
21 |
p. 357
|
artikel
|
| 126 |
Additional BCR-ABL1 Mutations Identified By Sensitive Mass Spectrometry In Chronic Phase CML Patients With T315I Treated With Ponatinib Are Associated With Relatively Inferior Responses and Outcome
|
Parker, Wendy T
|
|
|
122 |
21 |
p. 651
|
artikel
|
| 127 |
Addition Of Clarithromycin To Lenalidomide and Dexamethasone (BiRd) Is Effective In Multiple Myeloma After Progression On Lenalidomide and Dexamethasone
|
Ghosh, Nilanjan
|
|
|
122 |
21 |
p. 1960
|
artikel
|
| 128 |
A Decade Of Imatinib As First-Line Treatment Of Chronic Myeloid Leukemia: A Single - Latin American Institution Experience
|
Garcia, Alvaro Cabrera
|
|
|
122 |
21 |
p. 5194
|
artikel
|
| 129 |
A Deletion Of About 11kb Starting From 0.5 Kb 5' To The β-Globin Gene Reactivates Foetal Haemoglobin and Leads To β Thalassemia Intermedia When Associated To a β-Zero Thalassemic Mutation
|
Beris, Photis
|
|
|
122 |
21 |
p. 4702
|
artikel
|
| 130 |
Adenosine Inhibits Pro-Inflammatory Thrombin Signaling In Endothelial Cells
|
Hassanian, Seyed Mahdi
|
|
|
122 |
21 |
p. 1064
|
artikel
|
| 131 |
Adenosine Is A Common Factor Regulating Erythrocyte 2,3-Bisphosphate Induction In Normal Individuals At High Altitude and In Patients With Sickle Cell Disease
|
Zhang, Yujin
|
|
|
122 |
21 |
p. 952
|
artikel
|
| 132 |
Adhesion Of Acute Myeloid Leukemia Blasts To E-Selectin In The Vascular Niche Enhances Their Survival By Mechanisms Such As Wnt Activation
|
Chien, Sylvia
|
|
|
122 |
21 |
p. 61
|
artikel
|
| 133 |
A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine
|
Oelschlaegel, Uta
|
|
|
122 |
21 |
p. 2780
|
artikel
|
| 134 |
Adjusting For Drug Wastage In Economic Evaluations Of New Therapies For Hematologic Malignancies: A Systematic Review Of The Literature and Implications
|
Cheung, Matthew C.
|
|
|
122 |
21 |
p. 2928
|
artikel
|
| 135 |
Administration Of An Oral PDE5 Inhibitor, Tadalafil In Conjunction With a Lenalidomide Containing Regimen In Patients With Multiple Myeloma
|
Ghosh, Nilanjan
|
|
|
122 |
21 |
p. 1959
|
artikel
|
| 136 |
Administration Of Anti-CD20 Mab Is Highly Effective In Preventing But Ineffective In Treating Chronic GVHD While Preserving A Strong GVL Effect
|
Johnston, Heather F
|
|
|
122 |
21 |
p. 2010
|
artikel
|
| 137 |
Administration Of E-Selectin Antagonist GMI-1271 Improves Survival After High-Dose Chemotherapy By Alleviating Mucositis and Accelerating Neutrophil Recovery
|
Winkler, Ingrid G
|
|
|
122 |
21 |
p. 2266
|
artikel
|
| 138 |
Admixture In Sickle Cell Disease Defined By Genome Wide Ancestry Informative Markers Varies By Geographic Region In The United States
|
Wang, Zhengyuan
|
|
|
122 |
21 |
p. 995
|
artikel
|
| 139 |
Adolescents and Young Adults With Hemophagocytic Lymphohistiocytosis Who Undergo Allogeneic Hematopoietic Cell Transplantation Are At Increased Risk Of Mortality Compared To Younger Patients
|
Chandrakasan, Shanmuganathan
|
|
|
122 |
21 |
p. 2087
|
artikel
|
| 140 |
A Dominant-Negative GFI1B Mutation in Gray Platelet Syndrome
|
Van der Reijden, Bert A.
|
|
|
122 |
21 |
p. LBA-3
|
artikel
|
| 141 |
Adoptive Immunotherapy Following Umbilical Cord Blood Transplantation Using The Sleeping Beauty System and Artificial Antigen Presenting Cells To Generate Donor-Derived T Cells Expressing a CD19-Specific Chimeric Antigen Receptor
|
Kebriaei, Partow
|
|
|
122 |
21 |
p. 4208
|
artikel
|
| 142 |
Adoptive Immunotherapy With Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy In Patients With Chronic Lymphocytic Leukemia
|
Schuster, Stephen J.
|
|
|
122 |
21 |
p. 2874
|
artikel
|
| 143 |
Adoptive Transfer Of Ex Vivo “Educated” CD4+CD25+FoxP3+ Regulatory T Cells Effectively Treats Acute Graft Versus Host Disease Preserving Graft Versus Tumor Effect
|
Pierini, Antonio
|
|
|
122 |
21 |
p. 4485
|
artikel
|
| 144 |
Adoptive Transfer Of WT-1 Specific HLA Class 2 Restricted Donor-Derived T-cells Induces Sustained Remission Of AML Relapse Post Transplant Presenting As Leukemia Cutis
|
Prockop, Susan E.
|
|
|
122 |
21 |
p. 2085
|
artikel
|
| 145 |
Adoptive Treatment Of EBV-Associated Leiomyosarcoma In Immunodeficient Patients With EBV Specific Cytotoxic T Cells
|
Prockop, Susan E.
|
|
|
122 |
21 |
p. 3267
|
artikel
|
| 146 |
Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis
|
Iacobucci, Ilaria
|
|
|
122 |
21 |
p. 2622
|
artikel
|
| 147 |
Adult T-Cell Leukemia/Lymphoma Cells Were Eliminated By T Cells With Anti-CD38 Chimeric Antigen Receptor Through CD38 Expression Induced By All-Trans Retinoic Acid
|
Yoshida, Tetsumi
|
|
|
122 |
21 |
p. 1824
|
artikel
|
| 148 |
Advanced Extramedullary Hematopoiesis In a Transplanted Liver Graft As Initial Presentation Of Primary Myelofibrosis
|
Yacoub, Abdulraheem
|
|
|
122 |
21 |
p. 5256
|
artikel
|
| 149 |
Adverse Cytogenetic Abnormalities At Diagnosis Are The Most Important Predictor Of Relapse Post T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Advanced Myelodysplastic Syndrome (MDS)
|
Tamari, Roni
|
|
|
122 |
21 |
p. 3379
|
artikel
|
| 150 |
Adverse Events (AE) Under Imatinib Treatment Over 10 Years: Results From 1501 Patients Of The Randomized CML-Study IV
|
Hehlmann, Rüdiger
|
|
|
122 |
21 |
p. 4012
|
artikel
|
| 151 |
Adverse Events During Intensive Induction Chemotherapy For Acute Myeloid Leukemia (AML) Or High-Grade Myelodysplastic Syndromes (MDS)
|
Buckley, Sarah A.
|
|
|
122 |
21 |
p. 3899
|
artikel
|
| 152 |
Adverse Impact Of Elevated Pretransplantation Serum Ferritin Levels On Survival and Nonrelapse Mortality After Allogeneic Hematopoietic Stem Cell Transplantation In Children
|
Kondo, Osamu
|
|
|
122 |
21 |
p. 2168
|
artikel
|
| 153 |
Adverse Pregnancy Outcomes In High Risk Sickle Cell Women
|
Saraf, Pankhoori
|
|
|
122 |
21 |
p. 2218
|
artikel
|
| 154 |
Adverse Prognosis Of Extramedullary Disease In Patients With Chronic Myeloid Leukemia (CML) In The Tyrosine Kinase Inhibitor (TKI) Era: a Cohort Study Of 283 Blastic Phase CML Patients
|
Chae, Young Kwang
|
|
|
122 |
21 |
p. 2724
|
artikel
|
| 155 |
A Dynamic Alternative Splicing Program Regulates Gene Expression In A Differentiation Stage-Specific Manner During Terminal Erythropoiesis
|
Pimentel, Harold
|
|
|
122 |
21 |
p. 3413
|
artikel
|
| 156 |
A Family Of G-Rich Genomic Sequences Iinteract Specifically With The Pu27 Silencer Element Of The c-Myc Promoter
|
Thomas, Shelia
|
|
|
122 |
21 |
p. 1264
|
artikel
|
| 157 |
AF10 Fusion Transcripts Are Identified By HOXA9/10 and MEIS1 Overexpression In T-ALL: A Report From Children's Oncology Group AALL0434
|
Matlawska-Wasowska, Ksenia
|
|
|
122 |
21 |
p. 2601
|
artikel
|
| 158 |
A First In Human Dose Escalation Study Of CC-122, A First-In-Class Pleiotropic Pathway Modulator™ (PPM) Compound In Subjects With Relapsed Or Refractory Solid Tumors, Multiple Myeloma and Non-Hodgkin's Lymphoma
|
Rasco, Drew W
|
|
|
122 |
21 |
p. 2905
|
artikel
|
| 159 |
A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma
|
Borate, Uma
|
|
|
122 |
21 |
p. 1437
|
artikel
|
| 160 |
A First-In-Man Phase 1 Study Of CUDC-907, a First-In-Class Chemically-Designed Dual Inhibitor Of PI3K and HDAC In Patients With Refractory Or Relapsed Lymphoma and Multiple Myeloma
|
Younes, Anas
|
|
|
122 |
21 |
p. 4363
|
artikel
|
| 161 |
A Functional Interplay Between Pyk2 and Src Family Kinases Links Ca2+ Signaling To Protein Tyrosine Phosphorylation In Thrombin-Stimulated Platelets
|
Canobbio, Ilaria
|
|
|
122 |
21 |
p. 2299
|
artikel
|
| 162 |
Age-Adjusted D-Dimer Cut-off Levels to Rule out Pulmonary Embolism: A Prospective Outcome Study
|
Righini, Marc
|
|
|
122 |
21 |
p. LBA-4
|
artikel
|
| 163 |
Age-Associated DNA Methylation Signature Reveals Premature Aging In Patients With Aplastic Anemia and Dyskeratosis Congenita Which Correlates With Telomere Shortening
|
Beier, Fabian
|
|
|
122 |
21 |
p. 1223
|
artikel
|
| 164 |
Age Dependency Of Coagulation Parameters During Childhood
|
Toulon, Pierre A.
|
|
|
122 |
21 |
p. 2341
|
artikel
|
| 165 |
Age Does Not Predict Outcomes For Elderly Patients With Myelodysplastic Syndromes Undergoing Hematopoietic Stem Cell Transplantation With Reduced-Intensity Conditioning
|
Abel, Gregory A.
|
|
|
122 |
21 |
p. 2147
|
artikel
|
| 166 |
A 13-Gene Panel Targeted To Investigate CLL By Next-Generation Amplicon Deep-Sequencing Can Be Successfully Implemented In Routine Diagnostics
|
Kohlmann, Alexander
|
|
|
122 |
21 |
p. 867
|
artikel
|
| 167 |
A Genetic Screen In Zebrafish Identified Dlst As a Potential Therapeutic Target For Human Acute T-Lymphoblastic Leukemia
|
Anderson, Nicole M
|
|
|
122 |
21 |
p. 1273
|
artikel
|
| 168 |
A Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab and Anthracycline-Based Chemotherapy: A Lysa and Iowa/Mayo Clinic SPORE Multistage Study
|
Ghesquieres, Herve
|
|
|
122 |
21 |
p. 76
|
artikel
|
| 169 |
A Genome Wide shRNA Screen In Primary Human AML Cells Identifies ROCK1 As a Novel Therapeutic Target
|
Wermke, Martin
|
|
|
122 |
21 |
p. 170
|
artikel
|
| 170 |
Age-Stratified Analysis Of The Prognostic Role Of Minimal Residual Disease Detection By Flow Cytometry, In Adult Patients With Acute Myeloid Leukemia
|
Buccisano, Francesco
|
|
|
122 |
21 |
p. 2649
|
artikel
|
| 171 |
Aggressive Non-Hodgkin Lymphoma: Predictive Value Of Sarcopenia and Skeletal Muscle Density On Prognosis With Rituximab Containing Therapy
|
Chu, Michael P
|
|
|
122 |
21 |
p. 3023
|
artikel
|
| 172 |
A Global Proteomic Pathway Map In Acute Myeloid Leukemia (AML)
|
Hu, Chenyu W
|
|
|
122 |
21 |
p. 1302
|
artikel
|
| 173 |
AGM-Derived Endothelial Cells and Notch Ligands Provide Embryonic Hematopoietic Stem Cell-Supportive Niches In Vitro
|
Hadland, Brandon K
|
|
|
122 |
21 |
p. 1167
|
artikel
|
| 174 |
AG-221 Offers a Survival Advantage In a Primary Human IDH2 Mutant AML Xenograft Model
|
Yen, Katharine
|
|
|
122 |
21 |
p. 240
|
artikel
|
| 175 |
Agonistic Anti-DR3 Antibody Expands Treg and Reduces Experimental Acute Graft-Versus-Host Disease
|
Kim, Byung-Su
|
|
|
122 |
21 |
p. 135
|
artikel
|
| 176 |
Agonist-Induced Kindlin-3 Phsphorylation Regulates αIIbβ3 Integrin Activation In HEL Cells and Platelets
|
Bialkowska, Katarzyna
|
|
|
122 |
21 |
p. 22
|
artikel
|
| 177 |
A High Complete Remission Rate Can Be Achieved In Older Patients (Age ≥60) With Acute Lymphoblastic Leukemia Regardless Of Induction Intensities: Single-Institution Experience At Memorial Sloan-Kettering Cancer Center
|
Park, Jae H
|
|
|
122 |
21 |
p. 2638
|
artikel
|
| 178 |
A Higher Number Of CD34+ Cells Collected During Mobilization Is Independently Associated With Successful Engraftment In Autologous Stem Cell Transplant Patients
|
Sharma, Amy
|
|
|
122 |
21 |
p. 5442
|
artikel
|
| 179 |
A Highly Selective SF3B1-Targeted Splicing Inhibitor Reduces Human CD34+ Cell Survival and Self-Renewal In Acute Myeloid Leukemia
|
Balaian, Larissa
|
|
|
122 |
21 |
p. 1653
|
artikel
|
| 180 |
A High- Risk Genetic Signature Is Predictive For Poor Outcome In Auto-Transplant Eigible Multiple Myeloma Patients Even With Use Of Novel Agents. A Single Institution Study
|
Romeril, Kenneth R.
|
|
|
122 |
21 |
p. 5371
|
artikel
|
| 181 |
A High Throughput Exome Sequencing Approach To Analyse Events Within a Good Responder CML Patient Under Imatinib At Diagnosis and Under Remission
|
Chacko, Anita
|
|
|
122 |
21 |
p. 5161
|
artikel
|
| 182 |
A HoxD11 Homeobox Gene Mutation Associated With Congenital Absent Radius But Without The Thrombocytopenia Of The TAR Syndrome Or a HoxA11 Mutation
|
Fleischman, Roger A.
|
|
|
122 |
21 |
p. 4837
|
artikel
|
| 183 |
Airway Hyper-Responsiveness Associated With Sickle Cell Disease Is Mediated By Placenta Growth Factor
|
Eiymo Mwa Mpollo, Marthe-Sandrine
|
|
|
122 |
21 |
p. 185
|
artikel
|
| 184 |
AK2 Deficiency In Zebrafish Recapitulates Human Reticular Dysgenesis, An Autosomal Recessive Form Of Severe Combined Immunodeficiency
|
Rissone, Alberto
|
|
|
122 |
21 |
p. 2416
|
artikel
|
| 185 |
A-Kinase Anchoring Proteins Mediate Healthy and Sickle Red Blood Cell Adhesion To Endothelial Laminin-5
|
Maciaszek, Jamie L.
|
|
|
122 |
21 |
p. 968
|
artikel
|
| 186 |
Akt Signalling Inhibition Promotes The Ex Vivo generation Of Minor Histocompatibility Antigen-Specific CD8+ Memory Stem T Cells
|
van der Waart, Anniek B.
|
|
|
122 |
21 |
p. 3269
|
artikel
|
| 187 |
AL Amyloidosis: Development Of a Conceptual Model and a Symptom Diary
|
Flood, Emuella
|
|
|
122 |
21 |
p. 5609
|
artikel
|
| 188 |
Alanine Scanning Mutagenesis of the VWF-A1 Flanking Regions of VWF and the Impact on Ristocetin-induced VWF Interaction with Platelets
|
Montgomery, Robert R.
|
|
|
122 |
21 |
p. 1103
|
artikel
|
| 189 |
ALDH Genes and Reactive Aldehydes Play Important Roles in HSCs and Leukemia and May Be Exploited to Treat AML
|
Gasparetto, Maura
|
|
|
122 |
21 |
p. 2893
|
artikel
|
| 190 |
ALDH2 Polymorphism In Japanese Children With Acquired Aplastic Anemia
|
Kawashima, Nozomu
|
|
|
122 |
21 |
p. 3717
|
artikel
|
| 191 |
Aldosterone Stimulates Neutrophils Leading To Increased β-Glucuronidase, Protein Disulfide Isomerase and Myeloperoxidase Secretion
|
Ramos-Rivera, Arelys
|
|
|
122 |
21 |
p. 2271
|
artikel
|
| 192 |
Alemtuzumab Achieved Durable Hematologic Response In Heavily Treated T-Large Granular Lymphocytosis Irrespective To STAT3 Mutation Or V-Beta Clone Size
|
Dumitriu, Bogdan
|
|
|
122 |
21 |
p. 3705
|
artikel
|
| 193 |
Alemtuzumab Is Safe and Associated With High Response Rates In Selected Patients With Myelodysplastic Syndrome
|
Ranpura, Vishal N.
|
|
|
122 |
21 |
p. 593
|
artikel
|
| 194 |
Algorithms and Processing Pipeline For Error Correction and Detection Of Significant Mutations In The Kinase Domain Of BCR-ABL Analyzed By Next-Generation Sequencing: Implications For Clinical Practice Of Chronic Myeloid Leukemia
|
Polakova, Katerina Machova
|
|
|
122 |
21 |
p. 3987
|
artikel
|
| 195 |
A Light Aggregometry Based Method To Measure The Percentage Of An Individual's Platelets That Are Inhibited By Aspirin
|
Schwartz, Kenneth A.
|
|
|
122 |
21 |
p. 2390
|
artikel
|
| 196 |
All Clones Are Not Equal: Somatic Hypermutation Significantly Enhances The Utility Of Tumor Tagging Rearrangements At IG Light Chain Loci In B Cell Malignancy
|
Carlson, Christopher S
|
|
|
122 |
21 |
p. 1376
|
artikel
|
| 197 |
Allele-Specific Effects Of U2AF1 Mutations On Alternative Splicing
|
Okeyo-Owuor, Theresa
|
|
|
122 |
21 |
p. 2748
|
artikel
|
| 198 |
Allele-Specific Loss Of The Mir-15a/16-1 Cluster Correlates With ZAP70 Expression In CLL Patients With 13q Deletion
|
Veronese, Angelo
|
|
|
122 |
21 |
p. 3753
|
artikel
|
| 199 |
Allelic Forms Of PRDM9 Associated With High Hyperdiploid Childhood Acute Lymphoblastic Leukaemia
|
Woodward, Eleanor L
|
|
|
122 |
21 |
p. 1351
|
artikel
|
| 200 |
Alloantibody Formation In Sickle Cell Disease
|
Sins, Joep
|
|
|
122 |
21 |
p. 2395
|
artikel
|
| 201 |
Allogeneic Compact Bone-Derived Mesenchymal Stem Cell Transplantation Attenuates The Severity Of Idiopathic Pneumonia Syndrome In a Murine Bone Marrow Transplantation Model
|
Qiao, Shukai
|
|
|
122 |
21 |
p. 4466
|
artikel
|
| 202 |
Allogeneic Cytokine-Induced Killer Cells Eliminate Host Dendritic Cells Due To The Enhanced Killing Activity By IFN-Gamma, Leading To Less Graft-Versus-Host Disease
|
Mase, Shintaro
|
|
|
122 |
21 |
p. 4495
|
artikel
|
| 203 |
Allogeneic Hematopoietic Cell Transplantation For Patients With Mycosis Fungoides and Sezary Syndrome: The Experience Of The EBMT Lymphoma Working Party With An Extended Five-Year Follow Up
|
Duarte, Rafael F.
|
|
|
122 |
21 |
p. 2094
|
artikel
|
| 204 |
Allogeneic Hematopoietic Cell Transplantation For Patients With Primary and Secondary Myelofibrosis: Report Of a Single Center Experience
|
Dorn, Christiane
|
|
|
122 |
21 |
p. 4538
|
artikel
|
| 205 |
Allogeneic Hematopoietic Cell Transplantation Is Effective In Patients With Advanced Systemic Mastocytosis: A Multicenter Retrospective Analysis
|
Ustun, Celalettin
|
|
|
122 |
21 |
p. 2145
|
artikel
|
| 206 |
Allogeneic Hematopoietic Cell Transplantation Using Fludarabine, Melphalan and Bortezomib (Flu/Mel/Vel) Conditioning For Consolidation Of VGPR Or CR In Myeloma
|
Nishihori, Taiga
|
|
|
122 |
21 |
p. 3390
|
artikel
|
| 207 |
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica
|
Greco, Raffaella
|
|
|
122 |
21 |
p. 5539
|
artikel
|
| 208 |
Allogeneic Hematopoietic Stem Cell Transplantation From Haploidentical Donor After Reduced Intensity Conditioning Regimen Allows Promising Disease Control In Patients With Hematological Diseases
|
Devillier, Raynier
|
|
|
122 |
21 |
p. 2139
|
artikel
|
| 209 |
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL): Results From The Group For Research On Adult ALL (GRAALL)
|
Dhédin, Nathalie
|
|
|
122 |
21 |
p. 552
|
artikel
|
| 210 |
Allogeneic Hematopoietic Stem-Cell Transplantation In AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: 10 Years Later
|
Shimoni, Avichai
|
|
|
122 |
21 |
p. 4635
|
artikel
|
| 211 |
Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT
|
Basak, Grzegorz W.
|
|
|
122 |
21 |
p. 2110
|
artikel
|
| 212 |
Allogeneic Hematopoietic Stem Cell Transplantation Of Patients With Wiskott-Aldrich Syndrome With Total Body Irradiation (TBI), Thiotepa and Fludarabine Or Cyclophosphamide Followed By T-Cell Depleted Grafts From Alternative Donors
|
Prockop, Susan E.
|
|
|
122 |
21 |
p. 4567
|
artikel
|
| 213 |
Allogeneic Hematopoietic Stem Cell Transplant Reverses The Phenotype Of DOCK8 Deficiency
|
Cuellar-Rodriguez, Jennifer
|
|
|
122 |
21 |
p. 2114
|
artikel
|
| 214 |
Allogeneic HSCT Patients Receiving More RBC Transfusions Are At Increased Risk For Development Of Grade 2-4 Acute Graft-Versus-Host Disease
|
Giver, Cynthia R.
|
|
|
122 |
21 |
p. 3298
|
artikel
|
| 215 |
Allogeneic HY Antibodies 3 Months Following Sex-Mismatched HCT Predicts Chronic Graft-Versus-Host Disease and Non-Relapse Mortality
|
Nakasone, Hideki
|
|
|
122 |
21 |
p. 147
|
artikel
|
| 216 |
Allogeneic Stem Cell Transplantation - A Long-Term Curative Approach In Patients ≥ 60 Years With Advanced Disease AML/MDS, - The Freiburg Experience Of 250 Consecutive Patients
|
Bertz, Hartmut
|
|
|
122 |
21 |
p. 2135
|
artikel
|
| 217 |
Allogeneic Stem Cell Transplantation For Acute Myeloid Leukemia With Normal Cytogenetics (CN-AML): Outcome, Risk Factors and Role Of Molecular Subgroups In 752 Patients – A Report From The Acute Leukemia Working Party Of EBMT
|
Schmid, Christoph
|
|
|
122 |
21 |
p. 921
|
artikel
|
| 218 |
Allogeneic Stem Cell Transplantation For Cytogenetically Normal Acute Myeloid Leukemia: Impact Of FLT3 and NPM1 Mutational Status
|
Hemmati, Philipp
|
|
|
122 |
21 |
p. 2104
|
artikel
|
| 219 |
Allogeneic Stem Cell Transplantation For Patients With Adrenoleukodystrophy. Nationwide Retrospective Study In Japan
|
Kato, Koji
|
|
|
122 |
21 |
p. 2148
|
artikel
|
| 220 |
Allogeneic Stem Cell Transplantation For Primary Refractory Hodgkin's Disease: Ablative Vs Reduced Intensity
|
Ozcelik, Tulay
|
|
|
122 |
21 |
p. 5526
|
artikel
|
| 221 |
Allogeneic Stem Cell Transplantation In Adults With High Risk Acute Lymphoblastic Leukemia (ALL) In 1. Remission (CR1): Promising, But Strongly Influenced By ALL Subtypes
|
Arnold, Renate
|
|
|
122 |
21 |
p. 3409
|
artikel
|
| 222 |
Allogeneic Stem Cell Transplantation In Chronic Myeloid Leukemia In TKIs Era
|
Ahmed, Parvez
|
|
|
122 |
21 |
p. 5554
|
artikel
|
| 223 |
Allogeneic Stem Cell Transplantation In Philadelphia Negative Myeloproliferative Or Myelodysplastic/Myeloproliferative Neoplasms: A Retrospective Analysis From The Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC)
|
Cahu, Xavier
|
|
|
122 |
21 |
p. 3373
|
artikel
|
| 224 |
Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin´s Lymphoma
|
Rivas, Maria Marta
|
|
|
122 |
21 |
p. 5511
|
artikel
|
| 225 |
Allogeneic Stem-Sell Transplantation In Multiple Myeloma In Real Practice: Long-Term Results From a Single Institution
|
Jiménez, Raquel
|
|
|
122 |
21 |
p. 5524
|
artikel
|
| 226 |
Allo-HSCT From Unrelated Donors Improves The Outcome Of Elderly AML Patients In CR1
|
Nagahata, Yosuke
|
|
|
122 |
21 |
p. 2166
|
artikel
|
| 227 |
Alloimmunization To HLA Class I Antigens But Not H-Y Antigens Is Associated With Transfusion In Children With Sickle Cell Disease
|
Nickel, Robert S.
|
|
|
122 |
21 |
p. 39
|
artikel
|
| 228 |
Alloreactive T Cell Clonotypes Identified By In Vitro Mixed Lymphoid Reaction and High-Throughput Sequencing Exhibit Increased Frequency In Peripheral Blood Samples From Patients Following Allogeneic Hematopoietic Cell Transplantation For Chronic Lymphocytic Leukemia
|
Logan, Aaron C.
|
|
|
122 |
21 |
p. 149
|
artikel
|
| 229 |
All Roads Lead to Rome: Phenotypic Channeling to Uniform Differentiation Structures from Diverse Leukemia Genotypes by Mass Cytometry
|
Nolan, Garry
|
|
|
122 |
21 |
p. SCI-22
|
artikel
|
| 230 |
All-Trans Retinoic Acid Synergizes With FLT3 Tyrosine Kinase Inhibition To Eliminate FLT3/ITD-Expressing Leukemia Cells
|
Ma, Hayley S
|
|
|
122 |
21 |
p. 3960
|
artikel
|
| 231 |
Aln-TMP: A Subcutaneously Administered RNAi Therapeutic Targeting Tmprss6 For The Treatment Of β-Thalassemia
|
Butler, James
|
|
|
122 |
21 |
p. 2260
|
artikel
|
| 232 |
A Long-Term Phenotype Analysis Of 51 Patients With Upshaw–Schulman Syndrome In Japan, With Special References To Pregnancy and Renal Failure That Requires Hemodialysis
|
Fujimura, Yoshihiro
|
|
|
122 |
21 |
p. 3545
|
artikel
|
| 233 |
A Lower Dose Of Melphalan (140 mg/m2) As Preparative Regimen For Multiple Myeloma In Patients >65 Or With Renal Dysfunction
|
Saunders, Ila Maewal
|
|
|
122 |
21 |
p. 5536
|
artikel
|
| 234 |
A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy Against Anemia Of Chronic Disease
|
Fujiwara, Tohru
|
|
|
122 |
21 |
p. 3436
|
artikel
|
| 235 |
Alpha 1 Antitrypsin, C Reactive Protein, and Hemolysis Markers: Association With Cytokines Profile In Sickle Cell Disease Patients In Steady-State and Crisis-State
|
Carvalho, Magda
|
|
|
122 |
21 |
p. 4701
|
artikel
|
| 236 |
Alpha-2-Macroglobulin Is a Major Determinant Of a Lower Thrombin Generation In Infants and Children Compared To Adults
|
Kremers, Romy
|
|
|
122 |
21 |
p. 2344
|
artikel
|
| 237 |
ALT-1188: A New CXCR4 Antagonist In Development For Mobilization Of HSPCs
|
Rettig, Michael P.
|
|
|
122 |
21 |
p. 891
|
artikel
|
| 238 |
Alteration Of Cytogenetic Risk Stratification In New Diagnosis Of Leukemia By FISH Testing – Retrospective Review Of The SWOG Experience
|
Fang, Min
|
|
|
122 |
21 |
p. 1383
|
artikel
|
| 239 |
Alterations In Mitochondrial Priming May Be a Mechanism For Acquired Resistance To Therapy In Diffuse Large B-Cell Lymphoma
|
Brem, Elizabeth
|
|
|
122 |
21 |
p. 1764
|
artikel
|
| 240 |
Alterations In Specific Immune Cell Subsets In Children With Sickle Cell Disease
|
Nickel, Robert S.
|
|
|
122 |
21 |
p. 2208
|
artikel
|
| 241 |
Alterations Of The Chemokine Microenvironment In Chronic Lymphocytic Leukemia
|
SEILER, TILL M
|
|
|
122 |
21 |
p. 1619
|
artikel
|
| 242 |
Altered Expression and Mutation Analysis Of Heterogeneous Nuclear Ribonucleoprotein k In Bone Marrow Of Primary Myelofibrosis Patients
|
Bozinovic, Ksenija
|
|
|
122 |
21 |
p. 5272
|
artikel
|
| 243 |
Altered Glucose Metabolism In Rituximab-Chemotherapy Resistant Cells Is a Potential Target For Future Therapeutic Development
|
Gu, Juan
|
|
|
122 |
21 |
p. 4413
|
artikel
|
| 244 |
Alternative and Terminal Complement Pathway Biomarkers At Presentation More Precisely Define The Clinical Diagnosis Of aHUS
|
Cataland, Spero R
|
|
|
122 |
21 |
p. 3552
|
artikel
|
| 245 |
Alternative Donor Hematopoietic Transplantation For Patients Older Than 50 Years With AML In First Complete Remission: Unrelated Donor and Umbilical Cord Blood Transplantation Outcomes
|
Weisdorf, Daniel J.
|
|
|
122 |
21 |
p. 302
|
artikel
|
| 246 |
Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts
|
Feuchtinger, Tobias
|
|
|
122 |
21 |
p. 4573
|
artikel
|
| 247 |
Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD
|
Bachanova, Veronika
|
|
|
122 |
21 |
p. 161
|
artikel
|
| 248 |
Alternative Methods Of Thrombocytopenia: Patients With ITP Have Increased Megakaryocyte/T Cell Interactions In The Bone Marrow and Higher Serum TRAIL Levels
|
Onubogu, Ifeanyi K
|
|
|
122 |
21 |
p. 3531
|
artikel
|
| 249 |
A Mechanism For Switch Of Integrin Signaling Direction and a New Anti-Thrombotic Strategy Through Selective Outside-In Signaling Inhibition
|
Shen, Bo
|
|
|
122 |
21 |
p. 2295
|
artikel
|
| 250 |
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias
|
Giustacchini, Alice
|
|
|
122 |
21 |
p. 886
|
artikel
|
| 251 |
A Meta-Analysis Of Genome-Wide Association Studies Of Multiple Myeloma In Cases and Controls Of European Origin Identifies a Risk Locus In 12q23.1
|
Rand, Kristin A
|
|
|
122 |
21 |
p. 3111
|
artikel
|
| 252 |
A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc
|
Cozen, Wendy
|
|
|
122 |
21 |
p. 626
|
artikel
|
| 253 |
A Method To Identify Copy Number Aberrations (CNAs) From Whole Exome Sequence (WES) Data and Its Application To Multiple Myeloma Cell Lines and Patient Samples
|
Degenhardt, Jeremiah D
|
|
|
122 |
21 |
p. 4881
|
artikel
|
| 254 |
AMG 900, a Potent and Highly Selective Aurora Kinase Inhibitor Shows Promising Preclinical Activity Against Acute Myeloid Leukemia Cell Lines In Vitro and In Vivo
|
Cheung, Kam
|
|
|
122 |
21 |
p. 3823
|
artikel
|
| 255 |
A 40-Microrna Signature Characterizes JAK2V617F-Negative Essential Thrombocythemia: Role Of Mir-221 and Mir-203 In The Regulation Of The JAK-STAT Pathway
|
Navarro, Alfons
|
|
|
122 |
21 |
p. 2846
|
artikel
|
| 256 |
AML At First Relapse: A Real Life Picture
|
Boyle, Eileen Mary
|
|
|
122 |
21 |
p. 3895
|
artikel
|
| 257 |
AML Cells Utilize TNF-Driven JNK Signaling As a Critical NF-κB-Independent Survival Signal
|
Volk, Andrew
|
|
|
122 |
21 |
p. 2890
|
artikel
|
| 258 |
AML1-ETO Represses Multiple Transcription Factor Induced CTSG Activation by Reducing H3 Acetylation
|
Tan, Yun
|
|
|
122 |
21 |
p. 3750
|
artikel
|
| 259 |
A Modified Dose Intensive R- CODOX-M/IVAC For HIV-Associated Burkitt and Atypical Burkitt Lymphoma(BL) Demonstrates High Cure Rates and Low Toxicity: Prospective Multicenter Phase II Trial Of The AIDS Malignancy Consortium (AMC 048)
|
Noy, Ariela
|
|
|
122 |
21 |
p. 639
|
artikel
|
| 260 |
A Monoclonal IgM Antibody With Specificity To Heat Shock Protein GRP78/BIP Shows Anti- Myeloma Activity In Vitro and In Vivo, Synergy In Combination With Lenalidomide and Safety In a Pilot Phase I Study
|
Rasche, Leo
|
|
|
122 |
21 |
p. 3213
|
artikel
|
| 261 |
A Mouse Model Of Rothmund-Thomson Syndrome Reveals An Essential Role For Recql4 In Maintenance Of Hematopoiesis
|
DeLuca, Elisabetta
|
|
|
122 |
21 |
p. 591
|
artikel
|
| 262 |
A Multicenter Observational Study For Early Diagnosis Of Gaucher Disease In Patients With Splenomegaly and/Or Thrombocytopenia
|
Motta, Irene
|
|
|
122 |
21 |
p. 4712
|
artikel
|
| 263 |
A Multicenter Phase II Study Of Bendamustine In Combination With Rituximab In Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
|
Park, Steven I.
|
|
|
122 |
21 |
p. 1791
|
artikel
|
| 264 |
A Multicenter Phase II Study Of Bortezomib (VELCADE®) Combined With Rituximab For Untreated High Tumor Burden (HTB) Indolent Non-Hodgkin Lymphoma (NHL): Long-Term Follow-Up Of Outcomes and Examination Of Prognostic Factors
|
Evens, Andrew M
|
|
|
122 |
21 |
p. 1807
|
artikel
|
| 265 |
A Multicenter, Phase IV Observational Study Of Ofatumumab In Chronic Lymphocytic Leukemia (CLL): A European Research Initiative On CLL (ERIC) Study
|
Moreno, Carol
|
|
|
122 |
21 |
p. 1645
|
artikel
|
| 266 |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy and Safety Of Siltuximab, An Anti-Interleukin-6 Monoclonal Antibody, In Patients With Multicentric Castleman's Disease
|
Wong, Raymond S
|
|
|
122 |
21 |
p. 505
|
artikel
|
| 267 |
A Multicenter Study On Hereditary Spherocytosis In Lebanon
|
Inati, Adlette
|
|
|
122 |
21 |
p. 4661
|
artikel
|
| 268 |
A Multicentre Retrospective UK Study Detailing Onset Of Graft Verus Host Disease, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem Cell Transpantation: Rates Of GVHD Are High But Death From GVHD Infrequent
|
Scarisbrick, Julia J
|
|
|
122 |
21 |
p. 4645
|
artikel
|
| 269 |
A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)
|
Jung, Chul Won
|
|
|
122 |
21 |
p. 4086
|
artikel
|
| 270 |
A Multiplex Flow Cytometry Bead Assay For Simultaneous Detection Of IgG, IgA, IgM Heparin-Dependent Antibodies
|
Sullivan, Mia
|
|
|
122 |
21 |
p. 3551
|
artikel
|
| 271 |
A Murine Model Of Hemorrhagic Shock/Resuscitation Demonstrates Transfusion Related Acute Lung Injury (TRALI) Induced By Stored Platelet Transfusions
|
McKenzie, Christopher G.J.
|
|
|
122 |
21 |
p. 789
|
artikel
|
| 272 |
A Myeloablative Conditioning Regimen With Fludarabine Demonstrates Good Results In UCBT With Hematologic Malignancies, Especially Acute Lymphoblastic Leukemia
|
Tong III, Juan
|
|
|
122 |
21 |
p. 4575
|
artikel
|
| 273 |
An Adapted Gating Strategy Integrating a Myelomonocytic Window Is Necessary For Correct Flow Cytometric Diagnosis In a Large Proportion Of AML With Mutated NPM1
|
Kull, Miriam
|
|
|
122 |
21 |
p. 2593
|
artikel
|
| 274 |
An Altered Macrophage Migration In Adipose Tissue Of Integrin Mac-1 (CD11b/CD18) Deficient Mice
|
Podolnikova, Nataly P.
|
|
|
122 |
21 |
p. 1031
|
artikel
|
| 275 |
An Altered Microenvironment Within The Spleens Of Patients With Myelofibrosis Affects CD34+ Cell Trafficking
|
Wang, Xiaoli
|
|
|
122 |
21 |
p. 2848
|
artikel
|
| 276 |
Analysis For Loss Of 13q Heterozygosity Using STR Or SNP Analysis Can Replace Analysis Of FLT3-ITD To Detect Prognostically Adverse AML
|
Schnittger, Susanne
|
|
|
122 |
21 |
p. 805
|
artikel
|
| 277 |
Analysis Of a Single Institutional Cohort Of 20,593 Patients Tested For Antiphospholipid Antibodies Indicates Significant Prospective Risk For Thrombosis
|
Yitzchak Goldstein, D.
|
|
|
122 |
21 |
p. 2366
|
artikel
|
| 278 |
Analysis Of 402 Cord Blood Units To Assess Factors Influencing Infused Viable CD34+ Cell Dose: The Critical Determinant Of Engraftment
|
Purtill, Duncan
|
|
|
122 |
21 |
p. 296
|
artikel
|
| 279 |
Analysis Of E2A Point Mutations In B Cell Leukemia
|
Soans, Eroica
|
|
|
122 |
21 |
p. 4850
|
artikel
|
| 280 |
Analysis Of EphA3 Expression In Hematologic Malignancies By Quantitative PCR
|
Woronicz, John
|
|
|
122 |
21 |
p. 4981
|
artikel
|
| 281 |
Analysis Of Gene Expression Profile In SUDHL6 Cells Of siRNA-Mediated BCL11A Downregulation
|
Wu, Hong
|
|
|
122 |
21 |
p. 3780
|
artikel
|
| 282 |
Analysis Of Hematological Improvement With Iron Chelation Therapy Using Deferasirox In Subject Ts With Therapy-Refractory Severe Aplastic Anemia
|
Jomen, Wataru
|
|
|
122 |
21 |
p. 4878
|
artikel
|
| 283 |
Analysis Of Hemostatic Characteristics using Thromboelastometry in Adults With Sickle Cell Disease and Controls
|
Janbain, Maissaa
|
|
|
122 |
21 |
p. 4766
|
artikel
|
| 284 |
Analysis Of Immune Cell Populations Before and After Autologous Hematopoietic Stem Cell Transplant For Multiple Myeloma: Association With Early Recovery Of Absolute Lymphocyte Count and Progression-Free Survival
|
Hahn, Theresa
|
|
|
122 |
21 |
p. 3348
|
artikel
|
| 285 |
Analysis Of Impact Of Distance From Residence To Treatment Center On The Outcome Of Patients With Acute Myeloid Leukemia
|
Lam, David W.
|
|
|
122 |
21 |
p. 1712
|
artikel
|
| 286 |
Analysis Of Leukemic Stem Cell Population Comparing NPM1
wt
and NPM1
mut
AML Patients and Potential Therapeutic Targets
|
Schneider, Vanessa
|
|
|
122 |
21 |
p. 2624
|
artikel
|
| 287 |
Analysis Of Micro-RNA-142 Mutations In a Cohort Of 944 Patients With MDS and AML
|
Thol, Felicitas
|
|
|
122 |
21 |
p. 2804
|
artikel
|
| 288 |
Analysis Of Molecular Responses and Chromosomal Aberrations In Patients With Polycythemia Vera Treated With Peg-Proline-Interferon Alpha-2b (AOP2014/P1101) In The Peginvera Study
|
Them, Nicole C.C.
|
|
|
122 |
21 |
p. 1589
|
artikel
|
| 289 |
Analysis Of Peripheral T-Cell Lymphoma (PTCL) Subtype By Race and Geography Using The Comprehensive Oncology Measures For Peripheral T-Cell Lymphoma Treatment (COMPLETE) Dataset
|
Carson, Kenneth R.
|
|
|
122 |
21 |
p. 4284
|
artikel
|
| 290 |
Analysis Of Responses (complete cytogenetic response and major molecular response) Achieved With Different Tyrosine Kinase Inhibitor (TKI) Modalities and Their Impact On Long Term Outcomes In Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) – Analysis From a Single Institution
|
Jain, Preetesh
|
|
|
122 |
21 |
p. 2728
|
artikel
|
| 291 |
Analysis Of T Cell Receptor Repertoire Reveals Evidence For Antigen-Specific Response In CLL Lymph Nodes
|
Pasikowska, Marta
|
|
|
122 |
21 |
p. 4141
|
artikel
|
| 292 |
Analysis Of The Lin- CD45- CD34/CD133+ Cell Population In G-CSF-Mobilized Peripheral Blood By Polychromatic Flow Cytometry and Micro RNA Profiling
|
Jiang, Yajuan
|
|
|
122 |
21 |
p. 4841
|
artikel
|
| 293 |
Analysis Of The Molecular Mechanisms Leading To Significantly Higher Serum Hepcidin and More Severe Anemia In Multicentric Castleman's Disease (MCD) Patients Than In Rheumatoid Arthritis (RA) Patients
|
Song, Soken-Nakazawa J.
|
|
|
122 |
21 |
p. 2181
|
artikel
|
| 294 |
Analysis Of TMPRSS6 Polymorphisms In Patients With Iron Deficiency Anemia Partially Responsive To Oral Iron Treatment
|
Poggiali, Erika
|
|
|
122 |
21 |
p. 3438
|
artikel
|
| 295 |
Analysis Of Transfusion Dependence Development and Disease Evolution In Patients With MDS and Del(5q) and Without Transfusion Needs At Diagnosis
|
Rojas, Silvia M
|
|
|
122 |
21 |
p. 1542
|
artikel
|
| 296 |
Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting
|
Clark, Nathan P
|
|
|
122 |
21 |
p. 1143
|
artikel
|
| 297 |
An Analysis Of Mechanisms Of Central Nervous System Infiltration In Acute Lymphoblastic Leukaemia Using Primary Cells Xenografted Into Immunodeficient Mice
|
Yousafzai, Yasar M
|
|
|
122 |
21 |
p. 3866
|
artikel
|
| 298 |
An Analysis Of Ph-Like ALL In Japanese Patients
|
Kiyokawa, Nobutaka
|
|
|
122 |
21 |
p. 352
|
artikel
|
| 299 |
An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia
|
McCavit, Timothy L.
|
|
|
122 |
21 |
p. 2206
|
artikel
|
| 300 |
An Antibody Targeted To The Anionic Region Of Human Protease Activated Receptor 4 Inhibits Thrombosis Without Influencing Bleeding
|
Mumaw, Michele M.
|
|
|
122 |
21 |
p. 2376
|
artikel
|
| 301 |
An Effective and Tolerable Chemoimmunotherapy Regimen For Relapsed/Refractory and Very-High Risk Chronic Lymphocytic Leukemia Combining Alemtuzumab With Pentostatin and Low Dose Rituximab
|
Zent, Clive S.
|
|
|
122 |
21 |
p. 1641
|
artikel
|
| 302 |
Anemia, Shortened Erythrocyte Lifespan and Stomatocytosis In a Flippase Mutant Mouse Strain
|
Lucy, Coupland
|
|
|
122 |
21 |
p. 2183
|
artikel
|
| 303 |
An Engineered Factor Fva Prevents Bleeding Induced By Anticoagulant Wild Type Activated Protein C
|
Von Drygalski, Annette
|
|
|
122 |
21 |
p. 203
|
artikel
|
| 304 |
An Epigenetic Mechanism Of Imatinib Via Demethylation Of MiR-203
|
Umemura, Tsukuru
|
|
|
122 |
21 |
p. 3766
|
artikel
|
| 305 |
An Essential Role For Transferrin Receptor 2 In Erythropoiesis During Iron Restriction
|
Wallace, Daniel F
|
|
|
122 |
21 |
p. 429
|
artikel
|
| 306 |
A Network Of Epigenetic Regulators Guide Developmental Hematopoiesis In Vivo
|
Kathrein, Katie L
|
|
|
122 |
21 |
p. 1174
|
artikel
|
| 307 |
A New ALAS2 Mutation Inducing a Male Lethal X-Linked Sideroblastic Anemia
|
Rose, Christian
|
|
|
122 |
21 |
p. 2199
|
artikel
|
| 308 |
A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1
|
Zahreddine, Hiba A
|
|
|
122 |
21 |
p. 821
|
artikel
|
| 309 |
A New Method For Electronic Crossmatch: ABO /Rh Blood Group Confirmation and Antibody Screening Concomitantly With Serologic Crossmatch
|
Demirkan, Fatih
|
|
|
122 |
21 |
p. 4833
|
artikel
|
| 310 |
A New Multinational Observational Study In Multiple Myeloma: Initial Report Of The PREAMBLE Study
|
Vij, Ravi
|
|
|
122 |
21 |
p. 1964
|
artikel
|
| 311 |
A New Murine Model Of Chronic Graft Versus Host Disease
|
Huang, Xin
|
|
|
122 |
21 |
p. 5429
|
artikel
|
| 312 |
A New Mutation Of The ALAS2 Gene In a Chinese Family With X-linked
|
Cui, Rui
|
|
|
122 |
21 |
p. 4674
|
artikel
|
| 313 |
A New Platform For Trivalent Bispecific Antibodies Used For T-Cell Redirected Killing Of B-Cell Malignancies
|
Rossi, Diane L
|
|
|
122 |
21 |
p. 3078
|
artikel
|
| 314 |
A New Prognostic Index In Diffuse Large B-Cell Lymphoma Using Serum Albumin: A Pilot Study Evaluating The Albumin Adjusted-International Prognostic Index (A-IPI)
|
Dalia, Samir
|
|
|
122 |
21 |
p. 4267
|
artikel
|
| 315 |
A New Prognostic Model for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type
|
Cai, Qingqing
|
|
|
122 |
21 |
p. 1769
|
artikel
|
| 316 |
A New Strategy Of MDS Treatment With Azacitidine (AZA): Induction With AZA Combined With Low Dose AraC Followed By Maintenance Therapy With AZA
|
Hirai, Manabu
|
|
|
122 |
21 |
p. 1536
|
artikel
|
| 317 |
Angelica Polysaccharide and TPO Have a Protective Effect On Hcmv-Induced Apoptosis In Megakaryocytes
|
Yang, Mo
|
|
|
122 |
21 |
p. 3553
|
artikel
|
| 318 |
Angiopoietin-Like Proteins Stimulate HSC Development Through Direct Interaction With Notch
|
Lin, Michelle I
|
|
|
122 |
21 |
p. 463
|
artikel
|
| 319 |
Angptl-4 Is Upregulated Under Inflammatory Conditions In The BM Of Mice, Expands Myeloid Progenitors and Accelerates Reconstitution Of Platelets After Myelosuppressive Therapy
|
Schumacher, Anne
|
|
|
122 |
21 |
p. 3677
|
artikel
|
| 320 |
An IHC Screen For EphA3 Positive FFPE Tumors
|
Locke, Darren
|
|
|
122 |
21 |
p. 4965
|
artikel
|
| 321 |
An Immunodeficient Mouse Model With Circulating Human Platelets To Evaluate The Platelet Clearance and Pharmacokinetics Of Platelet-Targeted Coagulation Factor VIIa
|
Tan, Siyuan
|
|
|
122 |
21 |
p. 2345
|
artikel
|
| 322 |
An Inborn Variation In The Anaplastic Lymphoma Receptor Tyrosine Kinase Gene (ALK) Increases Risk Of MAF (Musculoaponeurotic Fibrosarcoma Oncogene Homolog) High Expressing Myeloma
|
Vangsted, Annette Juul
|
|
|
122 |
21 |
p. 1908
|
artikel
|
| 323 |
An Inexpensive Ion Torrent-Based Deep Sequencing Assay Demonstrates Marked Superiority Over Sanger Sequencing For Routine Detection Of BCR-ABL1 Kinase Domain Mutations
|
Szankasi, Philippe
|
|
|
122 |
21 |
p. 2722
|
artikel
|
| 324 |
An Intensive Model Of Care For Adults With Sickle Cell Disease That Rapidly Reduces Hospital Admissions, Readmissions and Cost
|
Koch, Kathryn L.
|
|
|
122 |
21 |
p. 773
|
artikel
|
| 325 |
An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim
|
Stasi, Roberto
|
|
|
122 |
21 |
p. 1074
|
artikel
|
| 326 |
An International Comparison Of Survival Disparities In Patients With Lymphoma and Myeloma
|
Pulte, Dianne
|
|
|
122 |
21 |
p. 2925
|
artikel
|
| 327 |
An Internet-Based Registry For The Documentation Of Neoplastic Meningitis
|
Strik, Herwig
|
|
|
122 |
21 |
p. 5617
|
artikel
|
| 328 |
An iPSC-Based Model Of MDS For Phenotype-Driven Gene and Drug Discovery
|
Boussaad, Ibrahim
|
|
|
122 |
21 |
p. 859
|
artikel
|
| 329 |
Anisocytosis Is Associated With Decreased Survival In Patients With Newly Diagnosed Myelodysplastic Syndromes: A Single Center Experience
|
Sridharan, Ashwin
|
|
|
122 |
21 |
p. 5218
|
artikel
|
| 330 |
ANKHD1 Silencing Reduces In Vitro Clonogenicity and In Vivo Tumorogenicity Of Multiple Myeloma Cells
|
Dhyani, Anamika
|
|
|
122 |
21 |
p. 3168
|
artikel
|
| 331 |
ANKL Is Strongly EBV-Related, Frequent In Chromosome Aberrations and Gene Mutations, LMP2A/LMP1-CDK6-MDM2-CD44-Positive and Might Be Sensitive To L-Asparaginase-Containing Regimen
|
Zhou, Hongsheng
|
|
|
122 |
21 |
p. 3012
|
artikel
|
| 332 |
Annotation Of Pseudogenous Gene Segments By Massively Parallel Sequencing Of Rearranged Lymphocyte Receptor Loci
|
Emerson, Ryan O
|
|
|
122 |
21 |
p. 3480
|
artikel
|
| 333 |
A “non-fratricidal” αβ- T Cell Receptor That Targets Survivin Expressed By Hematological Malignancies
|
Arber, Caroline
|
|
|
122 |
21 |
p. 141
|
artikel
|
| 334 |
An Open-Label, Phase II Study Of The JAK1 Inhibitor INCB039110 In Patients With Myelofibrosis
|
Mascarenhas, John
|
|
|
122 |
21 |
p. 663
|
artikel
|
| 335 |
An Open-Label, Phase 2, Multicenter Study Of The Safety Of Long-Term Treatment With Siltuximab (an Anti-Interleukin-6 Monoclonal Antibody) In Patients With Multicentric Castleman's Disease
|
Van Rhee, Frits
|
|
|
122 |
21 |
p. 1806
|
artikel
|
| 336 |
An Open-Label Phase 2 Study Of Ofatumumab In Combination With a Novel AKT Inhibitor (Afuresertib) In Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL)
|
Chen, Christine I.
|
|
|
122 |
21 |
p. 4175
|
artikel
|
| 337 |
An Optimised In Vivo Modelling System For Adult Acute Lympoblastic Leukaemia (ALL) Enables Sensitive Detection Of Leukaemia Initiating Cells (LIC) and Drug Resistant Clones
|
Patel, Bella
|
|
|
122 |
21 |
p. 2641
|
artikel
|
| 338 |
A North American Experience Of Hemoglobin SC Disease, Its Complications, and Management
|
Naessens, Veronique
|
|
|
122 |
21 |
p. 2221
|
artikel
|
| 339 |
A Novel Activating Mutation Of CXCR4 Plays a Crucial Role In Waldenstrom Macroglobulinemia Biology
|
Roccaro, Aldo M
|
|
|
122 |
21 |
p. 272
|
artikel
|
| 340 |
A Novel and Highly Selective Dual PI3K/mTOR Kinase Inhibitor VS-5584, Shows Promising Therapeutic Potential For The Treatment Of Multiple Myeloma
|
Mustafa, Nurulhuda
|
|
|
122 |
21 |
p. 4433
|
artikel
|
| 341 |
A Novel Assay For The Preferential Detection Of “Pathogenic” HIT Antibodies
|
Padmanabhan, Anand
|
|
|
122 |
21 |
p. 1125
|
artikel
|
| 342 |
A Novel Automated Analysis Of Flow Cytometry Data Identifies Distinct Cell Signatures In The Immune System Of CLL Patients
|
Rueter, Jens
|
|
|
122 |
21 |
p. 2864
|
artikel
|
| 343 |
A Novel Bruton′s Tyrosine Kinase Inhibitor CC-292 In Combination With The Proteasome Inhibitor Carfilzomib Iimpacts Multiple Myeloma Bone Microenviroment With Resultant Anti-Myeloma Activity
|
Eda, Homare
|
|
|
122 |
21 |
p. 682
|
artikel
|
| 344 |
A Novel CD16xCD33 Bispecific Killer Cell Engager (BiKE) Mediates a Double Hit For Natural Killer (NK) Cells To Target CD33+ Myelodysplastic Syndrome (MDS) Cells and Myeloid Derived Suppressor Cells (MDSCs) At All Disease Stages
|
Gleason, Michelle K.
|
|
|
122 |
21 |
p. 385
|
artikel
|
| 345 |
A Novel Conditional Mouse Model For MLL-ENL Induced Acute Leukemia
|
Stavropoulou, Vaia
|
|
|
122 |
21 |
p. 1277
|
artikel
|
| 346 |
A Novel Cyclin Dependent Kinase Inhibitor P1446A Induces Apoptosis Of Chronic Lymphocytic Leukemia B Cells
|
Godbersen, Claire
|
|
|
122 |
21 |
p. 1636
|
artikel
|
| 347 |
A Novel Diagnostic Method For AITL By Detecting RHOA G17V Hotspot Mutation Using Allele-Specific Real-Time PCR
|
Nakamoto-Matsubara, Rie
|
|
|
122 |
21 |
p. 3000
|
artikel
|
| 348 |
A Novel EPO Gene Mutation In a Family With Autosomal Dominant Polycythemia
|
Lorenzo V, Felipe R
|
|
|
122 |
21 |
p. 950
|
artikel
|
| 349 |
A Novel Gain-Of-Function Mutation In The CARD Domain Of CARD11 (C49Y) Results In Benta Disease
|
Buchbinder, David K.
|
|
|
122 |
21 |
p. 3485
|
artikel
|
| 350 |
A Novel β Globin Gene Mutation, Reported As An α Chain Hemoglobin Variant By High Performance Liquid Chromatography (HPLC) & As Sickle Cell Trait On New Born Screening: A case Report
|
Nandan Seelaboyina, Kranthi
|
|
|
122 |
21 |
p. 954
|
artikel
|
| 351 |
A Novel Long Non-Coding RNA, SNHG4 Complex With Eukaryotic Initiation Factor-4E and Regulate Aberrant Protein Translation In Mantle Cell Lymphoma: Implications For Novel Biomarker
|
Hu, Guangzhen
|
|
|
122 |
21 |
p. 81
|
artikel
|
| 352 |
A Novel Molecular Mechanism In The Interplay Of Platelet GPIb-VWF-Fibrin In Thrombus Formation
|
Cruz, Miguel A.
|
|
|
122 |
21 |
p. 1065
|
artikel
|
| 353 |
A Novel Multi-Gene Expression Array Allows Highly Sensitive Detection Of Minimal Residual Disease and Predicts Relapse Outcomes In Acute Myeloid Leukemia
|
Goswami, Meghali
|
|
|
122 |
21 |
p. 3318
|
artikel
|
| 354 |
A Novel Mutation In Bruton Tyrosine Kinase Confers Acquired Resistance To Ibrutinib (PCI-32765) In CLL
|
Furman, Richard R.
|
|
|
122 |
21 |
p. 4914
|
artikel
|
| 355 |
A Novel Platform For The Identification Of Stromal-Derived Factors That Enhance Acute Lymphoblastic Leukemia Cell Survival In The Context Of Maintenance Chemotherapy
|
Patrick, Lauren B
|
|
|
122 |
21 |
p. 3861
|
artikel
|
| 356 |
A Novel Prognostic Model To Predict Relapse After Allogeneic Stem Cell Transplantation For Myelodysplastic Syndromes
|
Kenderian, Saad Sirop
|
|
|
122 |
21 |
p. 2098
|
artikel
|
| 357 |
A Novel Rapid Screening Assay for the Diagnosis of the Phenotypic Variants of Von Willebrand Disease (VWD)
|
Roberts, Jonathan C
|
|
|
122 |
21 |
p. 3567
|
artikel
|
| 358 |
A Novel Reduced-Toxicity Myeloablative Conditioningusing Full-Dose Busulfan and Melphalan For Cord Blood Transplantation Provides Durable Engraftment and Remission Without Increasing Non-Relapse Mortality In Advanced Myeloid Malignancies
|
Yamamoto, Hisashi
|
|
|
122 |
21 |
p. 2042
|
artikel
|
| 359 |
A Novel Role For Histone Deacetylase 11 (HDAC11) As a Regulator Of Neutrophil Function and Differentiation In Normal and Malignant Hematopoesis
|
Sahakian, Eva
|
|
|
122 |
21 |
p. 2267
|
artikel
|
| 360 |
A Novel Role For Histone Deacetylase 11 (HDAC11) In Plasma Cell Differentation and Survival
|
Sahakian, Eva
|
|
|
122 |
21 |
p. 1907
|
artikel
|
| 361 |
A Novel Role Of Tescalcin-Sodium/Hydrogen Exchange Axis Underlying Sorafenib Resistance In FLT3-ITD+ AML
|
Man, Cheuk Him
|
|
|
122 |
21 |
p. 3848
|
artikel
|
| 362 |
A Novel Sequestosome-1/p62 ZZ Domain Inhibitor Induces New Bone Formation In The Presence Of Myeloma In Vivo
|
Silbermann, Rebecca
|
|
|
122 |
21 |
p. 684
|
artikel
|
| 363 |
A Novel Small Molecule Inhibitor Of Deubiquitylating Enzyme USP14 and UCHL5 Induces Apoptosis In Myeloma Cells and Overcomes Bortezomib Resistance
|
Tian, Ze
|
|
|
122 |
21 |
p. 1923
|
artikel
|
| 364 |
A Novel Small Molecule STAT Inhibitor, BP-4-018, Demonstrates Significant Anti-Tumour Activity and Synergism With Bortezomib In Pre-Clinical In Vivo Models Of Multiple Myeloma
|
Croucher, Danielle C
|
|
|
122 |
21 |
p. 4441
|
artikel
|
| 365 |
A Novel Subtype-Classifier Of Pediatric Acute Lymphoblastic Leukemia Using Gexp Multiplexed System
|
Zhang, Han
|
|
|
122 |
21 |
p. 2589
|
artikel
|
| 366 |
A Novel Therapeutic Approach In Acute Myeloid Leukemia (AML): In Vivo Preclinical Pharmacokinetic (PK), Pharmacodynamic (PD) and Antileukemia Activities Of Synthetic 2'-O-Methylphosphorothioate Mir-29b
|
Wang, Hongyan
|
|
|
122 |
21 |
p. 3933
|
artikel
|
| 367 |
A Novel Therapy Of HLA-Mismatched Sibling Donor Combined With Third-Party Single Cord Blood Cell Transplantation In Patients With Hematologic MalignanciesÂFimproved Outcome Compared To Conventional Transplantation
|
Sun, Aining
|
|
|
122 |
21 |
p. 2088
|
artikel
|
| 368 |
A Novel TWIST2-ID2 Axis That Modulates The Growth and Imatinib Sensitivity Of CML CD34+ Cells
|
Zhao, Yun
|
|
|
122 |
21 |
p. 511
|
artikel
|
| 369 |
An RNAi-Therapeutic Targeting Tmprss6, in Conjunction With Oral Chelator Therapy, Ameliorates Anemia and Additively Diminishes Secondary Iron Overload In a Mouse Model Of β-Thalassemia Intermedia
|
Schmidt, Paul J
|
|
|
122 |
21 |
p. 1019
|
artikel
|
| 370 |
Antibodies Specific For Human Neutrophil Antigen 3a (HNA-3a) Recognize Complex Epitopes On Choline Transporter Protein 2 (CTL2): Implications For HNA-3a Antibody Detection
|
Bougie, Daniel W.
|
|
|
122 |
21 |
p. 3662
|
artikel
|
| 371 |
Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Significantly Mediate Burkitt Lymphoma (BL) Regression and Improve Survival In Human BL Xenografted NSG Mice
|
Chu, Yaya
|
|
|
122 |
21 |
p. 3263
|
artikel
|
| 372 |
Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells Produce Complete Responses With Acceptable Toxicity But Without Chronic B-Cell Aplasia In Children With Relapsed Or Refractory Acute Lymphoblastic Leukemia (ALL) Even After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
|
Lee III, Daniel W.
|
|
|
122 |
21 |
p. 68
|
artikel
|
| 373 |
Anti-CD19 Chimeric Antigen Receptor Controlled By The Suicide Gene HSVsr39TK In Hematopoietic Stem Cells For Immunotherapy Of B-Lineage Malignancies
|
Larson, Sarah M.
|
|
|
122 |
21 |
p. 1659
|
artikel
|
| 374 |
Anti-CD123 Chimeric Antigen Receptor T Cells (CART-123) Provide A Novel Myeloablative Conditioning Regimen That Eradicates Human Acute Myeloid Leukemia In Preclinical Models
|
Gill, Saar
|
|
|
122 |
21 |
p. 143
|
artikel
|
| 375 |
Anti-CD33 Chimeric Antigen Receptor Therapy For Acute Myeloid Leukemia
|
O'Hear, Carol E.
|
|
|
122 |
21 |
p. 1441
|
artikel
|
| 376 |
Anti-CD20 Chimeric Antigen Receptor Transduced T Cells Can Recognize Very Low Antigen Expression: Determination Of The Lower Threshold Required To Activate The CAR-T Cells
|
Watanabe, Keisuke
|
|
|
122 |
21 |
p. 4493
|
artikel
|
| 377 |
Anti-CD45 Monoclonal Antibody (MAb) Dose Optimization For Astatine-211 (211At)-Radioimmunotherapy (RIT) Of Relapsed Non-Hodgkin Lymphoma (NHL) In a Canine Model
|
Frost, Sofia H.L.
|
|
|
122 |
21 |
p. 5139
|
artikel
|
| 378 |
Anti-CD38 Pretargeted Radioimmunotherapy Eradicates Multiple Myeloma Xenografts In a Murine Model
|
Green, Damian J.
|
|
|
122 |
21 |
p. 882
|
artikel
|
| 379 |
Anticoagulation Inhibits Tumor Cell-Mediated Release Of Platelet Angiogenic Proteins and Disrupts The Platelet Angiogenic Potential
|
Battinelli, Elisabeth M.
|
|
|
122 |
21 |
p. 2303
|
artikel
|
| 380 |
Anticoagulation Prophylaxis With Enoxaparin For Patients With Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy
|
Sibai, Hassan
|
|
|
122 |
21 |
p. 2636
|
artikel
|
| 381 |
Anti-CXCL12/SDF-1 Spiegelmer® Nox-A12 Alone and In Combination With Bendamustine and Rituximab In Patients With Relapsed Chronic Lymphocytic Leukemia (CLL): Results From A Phase IIa Study
|
Gobbi, Marco
|
|
|
122 |
21 |
p. 1635
|
artikel
|
| 382 |
Anti-CXCL12/SDF-1 Spiegelmer® Nox-A12 Alone and In Combination With Bortezomib and Dexamethasone In Patients With Relapsed Multiple Myeloma: Results From A Phase IIa Study
|
Ludwig, Heinz
|
|
|
122 |
21 |
p. 1951
|
artikel
|
| 383 |
Anti-Factor VIII A2 Epitopes In a Murine Bleeding Model
|
Eubanks, Joshua
|
|
|
122 |
21 |
p. 1100
|
artikel
|
| 384 |
Anti-FVIII Autoantibodies Share Similar Characteristics In Acquired Hemophilia A Patients With and Without An Associated Disease
|
Kahle, Joerg
|
|
|
122 |
21 |
p. 1110
|
artikel
|
| 385 |
Anti-KIR Antibody Enhancement Of Anti-Lymphoma Activity Of Natural Killer Cells As Monotherapy and In Combination With Anti-CD20 Antibodies
|
Kohrt, Holbrook E
|
|
|
122 |
21 |
p. 4417
|
artikel
|
| 386 |
Anti-β2 Microglobulin Monoclonal Antibodies Overcome Bortezomib-Induced Drug Resistance In Multiple Myeloma By Inhibition Of Autophagy
|
Zhang, Mingjun
|
|
|
122 |
21 |
p. 929
|
artikel
|
| 387 |
Antimyeloma In Vitro Activity Of 15-Deoxy-D12,14-Prostaglandin J2 Is Associated With Endoplasmic Reticulum Stress In a Reactive Oxygen Species-Dependent Fashion
|
Demasi, Ana Paula
|
|
|
122 |
21 |
p. 4913
|
artikel
|
| 388 |
Anti-Neoplastic Effect Of High Affinity and Covalent-Binding Microtubule Stabilizing Agents In AML Cells Sensitive and Resistant By ABC-Transporter Overexpression
|
Pera, Benet
|
|
|
122 |
21 |
p. 4225
|
artikel
|
| 389 |
Anti-Obese Hormone Adiponectin Regulates Emergency Hematopoiesis and Antibacterial Response Through Downregulation Of Socs3 In Hematopoietic Progenitor Cells
|
Masamoto, Yosuke
|
|
|
122 |
21 |
p. 221
|
artikel
|
| 390 |
Antiphospholipid Antibodies Increase Von Willebrand Factor-Platelet String Formation From Human Endothelial Cells Under Physiologic Flow Conditions
|
Ng, Christopher J.
|
|
|
122 |
21 |
p. 2305
|
artikel
|
| 391 |
Antiphospholipid Antibodies Stimulate Release Of Endothelial Cell Microparticles Enriched In IL-1β
|
WU, Meifang
|
|
|
122 |
21 |
p. 35
|
artikel
|
| 392 |
Anti-Rh(D) Utilization Prior To and Following The FDA Mandate For Hemoglobinuria Screening 03/11/10
|
Varma, Mala
|
|
|
122 |
21 |
p. 4761
|
artikel
|
| 393 |
Antithymocyte Globulin and Role Of Stem Cell Source On Outcome In Myeloablative Conditioning Of Allogeneic Hematopoietic Stem Cell Transplantation With Identical Sibling and Matched Unrelated Donors - A Retrospective Study Of French Society Of Bone Marrow Graft Transplantation and Cellular Therapy -
|
Ravinet, Aurélie
|
|
|
122 |
21 |
p. 3382
|
artikel
|
| 394 |
Antithymocyte Globulin (Rabbit) Enhanced The Efficacy Of Tacrolimus and Mycophenolate For Graft-Versus-Host Disease Prophylaxis In Recipients Of Unrelated Stem Cell Transplant Resulting In Improvement Of Survival
|
Ratanatharathorn, Voravit
|
|
|
122 |
21 |
p. 3300
|
artikel
|
| 395 |
Antitumor Activities Of An Oral Selective HSP90α/β Inhibitor, TAS-116, In Combination With Bortezomib In Multiple Myeloma
|
Suzuki, Rikio
|
|
|
122 |
21 |
p. 4429
|
artikel
|
| 396 |
Anti Tumor Activity Of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) XPO1/CRM1 Antagonist In Patients (pts) With Relapsed / Refractory Multiple Myeloma (MM) Or Waldenstrom's Macroglobulinemia (WM)
|
Chen, Christine I.
|
|
|
122 |
21 |
p. 1942
|
artikel
|
| 397 |
Antitumor Activity Of The Glutaminase Inhibitor CB-839 In Hematological Malignances
|
Parlati, Francesco
|
|
|
122 |
21 |
p. 4226
|
artikel
|
| 398 |
Antitumor Effect Of Sepantronium Bromide (YM155), a Survivin Suppressant, In Combination With Bendamustine and Rituximab In Diffuse Large B-Cell Lymphoma
|
Kaneko, Naoki
|
|
|
122 |
21 |
p. 3073
|
artikel
|
| 399 |
Antitumor Efficacy Of DMSA Modified Fe3O4magnetic Nanoparticles Combined With Arsenic Trioxide and Adriamycin In Jurket Cells
|
Xiaohui, Cai
|
|
|
122 |
21 |
p. 4917
|
artikel
|
| 400 |
Anti-Tumour Efficacy Study Of The Bruton's Tyrosine Kinase (Btk) Inhibitor, ONO-4059, In Combination With The Glycoengineered Type II Anti-CD20 Monoclonal Antibody, Obinutuzumab (GA101) Demonstrates Superior In Vivo Efficacy Compared To ONO-4059 In Combination With Rituximab
|
Yoshizawa, Toshio
|
|
|
122 |
21 |
p. 3069
|
artikel
|
| 401 |
An Unbiased shRNA Library Screen Identifies Nucleocytoplasmic Transport As a Potential Target For Treatment Of Chronic Myeloid Leukemia
|
Khorashad, Jamshid Sorouri
|
|
|
122 |
21 |
p. 2707
|
artikel
|
| 402 |
An Unexpected Role For αIIbβ3 In Immune Complex Disorders
|
Zhi, Huiying
|
|
|
122 |
21 |
p. 2293
|
artikel
|
| 403 |
An Update On The Clinical Activity Of Resimmune, a Targeted Therapy Directed To CD3 Receptor, In Patients With Cutaneous T Cell Lymphomas--CTCL
|
Frankel, Arthur E.
|
|
|
122 |
21 |
p. 4381
|
artikel
|
| 404 |
An Update On The Robust Clinical Activity Of SL-401, a Targeted Therapy Directed To The Interleukin-3 Receptor On Cancer Stem Cells and Tumor Bulk, In Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
|
Frankel, Arthur E.
|
|
|
122 |
21 |
p. 2682
|
artikel
|
| 405 |
A NUP98-HOXD13 Leukemic Fusion Gene Leads To Aberrant Actin Localization In Dysplastic Megakaryocytes
|
Caudell, David L.
|
|
|
122 |
21 |
p. 2486
|
artikel
|
| 406 |
Any BCR-ABL Reduction Below 10% At 6 Months Of Therapy Significantly Improves Outcome For CML Patients With a Poor Response At 3 Months
|
Branford, Susan
|
|
|
122 |
21 |
p. 254
|
artikel
|
| 407 |
AOP2014/P1101, a Novel Peg-Proline-Interferon Alpha (IFNa) 2b, Specifically Targets JAK2V617F-Positive Polycythemia Vera (PV) Cells
|
Verger, Emmanuelle
|
|
|
122 |
21 |
p. 1611
|
artikel
|
| 408 |
A Pathologic Abdominal Ultrasonography At Diagnosis Of CLL Significantly Reduces The Time To Progression In Patients With Rai 0 Or Rai 1 Disease
|
Rossini, Fausto
|
|
|
122 |
21 |
p. 2869
|
artikel
|
| 409 |
A Patient Event Diary Improves Self-Management In Pediatric Sickle Cell Disease Patients
|
Busse, Jennifer Alison
|
|
|
122 |
21 |
p. 1723
|
artikel
|
| 410 |
APC/CCdh1 As a Mediator Of Hematopoietic Differentiation, Self-Renewal and Malignant Transformation
|
Schmidts, Andrea
|
|
|
122 |
21 |
p. 3676
|
artikel
|
| 411 |
A6 Peptide Is Selectively Cytotoxic For Chronic Lymphocytic Leukemia Cells
|
Zhang, Suping
|
|
|
122 |
21 |
p. 5303
|
artikel
|
| 412 |
A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results
|
Cappellini, Maria-Domenica
|
|
|
122 |
21 |
p. 3448
|
artikel
|
| 413 |
A Phase 1b, Dose-Finding Study Of Ruxolitinib Plus Panobinostat In Patients With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF): Identification Of The Recommended Phase 2 Dose
|
t Ribrag, Vincen
|
|
|
122 |
21 |
p. 4045
|
artikel
|
| 414 |
A Phase 1, Dose-Escalation Study (CHAMPION-1) Investigating Weekly Carfilzomib In Combination With Dexamethasone For Patients With Relapsed Or Refractory Multiple Myeloma
|
Berenson, James R.
|
|
|
122 |
21 |
p. 1934
|
artikel
|
| 415 |
A Phase I Dose Escalation Study Of Oral Bexarotene In Combination With Intravenous Decitabine In Patients With AML
|
Welch, John
|
|
|
122 |
21 |
p. 3931
|
artikel
|
| 416 |
A Phase I Dose Escalation Study Of TGR-1202, a Novel PI3K-δ Inhibitor, For Patients With Relapsed Or Refractory Hematologic Malignancies
|
Savona, Michael
|
|
|
122 |
21 |
p. 4373
|
artikel
|
| 417 |
A Phase II Clinical Trial Of Lenalidomide and Prednisone In Low and Intermediate-1 IPSS Risk, Non-Del (5q) MDS Patients
|
Komrokji, Rami S
|
|
|
122 |
21 |
p. 1506
|
artikel
|
| 418 |
A Phase II Expansion Study Of Vorinostat In Combination With Idarubicin and Cytarabine For Patients With Acute Myelogenous Leukemia (AML) With FLT3 Molecular Alterations
|
Takahashi, Koichi
|
|
|
122 |
21 |
p. 2684
|
artikel
|
| 419 |
A Phase I/II Combination Of RAD001 (Everolimus) and Lenalidomide For Relapsed Lymphoid Malignancy: Phase I Results
|
Reeder, Craig
|
|
|
122 |
21 |
p. 4350
|
artikel
|
| 420 |
A Phase I/II Open-Label Multicenter Study Of The Cyclin Kinase Inhibitor AT7519M Alone and In Combination With Bortezomib In Patients With Previously Treated Multiple Myeloma
|
Raje, Noopur
|
|
|
122 |
21 |
p. 1976
|
artikel
|
| 421 |
A Phase III Randomized, Double Blind, Placebo Controlled Multi-Center Study Of Panobinostat For Maintenance Of Response In Patients With Hodgkin Lymphoma Who Are At Risk For Relapse After High Dose Chemotherapy and Autologous Stem Cell Transplant: Final Results After Early Trial Discontinuation
|
von Tresckow, Bastian
|
|
|
122 |
21 |
p. 4648
|
artikel
|
| 422 |
A Phase III Study Of ASCT Vs Cyclophosphamide-Lenalidomide-Dexamethasone and Lenalidomide-Prednisone Maintenance Vs Lenalidomide Alone In Newly Diagnosed Myeloma Patients
|
Palumbo, Antonio
|
|
|
122 |
21 |
p. 763
|
artikel
|
| 423 |
A Phase I/II Study Of Cytarabine Or Azacitidine In Combination With Tosedostat In Older Patients With AML Or High-Risk MDS
|
DiNardo, Courtney D.
|
|
|
122 |
21 |
p. 2698
|
artikel
|
| 424 |
A Phase III Study Of Enzastaurin In Patients With High-Risk Diffuse Large B Cell Lymphoma Following Response To Primary Treatment: The Prelude Trial
|
Crump, Michael
|
|
|
122 |
21 |
p. 371
|
artikel
|
| 425 |
A Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy In Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Leukemia (SLL)
|
Mawad, Raya
|
|
|
122 |
21 |
p. 4191
|
artikel
|
| 426 |
A Phase I/II Study Of Hyper-CVAD Plus Everolimus In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
|
Daver, Naval
|
|
|
122 |
21 |
p. 3916
|
artikel
|
| 427 |
A Phase I-II Study Of The Efficacy and Safety Of Lenalidomide (LEN) Combined To Azacitidine (AZA) In Higher Risk MDS and AML With Del 5q – A Study By The Groupe Francophone Des Myelodysplasies (GFM)
|
Ades, Lionel
|
|
|
122 |
21 |
p. 2750
|
artikel
|
| 428 |
A Phase I/II Trial Evaluating The Use Of a Histone Deacetylase Inhibitor Panobinostat (LBH589) In Addition To Glucocorticoids In Patients With Acute Graft-Versus-Host Disease
|
Perez, Lia
|
|
|
122 |
21 |
p. 3308
|
artikel
|
| 429 |
A Phase I/II Trial Of Cyclophosphamide, Carfilzomib, Thalidomide and Dexamethasone (CYCLONE) In Patients With Newly Diagnosed Multiple Myeloma: Final Results Of MTD Expansion Cohort
|
Mikhael, Joseph R.
|
|
|
122 |
21 |
p. 3179
|
artikel
|
| 430 |
A Phase I/II Trial Of Pomalidomide, Bortezomib and Dexamethasone In Patients With Relpased Or Refractory Multiple Myeloma
|
Mikhael, Joseph R.
|
|
|
122 |
21 |
p. 1940
|
artikel
|
| 431 |
A Phase II Multi-Center Trial Of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) In Older Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients
|
Montillo, Marco
|
|
|
122 |
21 |
p. 4177
|
artikel
|
| 432 |
A Phase II, Single-Center, Open-Label Study Of Oral Panobinostat In Combination With Lenalidomide and Weekly Dexamethasone In Patients With Multiple Myeloma
|
Biran, Noa
|
|
|
122 |
21 |
p. 5392
|
artikel
|
| 433 |
A Phase II Study Of Aprepitant As Anti-Emetic Prophylaxis In Patients Receiving Induction Chemotherapy For AML
|
Brandwein, Joseph
|
|
|
122 |
21 |
p. 5035
|
artikel
|
| 434 |
A Phase II Study Of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) As Front Line Therapy For Patients With Peripheral T-Cell Lymphoma (PTCL): Preliminary Results From The T- Cell Consortium Trial
|
Advani, Ranjana H.
|
|
|
122 |
21 |
p. 3044
|
artikel
|
| 435 |
A Phase II Study Of Proteasome-Inhibition For Initial Therapy Of Chronic Graft-Versus-Host Disease
|
Herrera, Alex F.
|
|
|
122 |
21 |
p. 909
|
artikel
|
| 436 |
A Phase II Study Of The Combination Of Azacitidine and Lenalidomide In Patients (pts) With Higher Risk Myelodysplastic Syndromes (MDS)
|
Garcia-Manero, Guillermo
|
|
|
122 |
21 |
p. 2751
|
artikel
|
| 437 |
A Phase II Study Of The Efficacy and Safety Of An Intensified Schedule Of Azacitidine (AZA) In Intermediate-2 and High Risk MDS Patients
|
Ades, Lionel
|
|
|
122 |
21 |
p. 1513
|
artikel
|
| 438 |
A Phase II Study Of Tosedostat (TST) In Combination With Either Cytarabine Or Decitabine In Newly Diagnosed Older Patients With Acute Myeloid Leukemia (AML) Or High-Risk Myelodysplastic Syndrome (MDS)
|
Mawad, Raya
|
|
|
122 |
21 |
p. 3926
|
artikel
|
| 439 |
A Phase II Study Of V-BEAM (Bortezomib, Carmustine, Etoposide, Cytarabine, and Melphalan) As Conditioning Regimen Prior To Second Autologous Stem Cell Transplantation For Multiple Myeloma
|
Wang, Tzu-Fei
|
|
|
122 |
21 |
p. 5492
|
artikel
|
| 440 |
A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma
|
Bringhen, Sara
|
|
|
122 |
21 |
p. 685
|
artikel
|
| 441 |
A Phase II Trial Of Bortezomib-Rituximab Followed By Autologous Stem Cell Harvest (SCH) and Cladribine-Cyclophosphamide-Rituximab (2CdA-Cy-Rit) Consolidation As Primary Therapy Of Waldenström's Macroglobulinemia (WM)
|
Thomas, Sheeba K.
|
|
|
122 |
21 |
p. 4396
|
artikel
|
| 442 |
A Phase II Trial Of Eltrombopag For Patients With Chronic Lymphocytic Leukemia (CLL) and Thrombocytopenia
|
Jain, Nitin
|
|
|
122 |
21 |
p. 4186
|
artikel
|
| 443 |
A Phase II Trial Of Epigenetic Modulators Vorinostat In Combination With Azacitidine (azaC) In Patients With The Myelodysplastic Syndrome (MDS): Initial Results Of Study 6898 Of The New York Cancer Consortium
|
Silverman, Lewis R.
|
|
|
122 |
21 |
p. 386
|
artikel
|
| 444 |
A Phase I Single Ascending Dose Study Of NKTT120 In Stable Adult Sickle Cell Patients
|
Field, Joshua J.
|
|
|
122 |
21 |
p. 977
|
artikel
|
| 445 |
A Phase I Study Of AC220 (Quizartinib) In Combination With Cytarabine and Etoposide In Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances In Childhood Leukemia & Lymphoma (TACL) Study
|
Cooper, Todd Michael
|
|
|
122 |
21 |
p. 624
|
artikel
|
| 446 |
A Phase I Study Of An Anti-CD30 x Anti-CD16A Bispecific Tandab Antibody, AFM13, In Patients With Relapsed Or Refractory Hodgkin Lymphoma
|
Zhukovsky, Eugene
|
|
|
122 |
21 |
p. 5116
|
artikel
|
| 447 |
A Phase I Study Of Azacitidine After Donor Lymphocyte Infusion For Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
|
Ghobadi, Armin
|
|
|
122 |
21 |
p. 3320
|
artikel
|
| 448 |
A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies
|
Lancet, Jeffrey E
|
|
|
122 |
21 |
p. 3838
|
artikel
|
| 449 |
A Phase I Study Of Myeloablative Radioimmunotherapy Using Iodine-131 Anti-CD45 Antibody Followed By Autologous Stem Cell Transplantation For High-Risk B-Cell and T-Cell Non-Hodgkin Lymphoma and Hodgkin Lymphoma
|
Cassaday, Ryan D.
|
|
|
122 |
21 |
p. 3333
|
artikel
|
| 450 |
A Phase I Study Of Nilotinib As a c-Kit Inhibitor Combined With Re-Induction Chemotherapy For Relapsed and Refractory c-Kit Positive Acute Myeloid Leukemia
|
Brandwein, Joseph M.
|
|
|
122 |
21 |
p. 3961
|
artikel
|
| 451 |
A Phase I Study Of Panobinostat In Combination With ICE (Ifosfamide, Carboplatin and Etoposide) In Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma (cHL)
|
Oki, Yasuhiro
|
|
|
122 |
21 |
p. 252
|
artikel
|
| 452 |
A Phase I Study Of The Histone Deacetylase Inhibitor Entinostat Plus Clofarabine For Philadelphia Chromosome Negative, Poor Risk (Newly Diagnosed Older Adults or Adults with Relapsed and Refractory Disease) Acute Lymphoblastic Leukemia Or Bilineage/Biphenotypic Leukemia
|
Carraway, Hetty E
|
|
|
122 |
21 |
p. 1427
|
artikel
|
| 453 |
A Phase I Study Of The Oral Btk Inhibitor ONO-4059 In Patients With Relapsed/Refractory and High Risk Chronic Lymphocytic Leukaemia (CLL)
|
Salles, Gilles Andre
|
|
|
122 |
21 |
p. 676
|
artikel
|
| 454 |
A Phase I Study Of The Oral Btk Inhibitor ONO-4059 In Patients With Relapsed/Refractory B-Cell Lymphoma
|
Rule, Simon
|
|
|
122 |
21 |
p. 4397
|
artikel
|
| 455 |
A Phase I Study Of The Safety, Efficacy and Pharmacokinetics Of The First In Class Pyruvate Dehydrogenase Complex Inhibitor Cpi-613 In Patients With Advanced Hematologic Malignancies
|
Pardee, Timothy
|
|
|
122 |
21 |
p. 486
|
artikel
|
| 456 |
A Phase I Study Of The Vascular Disrupting Combretastatin, OXi4503, In Patients With Relapsed and Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)
|
Turner, Daniel
|
|
|
122 |
21 |
p. 1463
|
artikel
|
| 457 |
A Phase I Trial Of Anti-KIR Monoclonal Antibody IPH2101 and Lenalidomide For Multiple Myeloma
|
Benson Jr., Don M.
|
|
|
122 |
21 |
p. 3181
|
artikel
|
| 458 |
A Phase I Trial Of Zileuton In Sickle Cell Disease
|
Eiymo Mwa Mpollo, Marthe-Sandrine
|
|
|
122 |
21 |
p. 993
|
artikel
|
| 459 |
A Phase 1, Open Label Study To Evaluate The Drug Interaction Potential With Ketoconazole and The Effect Of Food On The Plasma Pharmacokinetics Of The Smoothened Inhibitor PF-04449913
|
Shaik, M.Naveed
|
|
|
122 |
21 |
p. 3857
|
artikel
|
| 460 |
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)
|
Furman, Richard R.
|
|
|
122 |
21 |
p. LBA-6
|
artikel
|
| 461 |
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors
|
Mark, Crowther
|
|
|
122 |
21 |
p. 3636
|
artikel
|
| 462 |
A Phase 1 Study Of ARRY-520 With Bortezomib (BTZ) and Dexamethasone (dex) In Relapsed Or Refractory Multiple Myeloma (RRMM)
|
Chari, Ajai
|
|
|
122 |
21 |
p. 1938
|
artikel
|
| 463 |
A Phase 1/2 Study Of Blinatumomab In Pediatric Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
|
Stackelberg, Arend von
|
|
|
122 |
21 |
p. 70
|
artikel
|
| 464 |
A Phase 1/2 Study Of Bosutinib (SKI-606) In Japanese Adults With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia (CML)
|
Takahashi, Naoto
|
|
|
122 |
21 |
p. 2736
|
artikel
|
| 465 |
A Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory CD30-Positive Non-Hodgkin Lymphomas: Interim Results In Patients With DLBCL and Other B-Cell Lymphomas
|
Bartlett, Nancy L.
|
|
|
122 |
21 |
p. 848
|
artikel
|
| 466 |
A Phase 1 Study Of JNJ-40346527, a Colony Stimulating Factor-1 Receptor (CSF-1R) Inhibitor, In Patients With Relapsed Or Refractory Hodgkin Lymphoma
|
von Tresckow, Bastian
|
|
|
122 |
21 |
p. 1812
|
artikel
|
| 467 |
A Phase 1/2 Study Of KW-2478, An Hsp 90 Inhibitor, In Combination With Bortezomib (BTZ) In Patients (Pts) With Relapsed/Refractory (R/R) Multiple Myeloma (MM)
|
Jamie, Cavanagh
|
|
|
122 |
21 |
p. 1967
|
artikel
|
| 468 |
A Phase 2 Study Of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) For Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy: Waldenström's Macroglobulinemia Cohort Results
|
Rosenthal, Allison C.
|
|
|
122 |
21 |
p. 4352
|
artikel
|
| 469 |
A Phase 2 Study Of Ruxolitinib In Patients With Splanchnic Vein Thrombosis Associated With Myeloproliferative Neoplasm. Preliminary Results
|
Pieri, Lisa
|
|
|
122 |
21 |
p. 1583
|
artikel
|
| 470 |
A Phase 2 Study Of Single-Agent Brentuximab Vedotin For Front-Line Therapy Of Hodgkin Lymphoma In Patients Age 60 Years and Above: Interim Results
|
Yasenchak, Christopher A.
|
|
|
122 |
21 |
p. 4389
|
artikel
|
| 471 |
A Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, In Patients With Advanced Leukemias
|
Konopleva, Marina
|
|
|
122 |
21 |
p. 3920
|
artikel
|
| 472 |
A Phase 1/2 Study Of The Safety and Activity Of Escalating Doses Of Lenalidomide Plus Rituximab For Patients With Refractory Or Relapsed Chronic Lymphocytic Leukemia (LLC-Lenar-08)
|
Tomas, Jose Francisco
|
|
|
122 |
21 |
p. 5304
|
artikel
|
| 473 |
A Phase 1 Study Of The Selective PI3Kδ Inhibitor Idelalisib (GS-1101) In Combination With Therapeutic Anti-CD20 Antibodies (Rituximab or Ofatumumab) In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia
|
Furman, Richard R.
|
|
|
122 |
21 |
p. 4180
|
artikel
|
| 474 |
A Phase 1 Trial Of Reolysin Alone In Patients With Refractory Or Relapsed Multiple Myeloma
|
Sborov, Douglas W.
|
|
|
122 |
21 |
p. 3208
|
artikel
|
| 475 |
A Phase 2 Trial Of The Fetal Hemoglobin Inducer HQK-1001 (2,2-dimethylbutyrate, Sodium Salt) In Non-Transfusion-Dependent β-Thalassemia
|
Inati, Adlette
|
|
|
122 |
21 |
p. 2261
|
artikel
|
| 476 |
A Pilot Study Of Bone Marrow and Adipose Tissue – Derived Mesenchymal Stem Cells In Chronic Myeloid Leukemia (CML); Mesenchymal Stem Cells Of The Bone Marrow Harbor The Bcr-Abl Fusion Gene In a CML Patient
|
Papadopoulou, Vasiliki
|
|
|
122 |
21 |
p. 1480
|
artikel
|
| 477 |
A Pilot Study Of Continuous Infusion Mycophenolate Mofetil For Graft Versus Host Disease Prophylaxis
|
Windreich, Randy M.
|
|
|
122 |
21 |
p. 4571
|
artikel
|
| 478 |
A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia
|
Martyr, Sabrina
|
|
|
122 |
21 |
p. 2479
|
artikel
|
| 479 |
A Pilot Study Of Sorafenib In Refractory Or Relapsed T-Cell Lymphoma Patients
|
Fraser, Juliet
|
|
|
122 |
21 |
p. 4356
|
artikel
|
| 480 |
A Pilot Study To Examine The Effect Of Extracorporeal Membrane Oxygenation (ECMO) On Plasma Factor XIII Levels
|
Sanchez, Dimarys
|
|
|
122 |
21 |
p. 4774
|
artikel
|
| 481 |
Apixaban Reduces Hospitalization In Patients With Venous Thromboembolism: An Analysis Of The AMPLIFY-EXT Trial
|
Liu, Xianchen
|
|
|
122 |
21 |
p. 3638
|
artikel
|
| 482 |
A Platform Minigene AAVS1 Targeted Safe Harbor Approach For Genetic Correction Of iPSC Derived From Patients With Each Of The 5 Genetic Forms Of Chronic Granulomatous Disease
|
Merling, Randall K
|
|
|
122 |
21 |
p. 1024
|
artikel
|
| 483 |
Aplicability Of The Predictive Model Of Response To Erythropoetic Stimulating Agents (ESA) From Myelodysplastic Syndromes (MDS) and Analysis Of Response and Overall Survival (OS) In a Series Of 99 Patients (Pts) With Chronic Myelomonocytic Leukemia (CMML) From The Spanish Registry Of MDS and The Düsseldorf-MDS Registry, Germany
|
Xicoy, Blanca
|
|
|
122 |
21 |
p. 2813
|
artikel
|
| 484 |
A Pooled Overall Survival Analysis of The COMFORT Studies: 2 Randomized Phase 3 Trials of Ruxolitinib For The Treatment of Myelofibrosis
|
Vannucchi, Alessandro M.
|
|
|
122 |
21 |
p. 2820
|
artikel
|
| 485 |
Apoptosis Of The All-Trans-Retinoic Acid (ATRA )-Sensitive (NB4 ) Cells Induced By Puerariae Radix Flavones In Vitro
|
Qun, Shen
|
|
|
122 |
21 |
p. 5041
|
artikel
|
| 486 |
A Possible Role Of The Tetraspanin CD9 In Bone Marrow Retention and Engraftment Of Human CD34+ Hematopoietic Stem/Progenitor Cells
|
Leung, Kam Tong
|
|
|
122 |
21 |
p. 3237
|
artikel
|
| 487 |
Apparent Involvement Of The Interferon, RNA Processing, and Wnt Signaling Pathways In Monoclonal B Lymphocytosis
|
Yan, Xiao-Jie
|
|
|
122 |
21 |
p. 4157
|
artikel
|
| 488 |
Application Of BOS 0-Potential Criteria As a Predictor For Bronchiolitis Obliterans Syndrome In Allogeneic Stem Cell Transplant Patients
|
Abedin, Sameem
|
|
|
122 |
21 |
p. 2060
|
artikel
|
| 489 |
Application Of The Revised International Prognostic Scoring System In Korean Patients With MDS and Clinical Significance Of Clonal Evolution
|
Park, Jae Hyeon
|
|
|
122 |
21 |
p. 5217
|
artikel
|
| 490 |
Appropriateness Of Prescribing Of Direct Oral Anticoagulants: A Prospective Cohort Study At CHU UCL Mont-Godinne-Dinant
|
Larock, Anne-Sophie
|
|
|
122 |
21 |
p. 4809
|
artikel
|
| 491 |
A Pre-Clinical Model Of Hematopoietic Stem Cell Based Immunotherapy For Cancer Utilizing The NY-ESO-1 T-Cell Receptor and sr39TK PET Reporter / Suicide Gene
|
Gschweng, Eric H.
|
|
|
122 |
21 |
p. 2020
|
artikel
|
| 492 |
A Prognostic Score For Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
Gruhn, Bernd
|
|
|
122 |
21 |
p. 3389
|
artikel
|
| 493 |
A Promoting Effect Of Spleen On Disseminated Leukemia Cells
|
Shi, Yingxu
|
|
|
122 |
21 |
p. 2594
|
artikel
|
| 494 |
A Proposed Prognostic Model For Overall Survival In The Oldest Old (>80 Years Old) Follicular Lymphoma Patients
|
Nabhan, Chadi
|
|
|
122 |
21 |
p. 3058
|
artikel
|
| 495 |
A Prospective, Multicenter Phase II Study Of Continuous Infusion Of FLAG For Patients Older Than 60 Years With Resistant Acute Myeloid Leukemia: A Comparison With Intensive Younger patients' Trial
|
Kim, Hawk
|
|
|
122 |
21 |
p. 3968
|
artikel
|
| 496 |
A Prospective Multicenter Study Of The Bruton's Tyrosine Kinase Inhibitor Ibrutinib In Patients With Relapsed Or Refractory Waldenstrom's Macroglobulinemia
|
Treon, Steven Peter
|
|
|
122 |
21 |
p. 251
|
artikel
|
| 497 |
A Prospective Study On Drug Monitoring Of Pegasparaginase and Erwinia Asparaginase and Asparaginase Antibodies In Pediatric Acute Lymphoblastic Leukemia
|
Tong, Wing H.
|
|
|
122 |
21 |
p. 2634
|
artikel
|
| 498 |
A Proteomics-Based Approach To Identifying Mechanisms Of Cancer-Associated Thrombosis: Potential Role For Immunoglobulins
|
Khorana, Alok A.
|
|
|
122 |
21 |
p. 1127
|
artikel
|
| 499 |
Aptamer TY04 Inhibits Multiple Myeloma Cell Growth Via Cell Cycle Arrest
|
Liu, Jing
|
|
|
122 |
21 |
p. 5390
|
artikel
|
| 500 |
A Randomized Comparison Of Maintenance Therapy With Subcutaneous Rituximab For 2 Years Versus Until Progression In Patients With Indolent Non-Hodgkin's Lymphoma: Interim Safety Data From The Mabcute Study
|
Rule, Simon
|
|
|
122 |
21 |
p. 3052
|
artikel
|
| 501 |
A Randomized Controlled Study Evaluating The Efficacy Of Aprepitant For Highly Emetogenic Chemotherapies In Hematological Malignancies
|
Nasu, Ryo
|
|
|
122 |
21 |
p. 1790
|
artikel
|
| 502 |
A Randomized, Multicenter Study (PALG CLL4/ ML 21283) Of Maintenance Treatment With Rituximab Versus Observation After Induction Treatment With Rituximab, Cladribine, and Cyclophosphamide (RCC) Regimen In Patients With Progressive Chronic Lymphocytic Leukemia: Interim Analysis
|
Robak, Tadeusz
|
|
|
122 |
21 |
p. 1640
|
artikel
|
| 503 |
A Randomized Open-Label Study To Evaluate The Efficacy Of Azacitidine For Post-Remission Therapy Of Acute Myeloid Leukemia In Elderly Patients (QOLESS AZA-AMLE)
|
Oliva, Esther Natalie
|
|
|
122 |
21 |
p. 3967
|
artikel
|
| 504 |
A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization
|
Lopez-Guillermo, Armando
|
|
|
122 |
21 |
p. 369
|
artikel
|
| 505 |
A Randomized Phase II Study Of Sapacitabine In MDS Refractory To Hypomethylating Agents
|
Garcia-Manero, Guillermo
|
|
|
122 |
21 |
p. 2752
|
artikel
|
| 506 |
A Randomized Phase 3 Trial Of Melphalan-Lenalidomide-Prednisone (MPR) Or Cyclophosphamide-Prednisone-Lenalidomide (CPR) Vs Lenalidomide Plus Dexamethsone (Rd) In Elderly Newly Diagnosed Multiple Myeloma Patients
|
Palumbo, Antonio
|
|
|
122 |
21 |
p. 536
|
artikel
|
| 507 |
A Randomized Study Of Music Therapy In Patients Undergoing Autologous Stem Cell Transplant: Decrease In Narcotic Medication Use For Pain Control
|
Duong, Hien K.
|
|
|
122 |
21 |
p. 1693
|
artikel
|
| 508 |
A Randomized Trial Of Daily Prednisone Versus Pulsed Dexamethasone In Treatment Naïve Patients With Idiopathic Thrombocytopenic Purpura
|
Matschke, Johannes
|
|
|
122 |
21 |
p. 325
|
artikel
|
| 509 |
A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12
|
Crump, Michael
|
|
|
122 |
21 |
p. 155
|
artikel
|
| 510 |
A Rapid and Robust Molecular Diagnostic Approach For Multiple Myeloma – Results From a Large Trial Cohort
|
Kaiser, Martin F.
|
|
|
122 |
21 |
p. 3097
|
artikel
|
| 511 |
A Rare Genetic Polymorphism In C5 Confers Poor Response To The Anti-C5 Monoclonal Antibody Eculizumab In 11 Japanese Patients With PNH
|
Nishimura, Jun-ichi
|
|
|
122 |
21 |
p. 3709
|
artikel
|
| 512 |
A Rare Population of Stem Cell Memory T Cells is an Apex of the Hierarchy of Adult T-Cell Leukemia
|
Nagai, Yuya
|
|
|
122 |
21 |
p. 3001
|
artikel
|
| 513 |
ARC Supports Leukemia-Stromal Interactions By Regulating Multiple Receptor-Chemokine Axes In AML
|
Carter, Bing Z
|
|
|
122 |
21 |
p. 3947
|
artikel
|
| 514 |
ARC Suppresses Cell Death By Antagonizing p53 Function and Suppressing TRAIL In AML Cells
|
Mak, Po Yee
|
|
|
122 |
21 |
p. 2688
|
artikel
|
| 515 |
Are Absolute Monocyte Count and The Lymphocyte-Monocyte Ratio (LMR) Valid Prognostic Factors In Classical Hodgkin Lymphoma? An Evaluation Based On Data From 1079 Patients
|
Sacchi, Stefano
|
|
|
122 |
21 |
p. 1754
|
artikel
|
| 516 |
A Real Life Survey On Erythropoietin Alpha Treatment In a Cohort Of 1049 Low Risk MDS Patients: An Italian MDS Registry Study
|
Messa, Emanuela
|
|
|
122 |
21 |
p. 745
|
artikel
|
| 517 |
Are Outcomes Worse For Patients With Polycythemia Vera compared to Polycythemia Of Unknown Cause? – a Retrospective Analysis Of Single Institution Patient Cohorts
|
Chacko, Joseph
|
|
|
122 |
21 |
p. 4079
|
artikel
|
| 518 |
A Report On a Phase 2 Trial Of Combination Therapy With Lenalidomide and Azacitidine In Patients With Non-Del 5q, Low Risk MDS
|
Shammo, Jamile M.
|
|
|
122 |
21 |
p. 5232
|
artikel
|
| 519 |
Are Racial and Ethnic Disparities In Acute Myeloid Leukemia Due To Differences In Treatment?
|
Patel, Manali I.
|
|
|
122 |
21 |
p. 726
|
artikel
|
| 520 |
A Restrospective Review Of Thrombophilia Evaluation At a Single Academic Institution
|
Naidzionak, Uladzislau
|
|
|
122 |
21 |
p. 4796
|
artikel
|
| 521 |
A Retrospective Analysis Of The Association Between Common Myeloablative Conditioning Regimens and Hepatotoxicity
|
Patel, Rushang D.
|
|
|
122 |
21 |
p. 5515
|
artikel
|
| 522 |
A Retrospective Evaluation Of Insurance Status As It Relates To Outcomes In Diffuse Large B-Cell Lymphoma
|
Little, Bryan J
|
|
|
122 |
21 |
p. 1702
|
artikel
|
| 523 |
A Retrospective Review Of Factor X Levels and Bleeding Risk In Patients With Amyloidosis
|
Konde, Anish S.
|
|
|
122 |
21 |
p. 3603
|
artikel
|
| 524 |
A Retrospective Study Of The Anti-Proteinuric Effects Of Hydroxyurea and Angiotensin-Converting Enzyme Inhibitors Or Angiotensin II Receptor Blockers In Adults With Sickle Cell Disease
|
Grist, Caroline
|
|
|
122 |
21 |
p. 4678
|
artikel
|
| 525 |
A Review Of Computed Tomography Pulmonary Angiograms In Three Teaching Hospitals: The Rise Of Sub-Segmental Pulmonary Emboli and Their Management
|
Goy, Jennifer
|
|
|
122 |
21 |
p. 932
|
artikel
|
| 526 |
Are We Appropriately Using Intravenous Immunoglobulin In The Saskatoon Health Region?
|
Manna, Mita
|
|
|
122 |
21 |
p. 4825
|
artikel
|
| 527 |
Arginine Deprivation With Pegylated Arginine Deiminase Induces Death Of Acute Myeloid Leukaemia Cells In Vivo
|
Miraki-Moud, Farideh
|
|
|
122 |
21 |
p. 1458
|
artikel
|
| 528 |
Arginine Methylation Of RBM15 By PRMT1 Controls Alternative Splicing Of Genes Involved In Megakaryocyte Differentiation
|
Zhao, Xinyang
|
|
|
122 |
21 |
p. 2443
|
artikel
|
| 529 |
Argonaute2 promotes myeloma angiogenesis by deregulation of microRNAs
|
Lijuan, Chen
|
|
|
122 |
21 |
p. 5334
|
artikel
|
| 530 |
A Risk-Prediction Model For Identifying Venous Thromboembolism In Hospitalized Pediatric Patients: A Single Institution Retrospective Case-Control Analysis
|
Goel, Ruchika
|
|
|
122 |
21 |
p. 2957
|
artikel
|
| 531 |
A Risk Score Integrating BAALC, ERG and WT1 Expression Can Be Used To Improve Risk Stratification In Acute Promyelocytic Leukemia
|
Hecht, Anna
|
|
|
122 |
21 |
p. 1323
|
artikel
|
| 532 |
Arming An Anti-CD38, Myeloma-Targeting Antibody With An Attenuated IFNα Provides >10,000-Fold Enhanced Tumor-Specific Activity Compared To Native IFNα
|
Pogue, Sarah L.
|
|
|
122 |
21 |
p. 1956
|
artikel
|
| 533 |
A Robust Ex-Vivo Erythropoiesis System For Studying Transcriptional Regulation Of Globin Genes In Thalassaemia
|
Rayabaram, Janakiram
|
|
|
122 |
21 |
p. 2259
|
artikel
|
| 534 |
A Robust Screening Assay For Diamond Blackfan Anemia Candidate Drugs
|
Siva, Kavitha
|
|
|
122 |
21 |
p. 2472
|
artikel
|
| 535 |
A Role For a Multi-Drug Resistance Protein (MRP4/ABCC4) In Pediatric Acute Myeloid Leukemia (AML)
|
Lian, Shang Li
|
|
|
122 |
21 |
p. 2518
|
artikel
|
| 536 |
A Role For MMP-3 In The Modulation Of Early T Cell Responses In Gvhd
|
Rosenberg, Stephen M
|
|
|
122 |
21 |
p. 3258
|
artikel
|
| 537 |
Array-Based Comparative Genomic Hybridization (aCGH) In Myelofibrosis Reveals Divergent Genetic Copy Number Alterations Among Patients With Post-Essential Thrombocythemia-Myelofibrosis/Post-Polycythemia Rubra Vera-Myelofibrosis (PET-MF and PPV-MF) and Patients With Idiopathic Myelofibrosis
|
Savona, Michael
|
|
|
122 |
21 |
p. 5266
|
artikel
|
| 538 |
Array-Based Integrative Analysis Of Epigenomic and Transcriptomic Alterations In CD71+ Bone Marrow Erythroprogenitor Cells From Patients With Myelodysplastic Syndromes
|
Mossner, Maximilian
|
|
|
122 |
21 |
p. 1561
|
artikel
|
| 539 |
Array CGH Identifies Copy Number Changes In 10% Of 520 MDS Patients With Normal Karyotype: Deletions Encompass The Genes TET2, DNMT3A, ETV6, NF1, RUNX1, and STAG2 and Are Associated With Shorter Survival
|
Haferlach, Claudia
|
|
|
122 |
21 |
p. 1516
|
artikel
|
| 540 |
ARRY-520 Combined With Pomalidomide Displays Enhanced Anti-Tumor Activity In Preclinical Models Of Multiple Myeloma
|
Humphries, Michael J
|
|
|
122 |
21 |
p. 3167
|
artikel
|
| 541 |
Arsenic Trioxide (ATO) Or ATRA For Consolidation Treatment Of Standard Risk Non Elderly Newly Diagnosed APL– Second Interim Analysis Of a Randomized Trial (APL 2006) By The French Belgian Swiss APL Group
|
Ades, Lionel
|
|
|
122 |
21 |
p. 495
|
artikel
|
| 542 |
Arsenic Trioxide-Based Therapy Of Relapsed Acute Promyelocytic Leukemia: Updated Results Of The European Registry Of Relapsed APL (PROMYSE)
|
Lengfelder, Eva
|
|
|
122 |
21 |
p. 1406
|
artikel
|
| 543 |
Arsenic Trioxide Induces Apoptosis In Chronic Lymphocytic Leukemic Cells Through Down-Regulation Of Survivin Via The p53-Dependent Signaling Pathway
|
Zhang, Xiaohui
|
|
|
122 |
21 |
p. 5313
|
artikel
|
| 544 |
Arsenic Trioxide Induces Platelet Apoptosis
|
Wu, Yicun
|
|
|
122 |
21 |
p. 4738
|
artikel
|
| 545 |
Aryl Hydrocarbon Receptor Deficient Donor T Cells Display Decreased Migration and Cause Reduced Or Enhanced Graft-Versus-Host Diseases In Different Transplant Models
|
Lin, Kaifeng Lisa
|
|
|
122 |
21 |
p. 4477
|
artikel
|
| 546 |
A Second Autologous Stem Cell Transplant (ASCT2) Induces Superior Durability Of Response (DuR) Following Bortezomib-Containing Re-Induction Therapy For Relapsed Multiple Myeloma (MM): Final Results From The BSBMT/Ukmf Myeloma X (Intensive) Trial
|
Cook, Gordon
|
|
|
122 |
21 |
p. 765
|
artikel
|
| 547 |
A Sequential Two-Stage Dose Escalation Study Evaluating The Safety and Efficacy Of Eltrombopag In Thrombocytopenic Patients With Myelodysplastic Syndrome (MDS) Resistant To Hypomethylating Agents (HMA)
|
Komrokji, Rami S
|
|
|
122 |
21 |
p. 2760
|
artikel
|
| 548 |
A Significant Early Detection Of Poor Outcome In Acute Myeloid Leukemia Patients Having a Minimal Residual Disease Using Multiparameter Flow Cytomerty Combined To Mixed Chimerism At Three Months After Allogeneic Hematopoietic Stem Cell Transplantation
|
Beckerich, Florence
|
|
|
122 |
21 |
p. 4639
|
artikel
|
| 549 |
A Simple Genetic Thrombosis Score Of Five Single Nucleotide Polymorphisms Is Associated With Risk Of First Venous Thrombosis In Pregnant Women
|
Bare, Lance A.
|
|
|
122 |
21 |
p. 3617
|
artikel
|
| 550 |
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients
|
Larocca, Alessandra
|
|
|
122 |
21 |
p. 687
|
artikel
|
| 551 |
A Single-Arm, Open-Label, Multi-Center Phase I/II Study Of The Combination Of Panobinostat and Carfilzomib In Patients (pts) With Relapsed Or Relapse/Refractory Multiple Myeloma (MM)
|
Berdeja, Jesus
|
|
|
122 |
21 |
p. 1937
|
artikel
|
| 552 |
A Single Center Experience With Pralatrexate Alone Or In Combination With Bexarotene: Long Term Responses In Advanced Stage Relapsed/Refractory Cutaneous T-Cell Lymphoma
|
Talpur, Rakhshandra
|
|
|
122 |
21 |
p. 5113
|
artikel
|
| 553 |
A Single Center Phase II Trial Of 90yttrium-Ibritumomab-Tiuxetan Produces High Response Rates As First-Line Therapy For Early Stage B Cell Indolent Lymphoma, Including Bulky Disease
|
Samaniego, Felipe
|
|
|
122 |
21 |
p. 3039
|
artikel
|
| 554 |
A Single Micro-RNA Can Completely Rescue B-Cell Differentiation Arrest Due To EBF1 Deficiency: Can Micro-RNA Control Cell Fate As a Potential Alternative Of Transcriptional Factor?
|
Chanda, Bidisha
|
|
|
122 |
21 |
p. 338
|
artikel
|
| 555 |
A Single Nucleotide Polymorphism Of Growth Factor Independence 1 (GFI136N) is a Novel Prognostic Marker For The Progression Of Myelodysplastic Syndrome To Acute Myeloid Leukemia
|
Michel, Lars C.
|
|
|
122 |
21 |
p. 2491
|
artikel
|
| 556 |
A Small Molecule, Shikonin, Dually Functions As a Proteasome Inhibitor and a Necroptosis Inducer In Multiple Myeloma Cells
|
Wada, Naoko
|
|
|
122 |
21 |
p. 3172
|
artikel
|
| 557 |
A Specific Mechanism By Which NPM1 mutations Impede Myeloid Differentiation Also Explains The Link With DNMT3A Mutation
|
Gu, Xiaorong
|
|
|
122 |
21 |
p. 1254
|
artikel
|
| 558 |
Assessing B Lymphocyte Clonal Diversity, Expansion, and Convergent Evolution By High-Throughput Sequencing Of Rearranged IGH Segments From Naïve and Memory Repertoires
|
DeWitt III, William S
|
|
|
122 |
21 |
p. 1045
|
artikel
|
| 559 |
Assessment Of a Novel Synthetic Collagen Reagent By Platelet Aggregometry
|
Jeske, Walter
|
|
|
122 |
21 |
p. 3645
|
artikel
|
| 560 |
Assessment Of Drug Toxicity In Patients With and Without Renal Impairment Receiving Lenalidomide At a Large Academic Institution
|
Leblebjian, Houry
|
|
|
122 |
21 |
p. 1977
|
artikel
|
| 561 |
Assessment Of Early Cytogenetic Response By 3 Months Versus >3-6 Months Or No Response By 6 Months As a Predictor Of Long-Term Clinical Outcomes In a Phase 1/2 Study Of Bosutinib In Chronic Phase CML
|
Cortes, Jorge E.
|
|
|
122 |
21 |
p. 1484
|
artikel
|
| 562 |
Assessment Of Endothelial Damage and Cardiac Injury In a Mouse Model Mimicking Thrombotic Thrombocytopenic Purpura
|
Le Besnerais, Maelle
|
|
|
122 |
21 |
p. 447
|
artikel
|
| 563 |
Assessment Of EZH2 Expression In CD34+ Bone Marrow Progenitor Cells Of Patients Of Myelodysplastic Syndromes (MDS)
|
Wei, Yue
|
|
|
122 |
21 |
p. 2805
|
artikel
|
| 564 |
Assessment Of Human Equilibrative Nucleoside Transporter 1 (hENT1) – Expression By Flow Cytometry In Acute Myeloid Leukemia and Myelodysplastic Syndromes and Correlation To Clinical Outcome In Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy
|
Bellos, Frauke
|
|
|
122 |
21 |
p. 2582
|
artikel
|
| 565 |
Assessment Of Hypersensitivity Reactions and Feasibility Of a 60 Minute Rapid Infusion Rituximab Protocol At a Comprehensive Cancer Center
|
Dotson, Emily
|
|
|
122 |
21 |
p. 2985
|
artikel
|
| 566 |
Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry
|
Lacombe, Francis
|
|
|
122 |
21 |
p. 2613
|
artikel
|
| 567 |
Assessment Of Non-Transfusional Iron Accumulation In Asian Patients With Hemoglobin E β Thalassemia
|
St Pierre, Tim G
|
|
|
122 |
21 |
p. 2262
|
artikel
|
| 568 |
Assessment Of The Clinical Diagnostic Value Of Hevylite™ Analysis Compared With Routine Serum Protein Electrophoresis Screening and/Or Monitoring
|
Gates, Jon P
|
|
|
122 |
21 |
p. 5360
|
artikel
|
| 569 |
Assessment Of The Endocrine Function Of Patients With Sickle Cell Disease After Allogeneic Hematopoietic Stem Cell Transplantation
|
Gharwan, Helen
|
|
|
122 |
21 |
p. 4646
|
artikel
|
| 570 |
Assessment Of The Hematopoietic Cell Transplantation Comorbidity Index In Older Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
|
Keebler, Chandra
|
|
|
122 |
21 |
p. 5506
|
artikel
|
| 571 |
Assessment Of The Validation and Performance Of The Cone and Plate(let) Analyzer (CPA) In The Diagnosis Of Von Willebrand's Disease
|
Lubetsky, Aaron
|
|
|
122 |
21 |
p. 2351
|
artikel
|
| 572 |
Assessment Of The Value Of a Day 14 Bone Marrow In Newly Diagnosed AML
|
Yezefski, Todd Allen
|
|
|
122 |
21 |
p. 5002
|
artikel
|
| 573 |
Assisted Administration Of Subcutaneous 5-Azacytidine to The Patient's Home. Significant Reduction Of Indirect Costs Incurred By Care Recipients and Unpaid Caregivers Together With a Total Adhesion To The Treatment Schedule and Same Safety
|
Iuliano, Francesco
|
|
|
122 |
21 |
p. 5587
|
artikel
|
| 574 |
Association Between Gene Expression Profiles and Commonly Mutated Genes In The Hematopoietic Stem Cells Of Patients With Myelodysplastic Syndromes
|
Pellagatti, Andrea
|
|
|
122 |
21 |
p. 2779
|
artikel
|
| 575 |
Association Between Immunoparesis and a Skewed Free Light Chain (FLC) Ratio: A New Prognostic Factor Of Progression from MGUS To Multiple Myeloma?
|
Pizzuti, Michele
|
|
|
122 |
21 |
p. 5314
|
artikel
|
| 576 |
Association Between Inherited and Acquired Thrombophilias and The Post Thrombotic Syndrome: A Systematic Review and Metaanalysis
|
Rabinovich, Anat
|
|
|
122 |
21 |
p. 4797
|
artikel
|
| 577 |
Association Between S6K1 Phosphorylation and Cytotoxic Efficacy Of S6K1 Inhibitors
|
Liu, Hongqi
|
|
|
122 |
21 |
p. 5576
|
artikel
|
| 578 |
Association Between Treatment Adherence and Response Among Patients With Chronic Myeloid Leukemia (CML) Receiving First-Line TKIs In The Community Setting
|
Di Bella, Nicholas J.
|
|
|
122 |
21 |
p. 2733
|
artikel
|
| 579 |
Association Of Bleeding Tendency With Time Under Target FIX Activity Levels In Severe Hemophilia B Patients Treated With Recombinant Factor IX Fc Fusion Protein
|
Shapiro, Amy
|
|
|
122 |
21 |
p. 2349
|
artikel
|
| 580 |
Association Of Cardiac Iron By T2* With Innate Immune Markers In Transfusion-Dependent Thalassemia Patients Undergoing Combined Chelation Therapy
|
Walter, Patrick B
|
|
|
122 |
21 |
p. 3450
|
artikel
|
| 581 |
Association Of Chemokine Receptor CCR5, CCR6 and CCR7 Expressions On T Lymphocyte Subsets In Recipients After Allo-HSCT With Acute GvHD
|
Wang, Meng
|
|
|
122 |
21 |
p. 4596
|
artikel
|
| 582 |
Association Of Cytogenetic Response (CyR) With RBC Transfusion-Independence (RBC-TI) and AML-Free Survival In Lenalidomide (LEN)-Treated Patients (Pts) With IPSS Low-/Int-1-Risk Myelodysplastic Syndromes (MDS) With Del(5q)
|
Sekeres, Mikkael A.
|
|
|
122 |
21 |
p. 390
|
artikel
|
| 583 |
Association Of FLT3 Mutations With Unfavorable Factors In AML and APL Patients
|
Shmunk, Irina
|
|
|
122 |
21 |
p. 4967
|
artikel
|
| 584 |
Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis
|
Urbano-Ispizua, Alvaro
|
|
|
122 |
21 |
p. 2093
|
artikel
|
| 585 |
Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT
|
Giebel, Sebastian
|
|
|
122 |
21 |
p. 2150
|
artikel
|
| 586 |
Association Of Large Granular Lymphocytic Leukemia (LGL) With B-Cell Lymphoproliferative Disorders
|
Skarbnik, Alan P.Z.
|
|
|
122 |
21 |
p. 1387
|
artikel
|
| 587 |
Association Of More Than One B Cell Clone Arises In Any Type Of Leukemic Chronic B Cell Disorder
|
Lazarian, Gregory
|
|
|
122 |
21 |
p. 4161
|
artikel
|
| 588 |
Association Of Platelet Function Markers, Independent Of Platelet Count, With Bleeding Score In Patients With Immune Thrombocytopenia
|
Frelinger III, Andrew L.
|
|
|
122 |
21 |
p. 3534
|
artikel
|
| 589 |
Association Of Stringed Response and Immunoparesis Normalization After Bortezomib-Based Therapy Is Related To Better Outcomes In Multiple Myeloma
|
Andrade Sr., Marcio M
|
|
|
122 |
21 |
p. 5354
|
artikel
|
| 590 |
Association Of Treatment Induced Peripheral Neuropathy (TIPN) With Treatment Patterns and Outcomes In Patients (pts) With Newly Diagnosed Multiple Myeloma (NDMM)
|
Martin III, Thomas G.
|
|
|
122 |
21 |
p. 1750
|
artikel
|
| 591 |
Associations Of VEGF and VEGFR2 Polymorphisms With Increased Risk and Aggressiveness Of Multiple Myeloma
|
Carvalho Brito, Angelo Borsarelli
|
|
|
122 |
21 |
p. 1886
|
artikel
|
| 592 |
Astatine-211 Conjugated To Anti-CD20 Monoclonal Antibody Eliminates B-Cell Lymphoma In a Mouse Model
|
Green, Damian J.
|
|
|
122 |
21 |
p. 4415
|
artikel
|
| 593 |
A 2 Step Approach To Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Low Non-Relapse Related Mortality (NRM) and High Overall Survival (OS) Rates Confirmed In Second Generation Trial
|
Grosso, Dolores
|
|
|
122 |
21 |
p. 3360
|
artikel
|
| 594 |
Astragalus Polysaccharide has hematopoietic and thrombopoietic activities in an irradiation mouse model
|
Yang, Mo
|
|
|
122 |
21 |
p. 4216
|
artikel
|
| 595 |
A Strategy For Early Diagnosis Of Invasive Mold Infections In Children With Hematologic Malignancies
|
Mitchell Cohn, Shannon
|
|
|
122 |
21 |
p. 2959
|
artikel
|
| 596 |
A Strong Correlation Between Spot Urine Protein To Creatinine Ratio and 24-Hour Urine Protein Quantification For Proteinuria Assessment In Patients With Plasma Cell Dyscrasia
|
Susmitha, Apuri
|
|
|
122 |
21 |
p. 3155
|
artikel
|
| 597 |
A Study Of Myc and Mcl-1 Transcript Levels Before and During Tyrosine Kinase Inhibitor Therapy In Chronic Myeloid Leukemia Patients
|
Papadopoulou, Vasiliki
|
|
|
122 |
21 |
p. 5168
|
artikel
|
| 598 |
A Successful Model To Decrease Early and Preventable Deaths In Acute Promyelocytic Leukemia (APL) Through The Use Of a Simplified Algorithm and Expert Support In Experienced As Well As Smaller Leukemia Treatment Centers In The US
|
Jillella, Anand P.
|
|
|
122 |
21 |
p. 5597
|
artikel
|
| 599 |
ASXL1 and SETBP1 Mutations and Their Prognostic Contribution In Chronic Myelomonocytic Leukemia: An International Study Of 431 Patients
|
Patnaik, Mrinal M
|
|
|
122 |
21 |
p. 1510
|
artikel
|
| 600 |
A Synthetic Evaluation Of Genetic and Pharmacological Resistance To Clopidogrel and On Treatment Residual Platelet Aggregation In Patients With Atherothrombosis
|
Gerotziafas, Grigoris T
|
|
|
122 |
21 |
p. 3631
|
artikel
|
| 601 |
A Synthetic Lethality Druggable Genome RNAi Screen Identifies Genes Mediating Sensitivity To Lenalidomide In Multiple Myeloma Including RSK2
|
Xiao Zhu, Yuan
|
|
|
122 |
21 |
p. 3084
|
artikel
|
| 602 |
A Systematic Review Of All Interventional Sickle Cell Trials Registered At Clinicaltrials.Gov
|
Lebensburger, Jeffrey D.
|
|
|
122 |
21 |
p. 2990
|
artikel
|
| 603 |
A Systematic Review Of The Role Of Erythropoietin In The Pathophysiology Of Anemia In Elderly Patients
|
Sriram, Swetha
|
|
|
122 |
21 |
p. 3432
|
artikel
|
| 604 |
A Systematic Review On Different Prothrombin Complex Concentrate Strategies To Reverse Vitamin K Antagonist Therapy
|
Khorsand, Nakisa
|
|
|
122 |
21 |
p. 3639
|
artikel
|
| 605 |
A Systematic Review On The Use Of Pharmacological Agents In Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
|
Radwi, Mansoor
|
|
|
122 |
21 |
p. 4745
|
artikel
|
| 606 |
A Systematic Search Into The Role Of IGHV Gene Replacement In Shaping The Immunoglobulin Repertoire Of Chronic Lymphocytic Leukemia
|
Yancopoulos, Sophia
|
|
|
122 |
21 |
p. 4129
|
artikel
|
| 607 |
At Clinically Achievable Concentrations Obatoclax (GX15-070) Potentiates The Cytotoxic Effect Of Cytarabine On Acute Myeloid Leukemia Cells By Enhancing DNA Damage
|
Ge, Yubin
|
|
|
122 |
21 |
p. 3829
|
artikel
|
| 608 |
A Therapeutic Vaccine In Adult T-Cell Leukemia Patients With Autologous Dendritic Cells Pulsed With Peptides Corresponding To Tax-Specific Cytotoxic T Lymphocyte Epitopes
|
Iino, Tadafumi
|
|
|
122 |
21 |
p. 5130
|
artikel
|
| 609 |
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status?
|
Aprile, Lara
|
|
|
122 |
21 |
p. 1482
|
artikel
|
| 610 |
A Third Generation Perfluorocarbon Causes Thrombocytopenia, Platelet Dysfunction and Changes In Blood Morphology in a Baboon Model Of Systemic Inflammation
|
Pidcoke, Heather F
|
|
|
122 |
21 |
p. 2327
|
artikel
|
| 611 |
A Threshold Optical Density Value In Immunoassay Predicts Thrombosis In Patients with Heparin Induced Thrombocytopenia
|
Paul, Asit K.
|
|
|
122 |
21 |
p. 4755
|
artikel
|
| 612 |
A T315I Gate Keeper Mutation Responding To Pegylated Interferon Alfa-2a (Peg-IFN) Monotherapy With Major Molecular Response (MMR4) At 12 Months In An Imatinib-Resistant Chronic Myeloid Leukemia (CML) Patient
|
Johnson-Ansah, Hyacinthe
|
|
|
122 |
21 |
p. 5179
|
artikel
|
| 613 |
A-To-I RNA Editing By ADAR1 Is Essential For Hematopoiesis
|
Liddicoat, Brian
|
|
|
122 |
21 |
p. 1199
|
artikel
|
| 614 |
A Transgenic Model Of Multiple Myeloma Bone Disease Shows Profound Mesenchymal Stem Cell Impairment
|
Gomez-Palou, Monica
|
|
|
122 |
21 |
p. 130
|
artikel
|
| 615 |
A Translocation (9;22)(p24;q11.2) In a Patient With CML
|
Abreu, Daniele Costa
|
|
|
122 |
21 |
p. 5184
|
artikel
|
| 616 |
A Two Centre Experience Of Use Of a Dual Virally Inactivated FVIII/VWF Product (Wilate®) In Patients With Von Willebrand Disease
|
Batty, Paul A
|
|
|
122 |
21 |
p. 1112
|
artikel
|
| 617 |
A Two-Year Follow-Up Of a Prospective Study Of Intensified Conditioning Regimen With High-Dose-Etoposide Allogeneic Hematopoietic Stem Cell Transplantation For Adult Acute Lymphoblastic Leukemia In China
|
Zhou, Hongsheng
|
|
|
122 |
21 |
p. 4570
|
artikel
|
| 618 |
A-Type Proanthocyanidins Prevent Engraftment Of Primary Acute Myelogenous Leukemia Cells In Mice and Exhibit Potentially Novel Anti-Leukemia Mechanisms
|
Bystrom, Laura M
|
|
|
122 |
21 |
p. 3962
|
artikel
|
| 619 |
Atypical E2F Dependent Dysregulation Of Cell Cycling By Microrna-142 Regulates T-Cell Responses and Experimental Graft-Versus-Host Disease
|
Sun, Yaping
|
|
|
122 |
21 |
p. 136
|
artikel
|
| 620 |
Atypical Hemolytic Uremic Syndrome In Japan Characterized By The Inhibitory Antibody-Based Hemolytic Assay and The Gene Analysis
|
Yoshida, Yoko
|
|
|
122 |
21 |
p. 2318
|
artikel
|
| 621 |
Augmented Berlin-Frankfurt-Muenster Based Therapy For Young Adults With Acute Lymphoblastic Leukemia (ALL)
|
Rytting, Michael E.
|
|
|
122 |
21 |
p. 1400
|
artikel
|
| 622 |
Augmented Cord Blood Stem Cell Collection, Making Adult Single Cord Transplant a Reality?
|
Dracker, Robert A.
|
|
|
122 |
21 |
p. 5447
|
artikel
|
| 623 |
A “Universal” Lectin-Mediated Interaction Drives B-Cell Receptor Signaling In Primary Follicular Lymphoma Cells
|
Packham, Graham
|
|
|
122 |
21 |
p. 4291
|
artikel
|
| 624 |
Auranofin Induces a Reversible In-Vivo Stress Response That Correlates With a Transient Clinical Effect In Patients With Chronic Lymphocytic Leukemia
|
Saba, Nakhle S
|
|
|
122 |
21 |
p. 3819
|
artikel
|
| 625 |
Aurora-A Kinase Expression In Untreated Patients With Chronic Lymphocytic Leukemia
|
Kadikoylu, Gurhan
|
|
|
122 |
21 |
p. 4896
|
artikel
|
| 626 |
Aurora A Kinase Is a Novel Therapeutic Target In The Myeloproliferative Neoplasms
|
Wen, Qiang Jeremy
|
|
|
122 |
21 |
p. 109
|
artikel
|
| 627 |
Aurora A Kinase Is Required For Hematopoiesis and Couples Polyploidization With Terminal Differentiation In Megakaryocytes Through Phosphorylation Of NF-E2
|
Goldenson, Benjamin
|
|
|
122 |
21 |
p. 219
|
artikel
|
| 628 |
Autoimmune Hemolytic Anemia In Cancer Patients At a Tertiary Center In Southern Nigeria
|
Korubo, Kaladada I.
|
|
|
122 |
21 |
p. 4658
|
artikel
|
| 629 |
Autoimmune Myelofibrosis (AIMF) – Clinical Features, Course and Outcome
|
Irene Piatek, Caroline
|
|
|
122 |
21 |
p. 3714
|
artikel
|
| 630 |
Autologous 3D Tissue-Engineered Bone Marrow For Drug Screening In MM Patients
|
De La Puente, Pilar
|
|
|
122 |
21 |
p. 132
|
artikel
|
| 631 |
Autologous Hematopoietic Cell Transplantation (HCT) Is Superior To Allogeneic Transplantation For Acute Promyelocytic Leukemia In Second Complete Remission (CR2)
|
Holter-Chakrabarty, Jennifer L.
|
|
|
122 |
21 |
p. 418
|
artikel
|
| 632 |
Autologous Hematopoietic Stem Cell Transplantation In Neuromyelitis Optica: A Retrospective Study Of The EBMT Autoimmune Diseases Working Party In Collaboration With The University Of Sao Paulo, Ribeirao Preto, Brazil
|
Greco, Raffaella
|
|
|
122 |
21 |
p. 2125
|
artikel
|
| 633 |
Autologous Hematopoietic Stem/Progenitor Cell (HSPC) Therapy For Monogenic Blood Disorders: Scalable, cGMP-Compliant Process For Generating Highly Efficient Genome Edited HSPC
|
Lee, Gary K
|
|
|
122 |
21 |
p. 4213
|
artikel
|
| 634 |
Autologous Stem Cell Collection In Lymphoma and Myeloma Patients: Single Center Analysis With Intention To Successful Mobilization and Collection Under Restricted Permission For Use Of Plerixafor
|
Hasbal, Baris
|
|
|
122 |
21 |
p. 5443
|
artikel
|
| 635 |
Autologous Stem Cell Transplantation For Acute Leukemias In Suzhou (China): Similar Outcome In CR1 Patients Compared With European Group For Blood and Marrow Transplantation (EBMT) Results: A Pair-Matched Analysis
|
Chen, Jia
|
|
|
122 |
21 |
p. 5527
|
artikel
|
| 636 |
Autologous Stem Cell Transplantation For Adult Burkitt Lymphoma In The Rituximab Era: A Retrospective Study Of The Lymphoma Working Party (LWP) Of The European Group For Blood and Marrow Transplantation (EBMT)
|
Ahmed, Syed
|
|
|
122 |
21 |
p. 3368
|
artikel
|
| 637 |
Autologous Stem Cell Transplantation For Multiple Myeloma In Patients Over Age 70: Decision Making, Eligibility, and Preliminary Outcomes
|
Schriber, Jeffrey R.
|
|
|
122 |
21 |
p. 3395
|
artikel
|
| 638 |
Autologous Stem Cell Transplantation Improves Survival For High Risk Cardiac Amyloidosis
|
Kongtim, Piyanuch
|
|
|
122 |
21 |
p. 3341
|
artikel
|
| 639 |
Autologous Stem Cell Transplantation In Immunoglobulin Light Chain Amyloidosis With Factor X Deficien
|
Cordes, Stefan F
|
|
|
122 |
21 |
p. 2151
|
artikel
|
| 640 |
Autologous Stem Cell Transplant Has a Role In Consolidating Chemotherapy Given At First Disease Progression In Multiple Myeloma Treated Exclusively With Novel Agents
|
Kishore, Bhuvan
|
|
|
122 |
21 |
p. 5514
|
artikel
|
| 641 |
Autologous Stem Cell Transplant Is a Feasible Treatment For Older Relapsed and Refractory Hodgkin Lymphoma Patients
|
Glick, Hillary
|
|
|
122 |
21 |
p. 3408
|
artikel
|
| 642 |
Autologous Transplantation Is Safe and Effective For Patients With Multiple Myeloma Related Renal Insufficiency
|
Greene, Claire C
|
|
|
122 |
21 |
p. 3388
|
artikel
|
| 643 |
Autologous Transplantation Of Thrombopoietin Derived-Hepatic Hematopoietic Progenitor Cells In Xenopus Laevis
|
Tanizaki, Yuta
|
|
|
122 |
21 |
p. 2453
|
artikel
|
| 644 |
Autophagy Is Required For Long-Term Hematopoietic Stem Cell (HSC) Function and G-CSF-Induced HSC Mobilization
|
Leveque, Lucie
|
|
|
122 |
21 |
p. 892
|
artikel
|
| 645 |
Autophagy Is Uncoupled From ATG5-Dependent Apoptosis in Cells Resistant To Proteasome Inhibition
|
Driscoll, James
|
|
|
122 |
21 |
p. 4448
|
artikel
|
| 646 |
Autopsy Analysis On Epidemiology and Site of Involvement Of Invasive Fungal Infections (IFI) In Hematological Malignancies : A Retrospective Study at Hematologic Tertiary Care Department
|
Chierichini, Anna
|
|
|
122 |
21 |
p. 5589
|
artikel
|
| 647 |
Autosomal Recessive Diamond-Blackfan Anemia: Identification Of Mutations In MCM2 and Flnb
|
O'Brien, Kelly A
|
|
|
122 |
21 |
p. 589
|
artikel
|
| 648 |
Avascular Necrosis(AVN) and Surgical Intervention In Pediatric Acute Lymphoblastic Leukemia(ALL): A Retrospective Cohort Analysis From The Pediatric Health Information Systems (PHIS)
|
Heneghan, Mallorie B
|
|
|
122 |
21 |
p. 1689
|
artikel
|
| 649 |
Axl Represents a Therapeutic Target In T315I-Mutated and WT Chronic Myeloid Leukemia
|
Erdmann, Robert
|
|
|
122 |
21 |
p. 1469
|
artikel
|
| 650 |
Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation
|
Cabrera, Cristina Calderón
|
|
|
122 |
21 |
p. 2812
|
artikel
|
| 651 |
Azacitidine and Donor Lymphocyte Infusions As Treatment For Relapse After Allogeneic Stem Cell Transplantation - a Retrospective Multicenter Analysis In 115 Patients On Behalf Of The German Cooperative Transplant Study Group
|
Schroeder, Thomas
|
|
|
122 |
21 |
p. 4642
|
artikel
|
| 652 |
Azacitidine and Lenalidomide Combination In Higher-Risk Myelodysplastic Syndromes-Preliminary Results Of The Vilen-01 Protocol
|
Mittelman, Moshe
|
|
|
122 |
21 |
p. 1576
|
artikel
|
| 653 |
Azacitidine Improves Survival in Myelodysplastic Syndromes; Single Institute Retrospective Study
|
Takeda, June
|
|
|
122 |
21 |
p. 5215
|
artikel
|
| 654 |
Azacitidine In The Treatment Of Ph- Myeloproliferative Neoplasms In Blastic Phase: The Experience Of Gruppo Laziale For The Study Of Ph- SMPC
|
Andriani, Alessandro
|
|
|
122 |
21 |
p. 5270
|
artikel
|
| 655 |
Azacitidine Treatment For Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Harboring Chromosome 3q Abnormalities
|
Wanquet, Anne
|
|
|
122 |
21 |
p. 1512
|
artikel
|
| 656 |
Azacitidine With Or Without Entinostat For The Treatment Of Therapy-Related Myeloid Neoplasm: Further Results Of The E1905 North American Leukemia Intergroup Study
|
Prebet, Thomas
|
|
|
122 |
21 |
p. 2777
|
artikel
|
| 657 |
A Zebrafish Model Of Antithrombin III Deficiency Displays Bleeding and Thrombosis Secondary To Disseminated Intravascular Coagulation
|
Liu, Yang
|
|
|
122 |
21 |
p. 200
|
artikel
|
| 658 |
BAALC Acts As a Scaffold-Like Protein In The ERK Signaling Pathway and Promotes Leukemogenesis By Facilitating MEK–mediated ERK Activation
|
Morita, Ken
|
|
|
122 |
21 |
p. 2509
|
artikel
|
| 659 |
BAALC-Associated Mir-3151 Is An Independent Prognostic Factor In Younger Patients With Intermediate-Risk Cytogenetic Acute Myeloid Leukemia
|
Díaz-Beyá, Marina
|
|
|
122 |
21 |
p. 2577
|
artikel
|
| 660 |
Backtracking Of The Genetic Events Preceding Acute Leukemia Diagnosis
|
Zimmermannova, Olga
|
|
|
122 |
21 |
p. 2562
|
artikel
|
| 661 |
Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)
|
Lodé, Laurence
|
|
|
122 |
21 |
p. 520
|
artikel
|
| 662 |
Baicalein Synergy Lenalidomide To Induce Apoptosis Of Myeloma Cell
|
Zhang Jr., Ruibo
|
|
|
122 |
21 |
p. 5328
|
artikel
|
| 663 |
BALB/c- Specific L29V Polymorphism In SIRPA Determines The Efficient Engraftment Of Human Hematopoiesis In Xenogeneic Model
|
Iwamoto, Chika
|
|
|
122 |
21 |
p. 337
|
artikel
|
| 664 |
Bam Regimen Followed By High-Dose Therapy and Autologous Stem Cell Transplantation As First-Line Treatment Of Primary Central Nervous System Lymphoma: A Multicenter Study From Spanish Group GEL-TAMO
|
López-Parra, M
|
|
|
122 |
21 |
p. 4349
|
artikel
|
| 665 |
B and T Lymphocyte Attenuator (BTLA)/Herpes Virus Entry Mediator (HVEM) Interaction: Attenuating Virus Specific CD8+T Cell Function In HTLV-1 Infection
|
Chibueze, Ezinne Chioma
|
|
|
122 |
21 |
p. 4727
|
artikel
|
| 666 |
B-1239, a Novel Anti-BAFF-R Afucosylated Human Antibody, Promotes Potent Natural Killer Cell- Mediated Antibody Dependent Cellular Cytotoxicity In Chronic Lymphocytic Leukemia Cells In- Vitro and Depletion Of Circulating Leukemic CLL B Cells In-Vivo
|
McWilliams, Emily M.
|
|
|
122 |
21 |
p. 4185
|
artikel
|
| 667 |
Barriers To Clinical Trial Enrolment For Teenagers and Young Adults With Acute Lymphoblastic Leukaemia: The Impact of Age Eligibility Criteria
|
Fern, Lorna Anne
|
|
|
122 |
21 |
p. 1401
|
artikel
|
| 668 |
Barriers To Diagnosis In Myeloproliferative Neoplasms
|
Yip, Raymond H L
|
|
|
122 |
21 |
p. 5248
|
artikel
|
| 669 |
Barth Syndrome and Neutropenia
|
Dale, David C.
|
|
|
122 |
21 |
p. 3465
|
artikel
|
| 670 |
Baseline Assessment Of GPI-Anchored Protein Deficient Blood Cells In Patients With Bone Marrow Failure (The OPTIMA study)
|
Obara, Naoshi
|
|
|
122 |
21 |
p. 1241
|
artikel
|
| 671 |
Baseline Characteristics and Symptom Burden in RESPONSE: A Randomized, Open-Label, Phase 3 Study of Ruxolitinib In Polycythemia Vera Patients Resistant to or Intolerant of Hydroxyurea
|
Vannucchi, Alessandro M.
|
|
|
122 |
21 |
p. 4071
|
artikel
|
| 672 |
Baseline Characteristics Of Patients With Chronic Myeloid Leukemia In a Prospective Observational Study (SIMPLICITY)
|
Cortes, Jorge E.
|
|
|
122 |
21 |
p. 4026
|
artikel
|
| 673 |
Baseline Spleen Size and Mutations Involving ASXL1 and SRSF2 Predict Survival and Treatment Response In JAK Inhibitor Treated Myelofibrosis Patients
|
Pardanani, Animesh
|
|
|
122 |
21 |
p. 4048
|
artikel
|
| 674 |
BB02 Improves Therapeutical Effectiveness Of Extracorporeal Photopheresis With 8-MOP In a Murine Model Of Graft-Versus-Host Disease
|
Garcia-Bernal, David
|
|
|
122 |
21 |
p. 5416
|
artikel
|
| 675 |
BC2059: An Orally Bioavailable β-Catenin Inhibitor Potently Induces Apoptosis As A Single Agent and In Combination With Bortezomib In Multiple Myeloma
|
Savvidou, Ioanna
|
|
|
122 |
21 |
p. 1920
|
artikel
|
| 676 |
B-Cell Anergy Underlies Indolent Clinical Behavior Of CLL Stereotyped Subset #4
|
Ntoufa, Stavroula
|
|
|
122 |
21 |
p. 4115
|
artikel
|
| 677 |
B Cell Deficiency and CD21low B Cells As Markers For Measuring Cgvhd Severity and Activity In a Large Patient Cohort
|
Kuzmina, Zoya
|
|
|
122 |
21 |
p. 4623
|
artikel
|
| 678 |
B Cell Development Is Regulated By a-Synuclein, a Key Player In Parkinson's Disease
|
Xiao, Wenbin
|
|
|
122 |
21 |
p. 785
|
artikel
|
| 679 |
B-Cell Epitopes Within The A2 and C2 Domains Of Coagulant Factor VIII Refined By Orthologous Protein Antigenicity
|
Zakas, Philip M
|
|
|
122 |
21 |
p. 1101
|
artikel
|
| 680 |
B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Specific Copy Number Alterations Are Unique For Progressive Pediatric Chronic Myeloid Leukemia (CML): A Large Cohort Study
|
van der Sligte, Naomi E
|
|
|
122 |
21 |
p. 2715
|
artikel
|
| 681 |
B-Cell Receptor Selection Pattern and Natural History Of Follicular Lymphoma
|
Navarrete, Marcelo
|
|
|
122 |
21 |
p. 4258
|
artikel
|
| 682 |
B Cell Receptors Of Chlamydophila Psittaci negative MALT Lymphomas Of The Ocular Adnexa Recognize Common Self-Antigens
|
Zhu, Daxing
|
|
|
122 |
21 |
p. 4266
|
artikel
|
| 683 |
B-Cell Receptors Of Follicular Lymphoma Patients Recognize Themselves
|
Schulz, Angela
|
|
|
122 |
21 |
p. 633
|
artikel
|
| 684 |
B Cell Receptor with Variant Surface Isotypes Transduce Functional Signals by Elevating Phospho-ERK1/2 Levels in Hairy Cell Leukemia with Mutant BRAF
|
Weston-Bell, Nicola J
|
|
|
122 |
21 |
p. 1772
|
artikel
|
| 685 |
B Cell With Regulatory Function Are Enriched Within Transitional and IgM Memory B Cell Subsets In Healthy Donors But Are Reduced and Functionally Impaired In Patients With Chronic Graft-Versus-Host Disease
|
Sarvaria, Anushruti
|
|
|
122 |
21 |
p. 4478
|
artikel
|
| 686 |
BCL-2 Family Of Genes Is a Key Regulator In The Pathogenesis Of SF3B1 Mutant and Wild Type MDS With Ring Sideroblasts and Represents a Novel Drug Target In This Disease
|
Visconte, Valeria
|
|
|
122 |
21 |
p. 263
|
artikel
|
| 687 |
BCL-2 Inhibition As a Synthetic Lethal Approach To Target Isocitrate Dehydrogenase Mutations In Acute Myeloid Leukemia Stem Cells
|
Chan, Steven M.
|
|
|
122 |
21 |
p. 885
|
artikel
|
| 688 |
Bcl-2 Inhibitor ABT-199 (GDC-0199) Monotherapy Shows Anti-Tumor Activity Including Complete Remissions In High-Risk Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
|
Seymour, John F.
|
|
|
122 |
21 |
p. 872
|
artikel
|
| 689 |
BCL-2-Selective BH3 Mimetic ABT-199 Is a Potent Agent For Acute Myeloid Leukemia
|
Pan, Rongqing
|
|
|
122 |
21 |
p. 1456
|
artikel
|
| 690 |
BCOR and BCORL1 Mutations In Pediatric Acute Myeloid Leukemia
|
Hermkens, Malou C.H.
|
|
|
122 |
21 |
p. 3815
|
artikel
|
| 691 |
BCR-ABL Cooperates With a “Telomere-Associated Secretory Phenotype” (TASP) To Facilitate Malignant Proliferation Of Hematopoietic Stem Cells
|
Brümmendorf, Tim H.
|
|
|
122 |
21 |
p. 3976
|
artikel
|
| 692 |
BCR-ABL Fusion Transcripts In Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Experience With Ponatinib From MD Anderson Cancer Center
|
Jain, Preetesh
|
|
|
122 |
21 |
p. 2727
|
artikel
|
| 693 |
BCR-ABL1+ Leukemic Stem Cells Are Dependent On Selectin-Ligand Interactions For Engraftment In The Bone Marrow Niche
|
Krause, Daniela S.
|
|
|
122 |
21 |
p. 2703
|
artikel
|
| 694 |
BCR-ABL1-Like Cases In Pediatric Acute Lymphoblastic Leukemia: A Comparison Between COG/St. Jude and Dutch DCOG Signatures
|
Boer, Judith M.
|
|
|
122 |
21 |
p. 2633
|
artikel
|
| 695 |
BCR-ABL1 Molecular Remission After 90y-Epratuzumab Tetraxetan Radioimmunotherapy In CD22+ Ph+ B-ALL: A Potential New Treatment Paradigm
|
Chevallier, Patrice
|
|
|
122 |
21 |
p. 3910
|
artikel
|
| 696 |
BCR-ABL Splice Variants In Three Phases Of CML: Association With Disease Biology and Response To Imatinib
|
Zafar, Iqbal
|
|
|
122 |
21 |
p. 5191
|
artikel
|
| 697 |
BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406
|
Allen, Jessica L.
|
|
|
122 |
21 |
p. 910
|
artikel
|
| 698 |
Bendamustine and Rituximab Achieve a Major Survival Improvement Of Patients With Morbus Waldenström In Routine Care
|
Weide, Rudolf
|
|
|
122 |
21 |
p. 5611
|
artikel
|
| 699 |
Bendamustine and Rituximab Combination In Untreated Indolent Non Follicular B-Cell Non-Hodgkin's Lymphomas. A Phase II Study From The Fondazione Italiana Linfomi (INFL09)
|
Luminari, Stefano
|
|
|
122 |
21 |
p. 3049
|
artikel
|
| 700 |
Bendamustine, Bortezomib and Dexamethasone (BBD) As First-Line Treatment Of Patients (Pts) With Multiple Myeloma Who Are Not Candidates For High Dose Chemotherapy
|
Berdeja, Jesus
|
|
|
122 |
21 |
p. 3193
|
artikel
|
| 701 |
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM)
|
Offidani, Massimo
|
|
|
122 |
21 |
p. 1974
|
artikel
|
| 702 |
Bendamustine, Bortezomib and Dexamethasone (BVD) In Elderly Patients With Multiple Myeloma In First Relapse: Final Analysis Of The Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial
|
Rodon, Philippe
|
|
|
122 |
21 |
p. 1971
|
artikel
|
| 703 |
Bendamustine, Etoposide, Cytarabine and Melphalan (BeEAM) Followed By Autologous Stem Cell Transplantation Produce a 3-Year Progression-Free Survival Of 75% In Heavily Pre-Treated Hodgkin and Non-Hodgkin Lymphoma
|
Visani, Giuseppe
|
|
|
122 |
21 |
p. 2134
|
artikel
|
| 704 |
Bendamustine In Combination With Rituximab As First-Line Treatment For Indolent Non-Hodgkin Lymphoma: Retrospective Analysis Of An Spanish Registry
|
Solorzano, Silvia
|
|
|
122 |
21 |
p. 5094
|
artikel
|
| 705 |
Bendamustine Is Not Associated With An Increase In Infections – Systematic Review and Meta-Analysis Of Randomized Controlled Trials
|
Gafter-Gvili, Anat
|
|
|
122 |
21 |
p. 5125
|
artikel
|
| 706 |
Bendamustine, Low-Dose Dexamethasone, and Lenalidomide (BdL) For The Treatment Of Patients With Relapsed Multiple Myeloma Confirms Very Promising Results In a Phase I/II Study
|
Pozzi, Samantha
|
|
|
122 |
21 |
p. 3212
|
artikel
|
| 707 |
Bendamustine + Rituximab-Combinations and R-CHOP Achieve a Major Survival Improvement Of Patients With Follicular Lymphoma In Routine Care
|
Weide Prof. Dr., Rudolf
|
|
|
122 |
21 |
p. 5584
|
artikel
|
| 708 |
Bendamustine (Treanda®)-Based Regimens Are Effective In Mobilizing Peripheral Blood Hematopoietic Stem Cells For Autologous Transplantation
|
Green, Damian J.
|
|
|
122 |
21 |
p. 2033
|
artikel
|
| 709 |
Beneficial Effect Of Anticoagulants In The Management Of Patients With Acute Promyelocytic Leukemia (APL): Results Of a Multicenter, Retrospective Epidemiologic Study Of The Disseminated Intravascular Coagulation Patients In Japan
|
Kawasugi, Kazuo
|
|
|
122 |
21 |
p. 2373
|
artikel
|
| 710 |
Beneficial Effects Of Ionizing Radiation To Enhance Anti-Cancer Effects Of RIG-Like Receptor Stimulus
|
Yoshino, Hironori
|
|
|
122 |
21 |
p. 4721
|
artikel
|
| 711 |
BET Bromodomain Inhibition Reduces Leukemic Burden and Prolongs Survival In The Eμ-TCL1 Transgenic Mouse Model Of Chronic Lymphocytic Leukemia (CLL) Independent Of TP53 Mutation Status
|
Larsson, Connie A
|
|
|
122 |
21 |
p. 876
|
artikel
|
| 712 |
Bfr (bendamustine, fludarabine, rituximab) Nonmyeloablative Allogeneic Conditioning: A Novel Regimen Inducing Immunosuppression Without Myelosuppression
|
Khouri, Issa F.
|
|
|
122 |
21 |
p. 541
|
artikel
|
| 713 |
Bfr (bendamustine, fludarabine, rituximab) Vs. FCR Nonmyeloablative Allogeneic Conditioning In Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL): Outcome Results Including Minimal Residual Disease Analysis
|
Khouri, Issa F.
|
|
|
122 |
21 |
p. 3349
|
artikel
|
| 714 |
BH3 Profiling As Predictor Of 5-Azacytidine and Decitabine Clinical Responses
|
Tibes, Raoul
|
|
|
122 |
21 |
p. 603
|
artikel
|
| 715 |
BH3 Profiling Predicts On-Target Cell Death Due To Selective Inhibition Of BCL-2 By ABT-199 In Acute Myelogenous Leukemia
|
Hogdal, Leah
|
|
|
122 |
21 |
p. 238
|
artikel
|
| 716 |
Bifunctional Immunoactive siRNAs as an Approach to Personalized AML Therapy
|
Meinl, Hanna
|
|
|
122 |
21 |
p. 5036
|
artikel
|
| 717 |
Bim-Targeting Therapy Circumvents Adaptive Bortezomib-Resistance In Myeloma Through a Novel Cross-Link Between Autophagy and Apoptosis
|
Chen, Shuang
|
|
|
122 |
21 |
p. 601
|
artikel
|
| 718 |
Binding Of Immune Serine Proteases To Nucleic Acids Enhances Their Nuclear Localization and Promotes Their Cleavage Of Nucleic Acid-Binding Protein Substrates
|
Whangbo, Jennifer
|
|
|
122 |
21 |
p. 3471
|
artikel
|
| 719 |
Binding Of Recombinant Activated Factor VII (rFVIIa) To Human Platelets Identifies Donor Variation and Platelet Subpopulations With Increased Binding Of rFVIIa In Platelet Concentrates From Healthy Donors
|
Koehn, Jadranka
|
|
|
122 |
21 |
p. 3565
|
artikel
|
| 720 |
Binding Of VWF To Type IV Collagen: An Additional Collagen Binding Mechanism Beyond Types I, III, and VI Collagen?
|
Flood, Veronica H.
|
|
|
122 |
21 |
p. 333
|
artikel
|
| 721 |
Biocompatibility Assessment Of DNR-Peg-PLL-PLGA Nanoparticles In Vitro and In Vivo
|
Chen, Baoan
|
|
|
122 |
21 |
p. 4920
|
artikel
|
| 722 |
Bioengineered Coagulation Factor VIII Enables Long-Term Correction Of Murine Hemophilia A Following Liver-Directed Adeno-Associated Viral Vector Delivery
|
Brown, Harrison C.
|
|
|
122 |
21 |
p. 4210
|
artikel
|
| 723 |
Biological Parameters Predictive Of Percent Dense Red Blood Cell Decrease Under Hydroxyurea Therapy
|
Rakotoson, Marie Georgine
|
|
|
122 |
21 |
p. 990
|
artikel
|
| 724 |
Biologic Response and Adverse Events To Stimate In Patients With Von Willebrand Disease
|
Song, Xiangqian
|
|
|
122 |
21 |
p. 2365
|
artikel
|
| 725 |
Biology Of Mixed Phenotype Acute Leukemia In Successful Long-Term Cytokine-Free Three-Dimensional (3D) Static and Perfused 3D Hollow-Fibre Bioreactor Culture
|
Rende, Maria
|
|
|
122 |
21 |
p. 2603
|
artikel
|
| 726 |
Biomarkers and Clinical Characteristics Of Patients With and Without DVT In The Intensive Care Unit (ICU)
|
Sood, Suman L.
|
|
|
122 |
21 |
p. 1124
|
artikel
|
| 727 |
Biomarkers Of Bone Disease In Subjects With Hemophilia
|
Recht, Michael
|
|
|
122 |
21 |
p. 1113
|
artikel
|
| 728 |
Biomarkers Of Complement and Endothelial Activation, Inflammation, Thrombosis and Renal Injury In Patients (pts) With aHUS Treated With Eculizumab (ECU)
|
Cofiell, Roxanne
|
|
|
122 |
21 |
p. 2184
|
artikel
|
| 729 |
Biosimilar Compared With Originator Filgrastim For Related-Donor Allogeneic Stem Cell Mobilisation: A Prospective-Historical Control Study
|
Lefrère, Francois
|
|
|
122 |
21 |
p. 5512
|
artikel
|
| 730 |
Biosimilar G-CSF Based Mobilization Of Peripheral Blood Hematopoietic Stem Cells For Autologous and Allogeneic Stem Cell Transplantation
|
Schmitt, Michael
|
|
|
122 |
21 |
p. 5444
|
artikel
|
| 731 |
Birinapant Enhances Bendamustine-Induced Apoptosis In Activated B Cell-Diffuse Large Cell Lymphoma Cells
|
Joshi, Indira D
|
|
|
122 |
21 |
p. 5150
|
artikel
|
| 732 |
Bispecific Hexavalant Antibodies With Enhanced Trogocytosis For Treatment Of Lupus
|
Rossi, Edmund A
|
|
|
122 |
21 |
p. 2282
|
artikel
|
| 733 |
Biweekly Bortezomib Is More Efficacious Than Weekly Bortezomib When Used As First Line In Patients With Systemic AL Amyloidosis
|
Sachchithanantham, Sajitha
|
|
|
122 |
21 |
p. 1981
|
artikel
|
| 734 |
Blast Crisis CML Cells Require IFN-γ Conditioning For Effective GVL Whereas Chronic Phase CML Cells Do Not: An Explanation For Chronic Phase CML GVL-Sensitivity
|
Matte-Martone, Catherine
|
|
|
122 |
21 |
p. 2013
|
artikel
|
| 735 |
Bleeding Incidence Among Patients With Venous Thromboembolism: A Large US Insurance Database Analysis
|
Liu, Xianchen
|
|
|
122 |
21 |
p. 2916
|
artikel
|
| 736 |
Blockade Of CD47 Using SIRPαFc: Role Of The Fc Region In Anti-Leukemic Activity and Tolerability
|
Uger, Robert A.
|
|
|
122 |
21 |
p. 3935
|
artikel
|
| 737 |
Blocking Protein Secretion and Degradation Is a Novel Treatment Strategy For Malignant Cells With High Protein Load
|
Lowe, Eric
|
|
|
122 |
21 |
p. 4439
|
artikel
|
| 738 |
Blocking Protein S To Treat Hemophilia A
|
Bologna, Luca
|
|
|
122 |
21 |
p. 25
|
artikel
|
| 739 |
Blocking VIP Signaling Abrogates Upregulation Of PD1 and Increases Proliferation Of Allo-Reactive T-Cells In a Mixed Lymphocyte Reaction
|
Summerbell, Emily R
|
|
|
122 |
21 |
p. 1041
|
artikel
|
| 740 |
Blood Cell Replenishment and Bone Marrow Stem Cell Pool Renewal Are Regulated By Different Circadian Peaks Via Norepinephrine and TNFα/S1P Signaling
|
Golan, Karin
|
|
|
122 |
21 |
p. 217
|
artikel
|
| 741 |
Blood Soluble PD-L1 Protein In Aggressive Diffuse Large B-Cell Lymphoma Impacts patient's Overall Survival
|
Fest, Thierry
|
|
|
122 |
21 |
p. 361
|
artikel
|
| 742 |
Bloodstream Progenitor-Cell Traffic In Primary Myelofibrosis Reveals Cell Subsets Showing Some Features Of Very-Small Embryonnic-Like Stem Cells (VSELs), Along With Endothelial (PEC), Mesenchymal (MPC) and Hematopoietic (HPC) Progenitor Cells
|
Ojeda-Uribe, Mario
|
|
|
122 |
21 |
p. 5265
|
artikel
|
| 743 |
BMI1 Promotes Erythropoiesis Through Regulating Ribosome Biogenesis
|
Gao, Rui
|
|
|
122 |
21 |
p. 3707
|
artikel
|
| 744 |
BMS-936564 (Anti-CXCR4 Antibody) Induces Specific Leukemia Cell Mobilization and Objective Clinical Responses In CLL Patients Treated Under a Phase I Clinical Trial
|
Kashyap, Manoj Kumar
|
|
|
122 |
21 |
p. 4190
|
artikel
|
| 745 |
BMS-911543, A Selective JAK2 Inhibitor: A Multicenter Phase 1/2a Study In Myelofibrosis
|
Pardanani, Animesh
|
|
|
122 |
21 |
p. 664
|
artikel
|
| 746 |
BMT Doubles The Lifespan Of A Mouse Model Of Farber Disease and Corrects Hematopoietic Defects
|
Dworski, Shaalee
|
|
|
122 |
21 |
p. 1997
|
artikel
|
| 747 |
Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes
|
Abdelfatah, Mohamed
|
|
|
122 |
21 |
p. 4998
|
artikel
|
| 748 |
Bone Marrow Beta-Catenin Expression In Chronic Myelogenous Leukemia Patients Treated With Imatinib
|
Zhang, Xiaohui
|
|
|
122 |
21 |
p. 2739
|
artikel
|
| 749 |
Bone Marrow (BM) Stromal Expression Of Cytochrome P450 (CYP) Enzymes Protects Acute Myeloid Leukemia (AML) From All-Trans Retinoic Acid (atRA)
|
Su, Meng
|
|
|
122 |
21 |
p. 1449
|
artikel
|
| 750 |
Bone Marrow (BM) Versus Peripheral Blood Stem Cell (PBSC) For Haploidentical Transplantation With Nonmyeloblative (NMA) Conditioning Regimen and Post Infusion Cyclophosphamide
|
Castagna, Luca
|
|
|
122 |
21 |
p. 2119
|
artikel
|
| 751 |
Bone Marrow Cell Based Enzyme Replacement Prolongs Survival and Improves Disease Phenotypes In a Mouse Model Of Lethal Hypophosphatasia
|
Iijima, Osamu
|
|
|
122 |
21 |
p. 2897
|
artikel
|
| 752 |
Bone Marrow Endothelial Cells Protect Acute Myeloid Leukemia From Chemotherapy By Direct Contact: The BCAM/Laminin/VLA5 Axis As a Potential Therapeutic Target
|
Drusbosky, Leylah
|
|
|
122 |
21 |
p. 2546
|
artikel
|
| 753 |
Bone Marrow Fibrosis In Immune Thrombocytopenia (ITP) Patients Treated With Thrombopoietin Receptor Agonists (TRA) – a Single Center Long-Term Follow-Up
|
Ghanima, Waleed
|
|
|
122 |
21 |
p. 3527
|
artikel
|
| 754 |
Bone Marrow Fibrosis In Patients With Multiple Myeloma: A New Prognostic Factor For Survival?
|
Hallgrimsdottir, Tinna
|
|
|
122 |
21 |
p. 1946
|
artikel
|
| 755 |
Bone Marrow May Be More Informative Than Peripheral Blood To Evaluate Minimal Residual Disease During 1st and 2nd Year Follow Up After First-Line Fludarabine, Cyclophosphamide, and Rituximab For Chronic Lymphocytic Leukemia
|
Strati, Paolo
|
|
|
122 |
21 |
p. 1621
|
artikel
|
| 756 |
Bone Marrow Memory CD8 T Cells Positively Influence Hematopoietic Stem Cell Function
|
Geerman, Sulima
|
|
|
122 |
21 |
p. 3692
|
artikel
|
| 757 |
Bone Marrow Mesenchymal Stem Cell (BM-MSC) Release Microvesicles/Exosomes That Incorporate Into Hematopoietic Cells From MDS Patients and May Modify Their Behaviour
|
Muntión, Sandra
|
|
|
122 |
21 |
p. 863
|
artikel
|
| 758 |
Bone Marrow Mesenchymal Stem Cells Affect The Cell Cycle Arrest Effect Of Genotoxic Agents On Acute Lymphocytic Leukemia Cells Via p21 Down-Regulation
|
Zhang, Yiran
|
|
|
122 |
21 |
p. 4988
|
artikel
|
| 759 |
Bone Marrow Mesenchymal Stem Cells: Pre-Metastatic Niche For Breast Cancer
|
Feldman Sr., Leonardo Julio
|
|
|
122 |
21 |
p. 4859
|
artikel
|
| 760 |
Bone Marrow Microenvironment Affects The Pathogenesis Of Multiple Myeloma Through Downregulation Of Alternative Splicing Factor Fox2 In Myeloma Cells
|
Song, Weihua
|
|
|
122 |
21 |
p. 3085
|
artikel
|
| 761 |
Bone Marrow Microenvironment Induces Stem Cell-Like Phenotype In Acute Myeloid Leukemia
|
Battula, Venkata L
|
|
|
122 |
21 |
p. 2457
|
artikel
|
| 762 |
Bone Marrow Mobilization Of Endothelial Progenitor Cells Represents An Early Pathogenic Event During Multiple Myeloma Progression
|
Moschetta, Michele
|
|
|
122 |
21 |
p. 680
|
artikel
|
| 763 |
Bone Marrow Osteoblast Ablation Enhances Short-Term Hematopoietic Stem Cells Without Altering Long-Term Hematopoietic Stem Cell Populations and Accelerates Leukemia Development
|
Bowers, Marisa
|
|
|
122 |
21 |
p. 586
|
artikel
|
| 764 |
Bone Marrow Sinusoidal Integrity Regulates Hematopoietic Stem and Progenitor Cell Trafficking
|
Singh, Pratibha
|
|
|
122 |
21 |
p. 3687
|
artikel
|
| 765 |
Bone Marrow Staging For Lymphoma: A Re-Evaluation Of Clinical Utility
|
Jack, Andrew
|
|
|
122 |
21 |
p. 4278
|
artikel
|
| 766 |
Bone Marrow Stromal Cell-Derived Exosomes Facilitate Multiple Myeloma Cell Survival Through Inhibition Of The JNK Pathway
|
Wang, Jinheng
|
|
|
122 |
21 |
p. 679
|
artikel
|
| 767 |
Bone Marrow Stromal Cells Enhance DNA Damage Signaling Independent Of Stat3 Activation In Pediatric AML
|
Long, Xin
|
|
|
122 |
21 |
p. 2548
|
artikel
|
| 768 |
Bone Marrow Stromal Mediated Pro-Oncogenic Wnt/β-Catenin Antagonize sDKK1 and Promote Osteoclast Activity In Multiple Myeloma
|
Narayanan, Bhagavathi A
|
|
|
122 |
21 |
p. 3125
|
artikel
|
| 769 |
Bone Marrow suppression Due to ferric Carboxymaltose Infusion. First Reported Case
|
Brito-Babapulle, Finella MC
|
|
|
122 |
21 |
p. 4673
|
artikel
|
| 770 |
Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach
|
Gaziev, Javid
|
|
|
122 |
21 |
p. 2040
|
artikel
|
| 771 |
Bone Marrow WT1 Levels In Long-Term Survivors Of Core-Binding Factor AML and Acute Promyelocytic Leukemia
|
Nomdedeu, Josep F
|
|
|
122 |
21 |
p. 4946
|
artikel
|
| 772 |
Bone Turnover Biomarkers Are Useful In Monitoring Myeloma Bone Disease and As Early Predictor Biomarkers For Relapse Disease In Multiple Myeloma
|
Ting, Kay Reen
|
|
|
122 |
21 |
p. 1869
|
artikel
|
| 773 |
Bone Turnover In Multiple Myeloma: Impact Of Bortezomib-Based Induction Therapy, High-Dose Melphalan, and Lenalidomide Consolidation On Osteoblast and Osteoclast Function Within The GMMG-MM5 Trial
|
Seckinger, Anja
|
|
|
122 |
21 |
p. 1863
|
artikel
|
| 774 |
Boost and Loss Of Immune Responses Against Tumor-Associated Antigens In The Course Of Pregnancy As a Model For Immunotherapy
|
Lutz, Mathias
|
|
|
122 |
21 |
p. 4505
|
artikel
|
| 775 |
Boosting In Vivo CAR-Redirected Virus-Specific CTLs With Universal-Artificial Antigen Presenting Cells
|
Caruana, Ignazio
|
|
|
122 |
21 |
p. 4204
|
artikel
|
| 776 |
Boost Vaccination Improves Humoral Immune Response Against Influenza Virus In Patients With Multiple Myeloma
|
Hahn, Michael
|
|
|
122 |
21 |
p. 3206
|
artikel
|
| 777 |
Bortezomib-Based Chemotherapy Regimens Can Inmprove The Complete Remission In Newly Diagnosed Multiple Myeloma Patients With Bcl-2 and Survivin Overexpression
|
Wen, Zeng
|
|
|
122 |
21 |
p. 5349
|
artikel
|
| 778 |
Bortezomib Induction and Maintenance Treatment Improves Survival In Patients With Newly Diagnosed Multiple Myeloma:Extended Follow-Up Of The HOVON-65/GMMG-HD4 Trial
|
Sonneveld, Pieter
|
|
|
122 |
21 |
p. 404
|
artikel
|
| 779 |
Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation
|
Khan, Fatima
|
|
|
122 |
21 |
p. 5495
|
artikel
|
| 780 |
Bortezomib plus Dexamethasone versus Fludarabine plus Cyclophosphamide in initial treatment of patients with Waldenström macroglobulinemia
|
Zhang, Yaping
|
|
|
122 |
21 |
p. 5107
|
artikel
|
| 781 |
Bortezomib With High-Dose Melphalan, Arsenic Trioxide, and Ascorbic Acid In a Preparative Regimen For Multiple Myeloma: 5-Year Follow Up
|
Cornelison, A. Megan
|
|
|
122 |
21 |
p. 5547
|
artikel
|
| 782 |
Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Failure With Imatinib Plus Dasatinib and/Or Nilotinib: 36-Month Update
|
Cortes, Jorge E.
|
|
|
122 |
21 |
p. 4025
|
artikel
|
| 783 |
Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Resistance Or Intolerance To Imatinib: 48-Month Update
|
Brümmendorf, Tim H.
|
|
|
122 |
21 |
p. 2723
|
artikel
|
| 784 |
Both Host-Type and Donor-Type Mast Cells Protect Against Acute Graft-Versus-Host Disease
|
Araki, Raita
|
|
|
122 |
21 |
p. 3248
|
artikel
|
| 785 |
Both Intermittent and Continuous Dosing Regimens Of Pomalidomide Mediate Broad Activation Of Innate and Adaptive Immunity In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial
|
Dhodapkar, Kavita
|
|
|
122 |
21 |
p. 1949
|
artikel
|
| 786 |
Both PI3K p110α and p110δ Isoforms Control CD160-Mediated CLL Cell Viability and Cytokine Production
|
Farren, Timothy W.
|
|
|
122 |
21 |
p. 4124
|
artikel
|
| 787 |
BP5-087, a Novel STAT3 Inhibitor, Combines With BCR-ABL1 Inhibition To Overcome Kinase-Independent Resistance In Chronic Myeloid Leukemia
|
Eiring, Anna M.
|
|
|
122 |
21 |
p. 854
|
artikel
|
| 788 |
BRAFV600E Mutations Occur In The Hematopoietic Stem Cell Compartment In Hairy Cell Leukemia
|
Chung, Stephen S.
|
|
|
122 |
21 |
p. 816
|
artikel
|
| 789 |
BRCA1-Down-Regulation In Chronic Myeloid Leukemia (CML) Occurs Via The Deubiquitinase / Tumor Suppressor BRCA1-Associated Protein 1 (BAP1)
|
Dkhissi, Fatima
|
|
|
122 |
21 |
p. 3813
|
artikel
|
| 790 |
BRD4 Antagonist and Histone Deacetylase Inhibitor: A Novel Synergistic Combination Against Human Acute Myeloid Leukemia (AML) Cells
|
Fiskus, Warren
|
|
|
122 |
21 |
p. 485
|
artikel
|
| 791 |
Breast Implant-Associated Anaplastic Large Cell Lymphoma: Treatment Experience In 53 Patients
|
Hart, Alexandra
|
|
|
122 |
21 |
p. 5089
|
artikel
|
| 792 |
Breast Implant Related Anaplastic Large Cell Lymphoma ALK- (ALCL ALK-) – Case Report
|
Arbelaez, Alejandro
|
|
|
122 |
21 |
p. 5086
|
artikel
|
| 793 |
Brentuximab Vedotin Administered Before, During, and After Multi-Agent Chemotherapy In Patients (pts) With Newly-Diagnosed CD30+ Mature T- and NK-Cell Lymphomas
|
Fanale, Michelle A.
|
|
|
122 |
21 |
p. 4386
|
artikel
|
| 794 |
Brentuximab Vedotin Administered To Platinum-Refractory Transplant Naïve Hodgkin Lymphoma Patients Can Increase The Proportion Achieving FDG-PET Negative Status
|
Onishi, Maika
|
|
|
122 |
21 |
p. 2106
|
artikel
|
| 795 |
Brentuximab Vedotin: A Promising Therapeutic Option In An HIV Patient With Advanced Hodgkin lymphoma and Significant Hyperbilirubinemia From Liver Involvement
|
Georges, Peter
|
|
|
122 |
21 |
p. 5109
|
artikel
|
| 796 |
Brentuximab Vedotin Improves HCT-CI, CR Status, and Peri-Transplant Toxicity In Patients With Relapsed/Refractory Hodgkin Lymphoma Heading To RIC Allo-HCT
|
Chen, Robert
|
|
|
122 |
21 |
p. 3374
|
artikel
|
| 797 |
Bromodomain-Containing Protein 4 (BRD4): A Novel Marker and Drug Target Expressed In Neoplastic Cells In Advanced Mast Cell Neoplasms
|
Wedeh, Ghaith
|
|
|
122 |
21 |
p. 3747
|
artikel
|
| 798 |
Bruton′s Tyrosine Kinase Inhibitor Ibrutinib Interferes With Constitutive and Induced Pre-B Cell Receptor Signaling In B-Cell Acute Lymphoblastic Leukemia
|
Kim, Ekaterina
|
|
|
122 |
21 |
p. 1399
|
artikel
|
| 799 |
B Type Natriuretic Peptide (BNP) Less Than 200 Pg/Ml Represents Good Candidate For High Dose Melphalan and Predicts Longer Survival In Systemic Light Chain Amyloidosis
|
Hayashi, Toshiaki
|
|
|
122 |
21 |
p. 5523
|
artikel
|
| 800 |
Burden Of Illness and Treatment Patterns For Patients With Multiple Myeloma In a US Integrated Healthcare System
|
Rashid, Nazia
|
|
|
122 |
21 |
p. 3228
|
artikel
|
| 801 |
Burden Of Iron Deficiency Anemia In a Bariatric Surgery Population In The United States
|
Knight, Tyler
|
|
|
122 |
21 |
p. 1722
|
artikel
|
| 802 |
Busulfan / Melphalan / Bortezomib (Bu-Mel-Vel) Vs. High Dose Melphalan As Conditioning Regimen For Autologous Hematopoietic Cell Transplantation In Multiple Myeloma (MM)
|
Rodriguez, Tulio E.
|
|
|
122 |
21 |
p. 3357
|
artikel
|
| 803 |
Busulfan Targeted Dose In Hematopoietic Stem Cell Transplantation: The Impact In Toxicity, Sinusoidal Obstructive Syndrome and Survival
|
Esteves, Iracema
|
|
|
122 |
21 |
p. 4584
|
artikel
|
| 804 |
C5a Complement Depletion Suppresses In Vivo B Lymphoma Progression and Enhances Development Of Cellular Anti-Tumor Immune Response
|
Veeramani, Suresh
|
|
|
122 |
21 |
p. 1837
|
artikel
|
| 805 |
Calcineurin Inhibitor-Free GVHD Prophylaxis with Post-Transplant Cyclophosphamide and Brief-Course Sirolimus Results in Low Rates of Non-Relapse Mortality and Chronic GVHD Following Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation (PBSCT)
|
Sanacore, Melissa
|
|
|
122 |
21 |
p. 923
|
artikel
|
| 806 |
Calcium Isotopic Composition and Its Association With Multiple Myeloma Disease Activity
|
Gordon, Gwyneth W.
|
|
|
122 |
21 |
p. 3157
|
artikel
|
| 807 |
California Umbilical Cord Blood Collection Program: Addressing The Diversity Of The National Registry Through Creative Partnerships With Cord Blood Banks and Provision Of High-Quality Cord Blood Units For Research
|
Walker, Jon
|
|
|
122 |
21 |
p. 5441
|
artikel
|
| 808 |
Can Children and Adolescents With Chronic Myelogenous Leukemia Be Cured Without Stem Cell Transplant? A Single Center Experience
|
Giona, Fiorina
|
|
|
122 |
21 |
p. 4033
|
artikel
|
| 809 |
Can Clinical Parameters Predict Bone Marrow Involvement In DLBCL?
|
Baillargeon, Paul
|
|
|
122 |
21 |
p. 5071
|
artikel
|
| 810 |
Cannabidiol - An Innovative Strategy For Graft Versus Host Disease Prevention
|
Yeshurun, Moshe
|
|
|
122 |
21 |
p. 3299
|
artikel
|
| 811 |
Can Polymorphisms In Oxidative Stress Related Genes Be a Risk Factor For CML?
|
Gonçalves, Ana Cristina
|
|
|
122 |
21 |
p. 5156
|
artikel
|
| 812 |
Can “Seven Be The New Ten” - Adoption Of Restrictive Transfusion Strategies In a Community Hospital
|
Singh, Rahul
|
|
|
122 |
21 |
p. 2935
|
artikel
|
| 813 |
Car-Bird [Carfilzomib, Clarithromycin(Biaxin(R)), Lenalidomide/(Revlimid(R)), Dexamethasone) For Newly-Diagnosed Multiple Myeloma
|
Mark, Tomer M
|
|
|
122 |
21 |
p. 3216
|
artikel
|
| 814 |
Carboxyl Terminal Domains Of ADAMTS13 Inhibit The Formation Of Ultra Large VWF Strings and Platelet/Leukocyte Aggregates On Endothelial Cells In Murine Mesenteric Venules Via a Disulfide Bond Reduction Mechanism
|
Bao, Jialing
|
|
|
122 |
21 |
p. 445
|
artikel
|
| 815 |
Cardiac Derived Stromal Cells Inhibit Tumor Cell Proliferation: A Potential Role Of miR206
|
McNiece, Ian K.
|
|
|
122 |
21 |
p. 4861
|
artikel
|
| 816 |
Cardiac Failure In Juvenile Rats Caused By Continuous Long-Term Exposure To The Tyrosine Kinase Inhibitor Dasatinib Can Be Circumvented By An Intermittent Application Schedule
|
Geidel, Paula
|
|
|
122 |
21 |
p. 3984
|
artikel
|
| 817 |
Cardiac Iron Overload In Sickle-Cell Disease
|
Meloni, Antonella
|
|
|
122 |
21 |
p. 1013
|
artikel
|
| 818 |
Cardiac Toxicity Of High Dose Cyclophosphamide Post T Cell Replete HLA Haploidentical Hematopoietic Stem Cell Transplantation
|
Souchet, Laetitia
|
|
|
122 |
21 |
p. 5457
|
artikel
|
| 819 |
Cardiovascular Complications Of Thalassemia Patients In The Iron Chelation Therapy Era
|
Tantiworawit, Adisak
|
|
|
122 |
21 |
p. 5602
|
artikel
|
| 820 |
Cardio-Vascular Events Occurring On Ponatinib In Chronic Phase Chronic Myeloid Leukemia Patients, Preliminary Analysis Of a Multicenter Cohort
|
Nicolini, Franck E.
|
|
|
122 |
21 |
p. 4020
|
artikel
|
| 821 |
Carfilzomib and Bortezomib Containing Regimens Yield High Rates Of MRD Negative Autologous Hematopoietic Progenitor Cell (HPC) Grafts In Multiple Myeloma (MM) and High Risk Smoldering Myeloma (SMM)
|
Tageja, Nishant
|
|
|
122 |
21 |
p. 2030
|
artikel
|
| 822 |
Carfilzomib, a Second-Generation Proteasome Inhibitor, In Combination With The Btk Inhibitor Ibrutinib As a Novel Therapeutic Regimen For Treating Double Hit DLBCL
|
Dominici, Erin M
|
|
|
122 |
21 |
p. 1834
|
artikel
|
| 823 |
Carfilzomib Platform Study Using The LAGκ-1A Multiple Myeloma Xenograft Model
|
Sanchez, Eric
|
|
|
122 |
21 |
p. 4452
|
artikel
|
| 824 |
Carfilzomib PLUS Melphalan and Prednisone (CMP) Is A Promising Combination Therapy For The Treatment Of Elderly Patients With NEWLY Diagnosed Multiple Myeloma: Results Of A PHASE I/II Trial In 68 CASES
|
Moreau, Philippe
|
|
|
122 |
21 |
p. 1933
|
artikel
|
| 825 |
Carfilzomib, Rituximab and Dexamethasone (CaRD) Is Highly Active and Offers a Neuropathy Sparing Approach For Proteasome-Inhibitor Based Therapy In Waldenstrom's Macroglobulinemia
|
Peter Treon, Steven
|
|
|
122 |
21 |
p. 757
|
artikel
|
| 826 |
Case Report: Haploidentical Stem Cell Transplantation In a 78 Year-Old Patient
|
Carneiro, Thiago Xavier
|
|
|
122 |
21 |
p. 5468
|
artikel
|
| 827 |
Case Studies Of Remission In Adults With Immune Thrombocytopenia (ITP) Following Cessation Of Treatment With The TPO Receptor Agonist Romiplostim
|
Bussel, James B.
|
|
|
122 |
21 |
p. 328
|
artikel
|
| 828 |
Catastrophizing and Depression Are Associated With a Poorer Quality Of Life In Pediatric Patients With Sickle Cell Disease
|
Bakshi, Nitya
|
|
|
122 |
21 |
p. 1706
|
artikel
|
| 829 |
Cathecholamines Differently Regulate Human AML and Normal Hematopoietic Progenitor Cell Motility Via miR126 and RGS16
|
Avigdor, Abraham
|
|
|
122 |
21 |
p. 1413
|
artikel
|
| 830 |
Cathelicidin Mediates Anti Lymphoma Cytotoxicity By Human Macrophages
|
Bruns, Heiko
|
|
|
122 |
21 |
p. 3458
|
artikel
|
| 831 |
Causes and Consequences of Cancer-Associated Thrombocytosis
|
Sood, Anil
|
|
|
122 |
21 |
p. SCI-33
|
artikel
|
| 832 |
Caveolin-1 Is Required For T Cell-Mediated Acute GvHD
|
Wohlfeil, Sebastian
|
|
|
122 |
21 |
p. 4461
|
artikel
|
| 833 |
CBFβ/MYH11 Hypomethylation Signature In Patients With Acute Myeloid Leukaemia
|
Hajkova, Hana
|
|
|
122 |
21 |
p. 3774
|
artikel
|
| 834 |
CBL-C137, a Curaxin and Potent Suppressor Of NF-Kb Activity and Modulator Of p53 Function Is Active In Rituximab-Sensitive Or Resistant Activated B-Cell (ABC) Diffuse Large B-Cell Lymphoma (DLBCL) Cells
|
Ibabao, Christopher N.
|
|
|
122 |
21 |
p. 1836
|
artikel
|
| 835 |
CD28 and CD86 Regulate Integrin Surface Expression In Multiple Myeloma
|
Gavile, Catherine M
|
|
|
122 |
21 |
p. 4450
|
artikel
|
| 836 |
CD3 Antibody Treatment Prevents Gvhd and Allows For Rapid, Long Term, Multilineage Engraftment Of Unfractionated UCB Into Immunodeficient Mice
|
Wunderlich, Mark
|
|
|
122 |
21 |
p. 2018
|
artikel
|
| 837 |
CD34+CD38-CD58- Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
|
kong, Yuan
|
|
|
122 |
21 |
p. 354
|
artikel
|
| 838 |
CD166+CD34+ Cells Exhibit Marked Functional Differences During Fetal and Adult Life
|
Mokhtari, Saloomeh
|
|
|
122 |
21 |
p. 2435
|
artikel
|
| 839 |
CD117 (c-kit) Expression On CD34+ Cells Participates In The Cytogenetic Response To Imatinib In CML Patients In First Chronic Phase
|
Dybko, Jaroslaw
|
|
|
122 |
21 |
p. 3990
|
artikel
|
| 840 |
CD56+ Clonal Plasma Cells In Multiple Myeloma Are Associated With Unique Disease Characteristics and Have a Counterpart Of CD56+ Normal Plasma Cells With Increased Maturity
|
Schmidt-Hieber, Martin
|
|
|
122 |
21 |
p. 751
|
artikel
|
| 841 |
CD4+ctla-4+ t Lymphocytes Inversely Correlate With CD4+CD127+ T Cells In Brazilian Patients With Classical Hodgkin Lymphoma
|
Silva, Joyce M.K.
|
|
|
122 |
21 |
p. 4240
|
artikel
|
| 842 |
CD34+CXCR4(CD184)+ Cells Differentiate Into Myeloid Dendritic Cell Progenitors
|
Donahue, Robert E.
|
|
|
122 |
21 |
p. 4835
|
artikel
|
| 843 |
CD1d Expression Is Higher In Chronic Lymphocytic Leukemia Patients With Unfavorable Prognosis
|
Bojarska-Junak, Agnieszka
|
|
|
122 |
21 |
p. 5278
|
artikel
|
| 844 |
CD26+ (dipeptidyl peptidase IV positive) Cells In Harvest Material For Multiple Myeloma Autotransplantation
|
Kopinska, Anna
|
|
|
122 |
21 |
p. 5445
|
artikel
|
| 845 |
CD49d Is The Strongest Flow Cytometry-Based Predictor Of Overall Survival In Chronic Lymphocytic Leukemia
|
Bulian, Pietro
|
|
|
122 |
21 |
p. 672
|
artikel
|
| 846 |
CD161 Expression Identifies a Distinct Subset Of Drug-Effluxing Viral-Specific Memory CD4+ T Cells That Preferentially Survive Cytotoxic Chemotherapy
|
Muharrem Muftuoglu, MD
|
|
|
122 |
21 |
p. 2024
|
artikel
|
| 847 |
CD137 Expression Identifies Leukemia Specific CTL After In Vitro Priming Of Cord Blood T Cells
|
Antony, Jeyaraj
|
|
|
122 |
21 |
p. 3266
|
artikel
|
| 848 |
CD30 Expression Is Associated With Decreased Survival In Patients With Acute and Unfavorable Chronic Types Of Adult T-Cell Leukemia-Lymphoma
|
Campuzano-Zuluaga, German
|
|
|
122 |
21 |
p. 4312
|
artikel
|
| 849 |
CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients
|
Hamada, Yasuko
|
|
|
122 |
21 |
p. 2799
|
artikel
|
| 850 |
CD8+ /ICOS+ /CXCR5+ Tumor Infiltrating T-CELLS (CD8fc) Sharing Functional Similarities With TFH CELLS ARE Present In Classical Hodgkin'S Lymphoma Tissues Displaying A Specific “MIXED NODULARITY” Pattern
|
Le Thi, Suong
|
|
|
122 |
21 |
p. 4233
|
artikel
|
| 851 |
CD30 Immunohistochemical Expression In Diffuse Large B-Cell Lymphoma Is Associated With Decreased Overall Survival and The Non-Germinal Center Molecular Subtype
|
Collie, Angela M.B.
|
|
|
122 |
21 |
p. 4318
|
artikel
|
| 852 |
CD74 Interferes With The Expression Of Fas Receptor On The Cell Surface
|
Berkova, Zuzana
|
|
|
122 |
21 |
p. 4263
|
artikel
|
| 853 |
CD4+ Invariant Natural Killer T Cells Require NKG2D To Protect From Lethal Acute Graft-Versus-Host Disease
|
Schneidawind, Dominik
|
|
|
122 |
21 |
p. 898
|
artikel
|
| 854 |
CD133 Is a Positive Marker Of Human Cord Blood-Derived CD34-Negative Hematopoietic Stem Cells
|
Takahashi, Masaya
|
|
|
122 |
21 |
p. 1177
|
artikel
|
| 855 |
CD99 Is a Therapeutic Target On Disease Stem Cells In Acute Myeloid Leukemia and The Myelodysplastic Syndromes
|
Chung, Stephen S.
|
|
|
122 |
21 |
p. 2891
|
artikel
|
| 856 |
CD8α+ Jagged2high CD11bhigh Regulatory Dendritic Cells Prevent Acute Gvhd
|
Weng, Jianyu
|
|
|
122 |
21 |
p. 5428
|
artikel
|
| 857 |
CD62L Expression Is Associated With Chronic Lymphocytic Leukemia (CLL) Cell Survival In Vitro and Represents a Novel Therapeutic Target In CLL
|
Burgess, Melinda
|
|
|
122 |
21 |
p. 4136
|
artikel
|
| 858 |
CD40-Licensing Of Human Dendritic Cells Further Matures Tnfa-Treated Dcs But Does Not Mediate Resistance Against Inhibition Of T-Cell Proliferation By TREG
|
Eyrich, Matthias
|
|
|
122 |
21 |
p. 4726
|
artikel
|
| 859 |
CD133 Marks a Stem Cell Population That Drives Human Primary Myelofibrosis
|
Triviai, Ioanna
|
|
|
122 |
21 |
p. 1601
|
artikel
|
| 860 |
CD271+ Mesenchymal Stromal Cell Density Is High In Poor-Risk MDS and Independently Predicts Overall Survival
|
Johnson, Ryan C.
|
|
|
122 |
21 |
p. 1560
|
artikel
|
| 861 |
CD44 Monoclonal Antibody-Enhanced Clearance Of Chronic Myeloid Leukemia Stem Cells From The Malignant Niche
|
Hellqvist, Eva
|
|
|
122 |
21 |
p. 858
|
artikel
|
| 862 |
CD57+ NK CELLS ARE Increased In Patients With Multiple Myeloma and ARE Primed Effectors For ADCC, But NOT Natural Cytotoxicty
|
Hsu, Andy K
|
|
|
122 |
21 |
p. 1904
|
artikel
|
| 863 |
CD28 Regulates Metabolism In Multiple Myeloma For Cell Survival and Proliferation
|
Utley, Adam T
|
|
|
122 |
21 |
p. 5400
|
artikel
|
| 864 |
CD34+ Selected Cells For The Treatment Of Poor Graft Function Following Allogeneic Stem Cell Transplantation
|
Stasia, Alessandra
|
|
|
122 |
21 |
p. 3306
|
artikel
|
| 865 |
CD34-Selected, T Cell-Depleted Alternative Donor Stem Cell Transplantation For Children
|
Gilman, Andrew
|
|
|
122 |
21 |
p. 2064
|
artikel
|
| 866 |
CD20-Specific Engineered Toxin Body Demonstrates Direct Cell Kill Of Multiple B-Cell Non-Hodgkin's Lymphoma Types
|
Rajagopalan, Sangeetha
|
|
|
122 |
21 |
p. 5152
|
artikel
|
| 867 |
CD22-Targeted Chimeric Antigen Receptor (CAR) T Cells Containing The 4-1BB Costimulatory Domain Demonstrate Enhanced Persistence and Superior Efficacy Against B-Cell Precursor Acute Lymphoblastic Leukemia (ALL) Compared To Those Containing CD28
|
Haso, Waleed
|
|
|
122 |
21 |
p. 1431
|
artikel
|
| 868 |
CD38-Targeted Immunochemotherapy Of Multiple Myeloma: Preclinical Evidence For Its Combinatorial Use In Lenalidomide and Bortezomib Refractory/Intolerant MM Patients
|
Nijhof, Inger S.
|
|
|
122 |
21 |
p. 277
|
artikel
|
| 869 |
CD4+ T Cell Functions Are Potently Suppressed By The Janus Kinase 1/2 (JAK1/JAK2) Inhibitor Ruxolitinib
|
Yajnanarayana, Sowmya Parampalli
|
|
|
122 |
21 |
p. 2281
|
artikel
|
| 870 |
CD8+ T Cells Are Predominantly Protective In a Murine Model Of ITP and Is Required For Effective Steroid Therapy
|
Ma, Li
|
|
|
122 |
21 |
p. 1076
|
artikel
|
| 871 |
CD8+ Treg - From Mouse To Man
|
Holderried, Tobias A.W.
|
|
|
122 |
21 |
p. 3474
|
artikel
|
| 872 |
CD44v6 Is Required For In Vivo Tumorigenesis Of Human AML and MM Cells: Role Of Microenvironmental Signals and Therapeutic Implications
|
Nicolis di Robilant, Benedetta
|
|
|
122 |
21 |
p. 605
|
artikel
|
| 873 |
CDX2 regulates Human Leukemogenesis Via Modulation Of The Wnt-Signaling Pathway
|
Paczulla, Anna
|
|
|
122 |
21 |
p. 3746
|
artikel
|
| 874 |
CEBPA Gene Different Mutants Play Distinct Impacts On Tumor Suppressor Function Of C/EBP-Alpha and Bone Marrow Stromal Cells
|
Xiao, Haowen
|
|
|
122 |
21 |
p. 2519
|
artikel
|
| 875 |
C/EBPβ expressed By Bone Marrow Mesenchymal Stromal Cells Is Indispensable For Precursor B-Cell Lymphopoiesis
|
Yoshioka, Satoshi
|
|
|
122 |
21 |
p. 1213
|
artikel
|
| 876 |
Cell Cycle Deregulation Determines Acute Transformation In Chronic Type Adult T-Cell Leukemia/Lymphoma
|
Yoshida, Noriaki
|
|
|
122 |
21 |
p. 845
|
artikel
|
| 877 |
Cell Cycle Gene Sets Coordination In Multiple Myeloma and Plasma Cell Leukemia
|
Kryukov, Fedor
|
|
|
122 |
21 |
p. 1901
|
artikel
|
| 878 |
Cell-Intrinsic and Cell-Extrinsic Involvement Of C/EBPβ In The Regulation Of Hematopoietic Stem Cells
|
Tamura, Akihiro
|
|
|
122 |
21 |
p. 1202
|
artikel
|
| 879 |
Cell Non-Autonomous Modulation Of Tumor Cell Responses To Pharmacological Inhibition Of The Proteasome
|
Dhimolea, Eugen
|
|
|
122 |
21 |
p. 4454
|
artikel
|
| 880 |
Cell Of Origin Does Not Affect Outcomes In Early Stage Non-Bulky Diffuse Large B-Cell Lymphoma Treated With Short-Course Combined Modality Therapy
|
Lunning, Matthew A.
|
|
|
122 |
21 |
p. 3017
|
artikel
|
| 881 |
Cell Sorting Enables iFISH Detection Of Low BCR-ABL Producing Stem Cells In CML Patients Beyond Deep Molecular Remission
|
van Kooten Niekerk, Peter Buur
|
|
|
122 |
21 |
p. 1501
|
artikel
|
| 882 |
Cellular Immune Responses To Vector In a Gene Therapy Trial For Hemophilia B Using An AAV8 Self-Complementary Factor IX Vector
|
Basner-Tschakarjan, Etiena
|
|
|
122 |
21 |
p. 717
|
artikel
|
| 883 |
Cellular Intrinsic Mechanism Affecting The Outcome Of AML Treatment With Ara-C In a Syngeneic Mouse Model
|
Chen, Zheng
|
|
|
122 |
21 |
p. 5025
|
artikel
|
| 884 |
Cellular Mechanisms For Transferrin Receptor Endocytosis Vital For Terminal Erythroid Differentiation
|
Ishikawa, Yuichi
|
|
|
122 |
21 |
p. 3434
|
artikel
|
| 885 |
Center Experience and Calendar Year Of Transplantation Strongly Influence Short Term Survival After Autologous Peripheral Blood Transplantation In 1315 Patients With Light Chain Amyloidosis: An EBMT Analysis
|
Schonland, Stefan O
|
|
|
122 |
21 |
p. 417
|
artikel
|
| 886 |
Central Memory T Cells That Express High Level Of CD44 Mediate Strong Anti-Tumor Response Without Gvhd
|
Mo, Wenjian
|
|
|
122 |
21 |
p. 293
|
artikel
|
| 887 |
Central Nervous System Complications After Allogeneic Hematopoietic Cell Transplantation – Treatment Related Morbidity, Toxicity, Graft Versus Host Disease Or New Autoimmunity
|
Simon, Christoph
|
|
|
122 |
21 |
p. 2069
|
artikel
|
| 888 |
Central Nervous System Relapse In Adults With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
|
Hamdi, Amir
|
|
|
122 |
21 |
p. 3311
|
artikel
|
| 889 |
Cereblon (CRBN) Splicing Could Influence Response To IMiDs : A New PCR Strategy to Easily Detect and Semi-Quantify Loss Of The IMiDs Binding Domain
|
Ménard, Audrey
|
|
|
122 |
21 |
p. 3107
|
artikel
|
| 890 |
Cerebral Blood Flow and Oxygen Delivery In Response To Hyperoxia In Sickle Cell Anemia
|
Bush, Adam M
|
|
|
122 |
21 |
p. 2210
|
artikel
|
| 891 |
Cerebral Small Vessel Disease In Patients With Sickle Cell Disease: Initial Findings With Ultra-High Field 7T MRI
|
der Land, Veronica van
|
|
|
122 |
21 |
p. 1011
|
artikel
|
| 892 |
Cerebral Vein Thrombosis In Patients With Myeloproliferative Neoplasms
|
Martinelli, Ida
|
|
|
122 |
21 |
p. 4068
|
artikel
|
| 893 |
Cerebrospinal Fluid Correlates Of L-Asparaginase-Related Thrombotic Events
|
Priola, Ginna M
|
|
|
122 |
21 |
p. 3876
|
artikel
|
| 894 |
ceRNAs and ceRNA Networks in Normal and Malignant Hematopoiesis and Their Therapeutic Implications
|
Pandolfi, Pier Paolo
|
|
|
122 |
21 |
p. SCI-30
|
artikel
|
| 895 |
Cflar Genetic Variant Resulting In Alternate Splicing Determines Isoform Specific Production Of H-Cflar Protein and Is Predictive Of Cellular Cytoxicity Of Triptolide In Hapmap Lymphoblast and AML Cell Lines
|
Chauhan, Lata
|
|
|
122 |
21 |
p. 1287
|
artikel
|
| 896 |
Challenging Dogmas - Or How Much Evidence Is Necessary To Claim That There Is a Direct Developmental and Functional Link Between The Primordial Germ Cell (PGC) Lineage and Hematopoiesis?
|
Kucia, Magdalena
|
|
|
122 |
21 |
p. 1215
|
artikel
|
| 897 |
Change In Albumin Levels During Induction Predicts Survival Outcomes In Adult Acute Lymphoblastic Leukemia
|
Komatsubara, Kimberly
|
|
|
122 |
21 |
p. 1403
|
artikel
|
| 898 |
Change In Flow Mediated Dilation After Transfusion Is Dependent On BMI and Blood Age
|
Detterich, Jon A
|
|
|
122 |
21 |
p. 3653
|
artikel
|
| 899 |
Changes In Cell-Derived Plasma Microparticles During The Acute Chest Syndrome In Children With Sickle Cell Disease
|
McKinney, Christopher M
|
|
|
122 |
21 |
p. 2239
|
artikel
|
| 900 |
Changes In The Use Of Radiation Therapy Among Adolescents and Young Adults With Early Stage Classical Hodgkin Lymphoma: Implications For Survival and Risk Of Secondary Malignancies
|
Xavier, Ana
|
|
|
122 |
21 |
p. 722
|
artikel
|
| 901 |
Changes Of Coagulation Activation Parameters After Discontinuation Of VTE Treatment With Vitamin-K Antagonists, Apixaban, Rivaroxaban Or Dabigatran and Impact On Clinical Outcome After 12 Months
|
Werth, Sebastian
|
|
|
122 |
21 |
p. 3647
|
artikel
|
| 902 |
Changes Of Coagulation Parameters During The Menstrual Cycle
|
Halimeh, Susan
|
|
|
122 |
21 |
p. 4785
|
artikel
|
| 903 |
Changing Epidemiology and Improved Survival In Patients With Waldenstrom Macroglobulinemia: Review Of Surveillance, Epidemiology, and End Results (SEER) Data
|
Nelson, Sydney
|
|
|
122 |
21 |
p. 3135
|
artikel
|
| 904 |
Changing The Treatment Paradigm For Previously Treated Chronic Lymphocytic Leukemia Patients With Del(17p) Karyotype
|
Stephens, Deborah M
|
|
|
122 |
21 |
p. 2872
|
artikel
|
| 905 |
Characteristics and Outcome Of Acute Myeloid Leukemia Following Breast Cancer: Analysis Of 408 Cases and Controls
|
Gilabert, Marine
|
|
|
122 |
21 |
p. 1408
|
artikel
|
| 906 |
Characteristics and Outcome Of Children and Young Adults With Early T-Precusor (ETP) ALL Treated On UKALL 2003
|
Patrick, Katharine
|
|
|
122 |
21 |
p. 58
|
artikel
|
| 907 |
Characteristics and Outcome Of Multiple Myeloma (MM) In African Americans (AA) Receiving Novel Agents and Autologous Stem Cell Transplantation (ASCT)
|
Bhatnagar, Vishal
|
|
|
122 |
21 |
p. 2951
|
artikel
|
| 908 |
Characteristics and Outcome Of Myelodysplastic Syndromes (MDS) Patients With Autoimmune Diseases
|
Komrokji, Rami S
|
|
|
122 |
21 |
p. 746
|
artikel
|
| 909 |
Characteristics and Outcome Of 66 Patients With Extramedullary Plasmacytomas (EMPs) Included In a Phase III Pethema/GEM Study Of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma (MM)
|
Rosiñol, Laura
|
|
|
122 |
21 |
p. 3188
|
artikel
|
| 910 |
Characteristics and Outcomes Of Patients (pts) With Multiple Myeloma (MM) Who Develop Therapy (t)-Related Myelodysplastic Syndrome (MDS), t-Chronic Myelomonocytic Leukemia (CMML), Or t-Acute Myeloid Leukemia (AML)
|
Pemmaraju, Naveen
|
|
|
122 |
21 |
p. 1424
|
artikel
|
| 911 |
Characteristics and Outcomes Of Patients With Down Syndrome Associated Acute Lymphoblastic Leukaemia Treated On UKALL 2003
|
Patrick, Katharine
|
|
|
122 |
21 |
p. 56
|
artikel
|
| 912 |
Characteristics and Prognosis Of IgM Multiple Myeloma
|
Atrash, Shebli
|
|
|
122 |
21 |
p. 1881
|
artikel
|
| 913 |
Characteristics Associated With Transfusion Reaction Alerts At An Academic Medical Center
|
Henegan, John Clark
|
|
|
122 |
21 |
p. 4831
|
artikel
|
| 914 |
Characteristics Of 1455 Brazilian Lymphoma Patients Enrolled In Abrale (Brazilian Leukemia and Lymphoma Patients association)
|
Perini, Guilherme Fleury
|
|
|
122 |
21 |
p. 5616
|
artikel
|
| 915 |
Characteristics Of Chronic Lymphocytic Leukemia (CLL) In Senegal. Clinical Features, Cytology, Immunophenotype, Cytogenetic Abnormalities and Altered Expression Of Micro-RNA
|
Fall, Abibatou Sall
|
|
|
122 |
21 |
p. 5283
|
artikel
|
| 916 |
Characteristics Of Multiple Myeloma Patients With 6-Year Or Longer Progression-Free Survival After a Single Autologous Transplant
|
Adekola, Kehinde U.A.
|
|
|
122 |
21 |
p. 3366
|
artikel
|
| 917 |
Characteristics Of Paroxysmal Nocturnal Hemoglobinuria Clones In Colombian Patients
|
Londoño, Mónica
|
|
|
122 |
21 |
p. 4869
|
artikel
|
| 918 |
Characteristics Of Patients Included In The Myelofibrosis Real-World Practice-Based Network Research (ENRiCH) Data Platform
|
Hess, Gregory
|
|
|
122 |
21 |
p. 1580
|
artikel
|
| 919 |
Characterization and Quantification Of Rare BCR-ABL1 Fusion Transcripts
|
Schnittger, Susanne
|
|
|
122 |
21 |
p. 4013
|
artikel
|
| 920 |
Characterization Of An Acquired IgG Autoantibody To Bβ and γ Chains Of Fibrinogen Resulting In Delayed Fibrin Polymerization and Severe Bleeding
|
Lulla, Premal
|
|
|
122 |
21 |
p. 2362
|
artikel
|
| 921 |
Characterization Of a New Recombinant Human Factor VIIa (LR769)
|
Jerry, Grandoni
|
|
|
122 |
21 |
p. 3583
|
artikel
|
| 922 |
Characterization Of a Novel In Vitro Circulation System Designed To Model The Migration Of Primary CLL Cells Across The Vascular Endothelium
|
Walsby, Elisabeth J
|
|
|
122 |
21 |
p. 667
|
artikel
|
| 923 |
Characterization Of a Weakly Expressed KIR2DL1 Allele
|
Li, Hongchuan
|
|
|
122 |
21 |
p. 4847
|
artikel
|
| 924 |
Characterization Of Bone Marrow Derived CD34+ Cells With Different Mobility Potentials By Micro RNA Fingerprinting
|
Warbington, Blake
|
|
|
122 |
21 |
p. 4844
|
artikel
|
| 925 |
Characterization Of Chromatin Dynamics In Mammalian Erythropoiesis
|
Zhao, Baobing
|
|
|
122 |
21 |
p. 2434
|
artikel
|
| 926 |
Characterization Of Common Blood Test Abnormalities Potentially Aiding Diagnosis Of Mast Cell Activation Syndrome: A Preliminary Analysis
|
Afrin, Lawrence B
|
|
|
122 |
21 |
p. 5240
|
artikel
|
| 927 |
Characterization Of FLT3/ITD Resistant Cells and Identification Of Novel Therapeutic Targets Utilizing High Throughput Drug Screening
|
Tarlock, Katherine
|
|
|
122 |
21 |
p. 2522
|
artikel
|
| 928 |
Characterization Of Full-Length, Recombinant Amsh, USP9x, and USP1: Clinically-Relevant Deubiquitinases Involved In Hematological Malignancies
|
Russell, Nate
|
|
|
122 |
21 |
p. 4224
|
artikel
|
| 929 |
Characterization Of Genes and Pathways From The Comparison Between Bone Marrow B Cells As Well As Plasma Cells Of Waldenström Macroglobulinemia (WM) Vs. IgM Monoclonal Gammopathy Of Undetermined Significance (IgM-MGUS) Vs. Healthy Subjects Using Gene Profiling
|
Trojani, Alessandra
|
|
|
122 |
21 |
p. 3772
|
artikel
|
| 930 |
Characterization Of In Vitro Hdm2 E3 Ubiquitin Ligase-Mediated p53 Ubiquitination
|
Brasher, Bradley B
|
|
|
122 |
21 |
p. 4903
|
artikel
|
| 931 |
Characterization Of Leukemic Stem Cells In AML Cell Lines Using ALDH Staining
|
Lira Benício, Mariana Tereza
|
|
|
122 |
21 |
p. 5409
|
artikel
|
| 932 |
Characterization of lincRNA BALIR-6 in MLL rearranged B-lymphoblastic leukemia
|
Rodriguez-Malave, Norma Iris
|
|
|
122 |
21 |
p. 3730
|
artikel
|
| 933 |
Characterization Of Oncogenes On Chromosome 21 Identified By shRNA-Based Viability Screening
|
Stachorski, Lena
|
|
|
122 |
21 |
p. 1201
|
artikel
|
| 934 |
Characterization Of Pulmonary Compliance In Sickle Cell Patients Revealed Wide Variability
|
Mian, Hira S.
|
|
|
122 |
21 |
p. 989
|
artikel
|
| 935 |
Characterization Of RING Finger E3-Ubiquitin Ligase Cereblon In Hematopoietic Regulation
|
Han, Ying
|
|
|
122 |
21 |
p. 1207
|
artikel
|
| 936 |
Characterization Of Splenic Fibroblasts From Patients With Myelofibrosis
|
Wang, Xiaoli
|
|
|
122 |
21 |
p. 4107
|
artikel
|
| 937 |
Characterization Of T Follicular Helper Cells In Patients With Low Risk Myelodysplastic Syndromes
|
Lampropoulou, Polyxeni
|
|
|
122 |
21 |
p. 4729
|
artikel
|
| 938 |
Characterization Of The Effects Of Mutated EZH2 On Expression and Epigenome In a Mouse Lymphoma Model
|
Berg, Tobias
|
|
|
122 |
21 |
p. 346
|
artikel
|
| 939 |
Characterization Of The HLA Class II Ligandome In Acute Myeloid Leukemia (AML) Reveals Novel Candidates For Peptide-Based Immunotherapy
|
Stickel, Juliane S.
|
|
|
122 |
21 |
p. 5012
|
artikel
|
| 940 |
Characterization Of The Immature Platelet Fraction (IPF) Parameters In Children With Immune Thrombocytopenia
|
Ghemlas, Ibrahim A.
|
|
|
122 |
21 |
p. 3547
|
artikel
|
| 941 |
Characterization Of Von Willebrand Factor Splice Variants From Exonic & Intronic Splicing Mutations
|
Hawke, Lindsey G.
|
|
|
122 |
21 |
p. 1069
|
artikel
|
| 942 |
Characterizing The CpG Methylation Of Epstein-Barr Virus DNA In The Plasma Of Patients With Hodgkin Lymphoma and HIV-Associated Burkitt Lymphoma
|
Kanakry, Jennifer A.
|
|
|
122 |
21 |
p. 4232
|
artikel
|
| 943 |
Charlson Comorbidity Index (CCI) and Hematopoietic Cell Transplantation Specific-Comorbidity Index (HCT-CI) Do Not Predict Transplant Related Mortality (TRM) and Post-Transplant Outcomes In Young Patients Undergoing Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation
|
Paun, Oana V.
|
|
|
122 |
21 |
p. 4582
|
artikel
|
| 944 |
Chemo-Immunotherapy Combination Of Idelalisib With Bendamustine/Rituximab Or Chlorambucil/Rituximab In Patients With Relapsed/Refractory CLL Demonstrates Efficacy and Tolerability
|
Barrientos, Jacqueline C.
|
|
|
122 |
21 |
p. 4176
|
artikel
|
| 945 |
Chemoimmunotherapy With Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Bendamustine and Rituximab (BR) In Previously Untreated and Physically Fit Patients (pts) With Advanced Chronic Lymphocytic Leukemia (CLL): Results Of a Planned Interim Analysis Of The CLL10 Trial, An International, Randomized Study Of The German CLL Study Group (GCLLSG)
|
Eichhorst, Barbara
|
|
|
122 |
21 |
p. 526
|
artikel
|
| 946 |
Chemo-Immunotherapy With Hyper-CVAD/MA and Rituximab For B-Cell Lymphomas Leads To Prolonged Immune Suppression Compared To Conventional Treatment With R-CHOP
|
Matsuki, Eri
|
|
|
122 |
21 |
p. 1800
|
artikel
|
| 947 |
Chemosensitization and Mobilization Of AML/ALL/MDS With Plerixafor (AMD 3100), a CXCR4 Antagonist: A Phase I Study Of Plerixafor + Cytarabine and Etoposide In Pediatric Patients With Acute Leukemia and MDS
|
Cooper, Todd Michael
|
|
|
122 |
21 |
p. 2680
|
artikel
|
| 948 |
Chemotherapy Dose Adjustment For Obese Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Survey On Behalf Of The ALWP Of The EBMT
|
Shem-Tov, Noga
|
|
|
122 |
21 |
p. 4535
|
artikel
|
| 949 |
Chemotherapy-Induced Oral Mucositis: 11 SNPs Implicated In GWAS Of 972 Patients With Multiple Myeloma
|
Coleman, Elizabeth Ann
|
|
|
122 |
21 |
p. 3316
|
artikel
|
| 950 |
Chemotherapy With Infusion Related HLA-Mismatched Hematopoietic Stem Cells For Hematologic Malignancies: A Novel Therapeutic Strategy
|
Fu, Li
|
|
|
122 |
21 |
p. 5437
|
artikel
|
| 951 |
Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019 cells) Have Long-Term Persistence and Induce Durable Responses In Relapsed, Refractory CLL
|
Porter, David L.
|
|
|
122 |
21 |
p. 4162
|
artikel
|
| 952 |
Chimerism and Tolerance Without Gvhd In Mismatched Recipients Of Combined Hematopoietic Stem Cell/Kidney Transplants: Donor-Specific Hyporeactivity Is Not a Reliable Biomarker For Tolerance
|
Leventhal, Joseph
|
|
|
122 |
21 |
p. 912
|
artikel
|
| 953 |
Chimerism Induction Without GVHD Following Low Intensity Conditioning In MHC Disparate Recipients: Combining The Benefit Of Cyclophosphamide Post Transplant With The Tolerogenicity Of Megadose T Cell Depleted HSCT
|
Bachar-Lustig, Esther
|
|
|
122 |
21 |
p. 3238
|
artikel
|
| 954 |
Cholesterol Levels In Patients With Newly Diagnosed Chronic Lymphocytic Leukemia: A retrospective Multicenter Study
|
Yavasoglu, Irfan
|
|
|
122 |
21 |
p. 5292
|
artikel
|
| 955 |
CHOP/CHOP-Like-14 Vs. CHOP/CHOP-Like-21 For Patients With Aggressive Lymphoma – a Systematic Review and Meta-Analysis Of Randomized Controlled Trials
|
Vidal, Liat
|
|
|
122 |
21 |
p. 1798
|
artikel
|
| 956 |
CHOP-R and High-Dose Methotrexate In The Primary CNS Lymphoma Revisited. 10-Year Experience and 92 Patients From a Single Institution
|
Ostrowska, Beata
|
|
|
122 |
21 |
p. 3051
|
artikel
|
| 957 |
Chromatin Remodeling Enzyme CHD7 Negatively Regulate Hematopoietic Stem Cell Function
|
Hsu, Jingmei
|
|
|
122 |
21 |
p. 2413
|
artikel
|
| 958 |
Chromatographic Separation Of Fetal and Adult Hemoglobins For Nitric Oxide Quantification In Term Human Umbilical Cord Blood
|
Riccio, Daniel A.
|
|
|
122 |
21 |
p. 2192
|
artikel
|
| 959 |
Chromosomal Instability: A Probable Unfavorable Prognostic Factor For Patients Of Myeloidysplastic Syndromes
|
Xiao, Yajuan
|
|
|
122 |
21 |
p. 5243
|
artikel
|
| 960 |
Chromosome Instability Underlies Stem Cell Dysfunction and Neoplasia In Widespread Hematologic Disease Induced By Deregulated Cyclin E
|
Siu, Ka Tat
|
|
|
122 |
21 |
p. 220
|
artikel
|
| 961 |
Chromosome 1q21 Gains Confer Inferior Outcomes In Multiple Myeloma Treated With Bortezomib But Copy Number Variation and Percentage Of Plasma Cells Involved Have No Additional Prognostic Value
|
An, Gang
|
|
|
122 |
21 |
p. 1992
|
artikel
|
| 962 |
Chromosome 7q Hemizygosity Recapitulates MDS-Related Cellular Phenotypes In Genetically Engineered Human Pluripotent Stem Cells
|
Kotini, Andriana
|
|
|
122 |
21 |
p. 862
|
artikel
|
| 963 |
Chromosome 16q Located Genes CDH1, CDH13 and ADAMTS18 Are Correlated and Frequently Methylated But Not Associated With DNMTs levels In Human Lymphoma
|
Alkebsi, Lobna A
|
|
|
122 |
21 |
p. 4289
|
artikel
|
| 964 |
Chromothripsis-Mediated Structural Variations and Clonal Evolution In Recurrent Childhood High Hyperdiploid Acute Lymphoblastic Leukemia
|
Chen, Cai
|
|
|
122 |
21 |
p. 233
|
artikel
|
| 965 |
Chronic Graft Vs Host Disease Is The Strongest Predictor Of Outcome After Reduced Intensity Conditioning Stem Cell Transplantation In Chronic Lymphocytic Leukemia and Is Associated With Pretransplant B Cell Characteristics
|
Sirop Kenderian, Saad
|
|
|
122 |
21 |
p. 3375
|
artikel
|
| 966 |
Chronic Granulomatous Disease In Patients Reaching Adulthood: A Nationwide Retrospective Study Of 80 Cases In France
|
Dunogué, Bertrand
|
|
|
122 |
21 |
p. 1028
|
artikel
|
| 967 |
Chronic Idiopathic Neutropenia In Adults: Clinical Features In a 4-Year Prospective Study
|
Fattizzo, Bruno
|
|
|
122 |
21 |
p. 1026
|
artikel
|
| 968 |
Chronic Infection, a Neglected Cause Of Development Of Monoclonal Gammopathy Of Undetermined Significance (MGUS) and Myeloma
|
Feron, Delphine
|
|
|
122 |
21 |
p. 3116
|
artikel
|
| 969 |
Chronic Lymphocytic Leukemia Cells With Trisomy 12 Home To The Bone Marrow In a CXCR4-Independent Manner and Are Prone To Proliferate In Vitro
|
Hutterer, Evelyn
|
|
|
122 |
21 |
p. 870
|
artikel
|
| 970 |
Chronic Lymphocytic Leukemia-Derived Exosomes Stimulate Cells From The Microenvironment
|
Paggetti, Jerome
|
|
|
122 |
21 |
p. 3683
|
artikel
|
| 971 |
Chronic Myeloid Leukaemia Patients Treated In Teaching Hospitals Seem To Have a Survival Advantage Compared To Other Settings
|
Lauseker, Michael
|
|
|
122 |
21 |
p. 3997
|
artikel
|
| 972 |
Chronic Myeloid Leukemia After Adjuvant Treatment For Breast Cancer: Is It Therapy Related?
|
Kishtagari, Ashwin
|
|
|
122 |
21 |
p. 2740
|
artikel
|
| 973 |
Chronic Myeloid Leukemia: Clinical and Laboratory Features At Presentation To a Referral Hospital In Southern Nigeria
|
Korubo, Kaladada I.
|
|
|
122 |
21 |
p. 5174
|
artikel
|
| 974 |
Chronic Myeloid Leukemia (CML) Patients With Atypical e1a2 P190 BCR-ABL Translocation Show a Poor Response To Therapy With Tyrosine Kinase Inhibitors (TKI)
|
Montoriol-Sabaté, Carme
|
|
|
122 |
21 |
p. 5193
|
artikel
|
| 975 |
Chronic Myeloid Leukemia Patients In Tunisia: Epidemiology and Outcome In The Imatinib Era (A Multicentric Experience)
|
Ben Lakhal, Raihane
|
|
|
122 |
21 |
p. 4037
|
artikel
|
| 976 |
Chronic Myelomonocytic Leukemia With Preexisting Myelodysplastic Syndrome Or Myeloproliferative Neoplasm: Two Stages Of One Disease With Poor Prognosis
|
Xu, Yin
|
|
|
122 |
21 |
p. 1342
|
artikel
|
| 977 |
Chronic Neutrophilic Leukemia With Concurrent CSF3R and SETBP1 Mutations: Single Colony Clonality Studies, In Vitro Sensitivity To JAK Inhibitors and Lack Of Treatment Response To Ruxolitinib
|
Lasho, Terra L
|
|
|
122 |
21 |
p. 2830
|
artikel
|
| 978 |
Chronic Relapsing Remitting Sweet's Syndrome- a Harbinger Of Myelodysplastic Syndrome (MDS), Single Centre Analysis Of 31 Patients
|
Kulasekararaj, Austin G
|
|
|
122 |
21 |
p. 2793
|
artikel
|
| 979 |
Cidofovir Treatmenf For Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation For High Risk Hematological Malignancies
|
Crucitti, Lara
|
|
|
122 |
21 |
p. 4557
|
artikel
|
| 980 |
Cigarette Smoking Is An Under Recognised Cause Of Macrocytosis
|
O'Reilly, Maeve A
|
|
|
122 |
21 |
p. 4660
|
artikel
|
| 981 |
Circulating Endothelial Cells As a Reliable Marker Of Endothelial Damage In Children Undergoing Hematopoietic Stem Cell Transplantation
|
Touzot, Fabien
|
|
|
122 |
21 |
p. 2049
|
artikel
|
| 982 |
Circulating Endothelial Cells Enumeration Is a Helpful Tool In The Diagnosis Of GvHD In Patients Undergoing Allogeneic Hematopoietic Stem Cells Transplantation
|
Almici, Camillo
|
|
|
122 |
21 |
p. 2068
|
artikel
|
| 983 |
Circulating microRNA 483-5p in multiple myeloma as a novel biomarker for diagnosis and predicting survival
|
Xiaoyan, Qu
|
|
|
122 |
21 |
p. 5343
|
artikel
|
| 984 |
Circulating Mir-16 and Mir-25 As New Prognosticators For Multiple Myeloma
|
Pichiorri, Flavia
|
|
|
122 |
21 |
p. 1853
|
artikel
|
| 985 |
Circulating Periostin Is Elevated In Patients With Hemoglobinopathies and Correlates With Bone Mineral Density In Double Heterozygous Sickle-Cell/Beta-Thalassemia Patients; A Novel Marker Of Bone Strength?
|
Voskaridou, Ersi
|
|
|
122 |
21 |
p. 3445
|
artikel
|
| 986 |
Circulating Plasma Cells By Routine Complete Blood Count Identify Patients With Similar Outcome As Plasma Cell Leukemia
|
Shah, Rupin A
|
|
|
122 |
21 |
p. 5356
|
artikel
|
| 987 |
Circulating t(14;18)+ Cells As Predictive Markers Of Follicular Lymphoma Development
|
Roulland, Sandrine
|
|
|
122 |
21 |
p. 364
|
artikel
|
| 988 |
Circulatory Glycan-Modifying Enzymes As Systemic Regulators In Blood Cell Development
|
Lau, Joseph
|
|
|
122 |
21 |
p. 3686
|
artikel
|
| 989 |
Cirmtuzumab Vedotin (UC-961ADC3), An Anti-ROR1-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment For ROR1-Positive Leukemia and Solid Tumors
|
Cui, Bing
|
|
|
122 |
21 |
p. 1637
|
artikel
|
| 990 |
Cisplatin Fails To Stimulate Production Of Reactive Oxygen Species and Release Of Neutrophil Extracellular Traps By Human Neutrophils In Vitro
|
Pasalic, Leonardo
|
|
|
122 |
21 |
p. 4714
|
artikel
|
| 991 |
CITED2 Facilitates Apoptosis Induced By Histone Deacetylase Inhibitor SAHA In Human Pediatric Pre-B Acute Lymphoblastic Leukemia Cells
|
Du, Jinwei
|
|
|
122 |
21 |
p. 2913
|
artikel
|
| 992 |
Cited2 Is Required For The Maintenance Of Glycolytic Metabolism In Adult Hematopoietic Stem Cells
|
Du, Jinwei
|
|
|
122 |
21 |
p. 794
|
artikel
|
| 993 |
Citrate Synthase Activity Is Increased In Children With Sickle Cell Disease (SCD) On Hydroxyurea (HU) Therapy
|
Morris, Claudia R.
|
|
|
122 |
21 |
p. 4690
|
artikel
|
| 994 |
Clapd (Clarithromycin, Pomalidomide, Dexamethasone) Therapy In Relapsed Or Refractory Multiple Myeloma
|
Mark, Tomer M
|
|
|
122 |
21 |
p. 1955
|
artikel
|
| 995 |
Classification Of Acute Myelogenous Leukemia (AML) Based On Functionally Related Proteins Groups
|
Kornblau, Steven M.
|
|
|
122 |
21 |
p. 492
|
artikel
|
| 996 |
Class I/II Histone Deacetylase Inhibitors Are a Potential Therapeutic For Notch-1 Driven T Cell Acute Lymphoblastic Leukemia
|
Waibel, Michaela
|
|
|
122 |
21 |
p. 1435
|
artikel
|
| 997 |
Class I PI3K Isoforms Exert a Differential Role On Survival and Cell Trafficking In Multiple Myeloma
|
Sahin, Ilyas
|
|
|
122 |
21 |
p. 3159
|
artikel
|
| 998 |
Clinical Activity Of Idelalisib (GS-1101), a Selective Inhibitor Of PI3Kδ, In Phase 1 and 2 Trials In Chronic Lymphocytic Leukemia (CLL): Effect Of Del(17p)/TP53 Mutation, Del(11q), IGHV Mutation, and NOTCH1 Mutation
|
Coutre, Steven E.
|
|
|
122 |
21 |
p. 1632
|
artikel
|
| 999 |
Clinical Analysis Of 120 Cases Of Natural Killer/T Cell Lymphoma, Nasal Type By Single Hospital In The North-Western China
|
Liang, Rong
|
|
|
122 |
21 |
p. 5111
|
artikel
|
| 1000 |
Clinical and Biological Features Of Monoclonal B-Cell Lymphocytosis In Patients Referred To Hospital
|
Rodriguez-Hernandez, Ines
|
|
|
122 |
21 |
p. 5298
|
artikel
|
Tijdschrift beschrijving